1
|
Mathias SR, Knowles EEM, Mollon J, Rodrigue AL, Woolsey MK, Hernandez AM, Garret AS, Fox PT, Olvera RL, Peralta JM, Kumar S, Göring HHH, Duggirala R, Curran JE, Blangero J, Glahn DC. Cocktail-party listening and cognitive abilities show strong pleiotropy. Front Neurol 2023; 14:1071766. [PMID: 36970519 PMCID: PMC10035755 DOI: 10.3389/fneur.2023.1071766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2022] [Accepted: 02/21/2023] [Indexed: 03/11/2023] Open
Abstract
Introduction The cocktail-party problem refers to the difficulty listeners face when trying to attend to relevant sounds that are mixed with irrelevant ones. Previous studies have shown that solving these problems relies on perceptual as well as cognitive processes. Previously, we showed that speech-reception thresholds (SRTs) on a cocktail-party listening task were influenced by genetic factors. Here, we estimated the degree to which these genetic factors overlapped with those influencing cognitive abilities. Methods We measured SRTs and hearing thresholds (HTs) in 493 listeners, who ranged in age from 18 to 91 years old. The same individuals completed a cognitive test battery comprising 18 measures of various cognitive domains. Individuals belonged to large extended pedigrees, which allowed us to use variance component models to estimate the narrow-sense heritability of each trait, followed by phenotypic and genetic correlations between pairs of traits. Results All traits were heritable. The phenotypic and genetic correlations between SRTs and HTs were modest, and only the phenotypic correlation was significant. By contrast, all genetic SRT-cognition correlations were strong and significantly different from 0. For some of these genetic correlations, the hypothesis of complete pleiotropy could not be rejected. Discussion Overall, the results suggest that there was substantial genetic overlap between SRTs and a wide range of cognitive abilities, including abilities without a major auditory or verbal component. The findings highlight the important, yet sometimes overlooked, contribution of higher-order processes to solving the cocktail-party problem, raising an important caveat for future studies aiming to identify specific genetic factors that influence cocktail-party listening.
Collapse
Affiliation(s)
- Samuel R. Mathias
- Department of Psychiatry, Boston Children's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| | - Emma E. M. Knowles
- Department of Psychiatry, Boston Children's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| | - Josephine Mollon
- Department of Psychiatry, Boston Children's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| | - Amanda L. Rodrigue
- Department of Psychiatry, Boston Children's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| | - Mary K. Woolsey
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, United States
| | - Alyssa M. Hernandez
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, United States
| | - Amy S. Garret
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, United States
| | - Peter T. Fox
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, United States
- South Texas Veterans Health Care System, San Antonio, TX, United States
| | - Rene L. Olvera
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, United States
| | - Juan M. Peralta
- Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States
| | - Satish Kumar
- Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States
| | - Harald H. H. Göring
- Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States
| | - Ravi Duggirala
- Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States
| | - Joanne E. Curran
- Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States
| | - John Blangero
- Department of Human Genetics, South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States
| | - David C. Glahn
- Department of Psychiatry, Boston Children's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| |
Collapse
|
2
|
Mathias SR, Knowles EEM, Mollon J, Rodrigue AL, Woolsey MK, Hernandez AM, Garrett AS, Fox PT, Olvera RL, Peralta JM, Kumar S, Göring HHH, Duggirala R, Curran JE, Blangero J, Glahn DC. The Genetic contribution to solving the cocktail-party problem. iScience 2022; 25:104997. [PMID: 36111257 PMCID: PMC9468408 DOI: 10.1016/j.isci.2022.104997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Revised: 07/19/2022] [Accepted: 08/18/2022] [Indexed: 11/25/2022] Open
Abstract
Communicating in everyday situations requires solving the cocktail-party problem, or segregating the acoustic mixture into its constituent sounds and attending to those of most interest. Humans show dramatic variation in this ability, leading some to experience real-world problems irrespective of whether they meet criteria for clinical hearing loss. Here, we estimated the genetic contribution to cocktail-party listening by measuring speech-reception thresholds (SRTs) in 425 people from large families and ranging in age from 18 to 91 years. Roughly half the variance of SRTs was explained by genes (h 2 = 0.567). The genetic correlation between SRTs and hearing thresholds (HTs) was medium (ρ G = 0.392), suggesting that the genetic factors influencing cocktail-party listening were partially distinct from those influencing sound sensitivity. Aging and socioeconomic status also strongly influenced SRTs. These findings may represent a first step toward identifying genes for "hidden hearing loss," or hearing problems in people with normal HTs.
Collapse
Affiliation(s)
- Samuel R Mathias
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Emma E M Knowles
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Josephine Mollon
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Amanda L Rodrigue
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Mary K Woolsey
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX 78229, USA
| | - Alyssa M Hernandez
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX 78229, USA
| | - Amy S Garrett
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX 78229, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX 78229, USA.,South Texas Veterans Health Care System, San Antonio, TX 78229, USA
| | - Rene L Olvera
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Juan M Peralta
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Satish Kumar
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Harald H H Göring
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - David C Glahn
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| |
Collapse
|
3
|
Kochunov P, Zavaliangos-Petropulu A, Jahanshad N, Thompson PM, Ryan MC, Chiappelli J, Chen S, Du X, Hatch K, Adhikari B, Sampath H, Hare S, Kvarta M, Goldwaser E, Yang F, Olvera RL, Fox PT, Curran JE, Blangero J, Glahn DC, Tan Y, Hong LE. A White Matter Connection of Schizophrenia and Alzheimer's Disease. Schizophr Bull 2021; 47:197-206. [PMID: 32681179 PMCID: PMC7825012 DOI: 10.1093/schbul/sbaa078] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Schizophrenia (SZ) is a severe psychiatric illness associated with an elevated risk for developing Alzheimer's disease (AD). Both SZ and AD have white matter abnormalities and cognitive deficits as core disease features. We hypothesized that aging in SZ patients may be associated with the development of cerebral white matter deficit patterns similar to those observed in AD. We identified and replicated aging-related increases in the similarity between white matter deficit patterns in patients with SZ and AD. The white matter "regional vulnerability index" (RVI) for AD was significantly higher in SZ patients compared with healthy controls in both the independent discovery (Cohen's d = 0.44, P = 1·10-5, N = 173 patients/230 control) and replication (Cohen's d = 0.78, P = 9·10-7, N = 122 patients/64 controls) samples. The degree of overlap with the AD deficit pattern was significantly correlated with age in patients (r = .21 and .29, P < .01 in discovery and replication cohorts, respectively) but not in controls. Elevated RVI-AD was significantly associated with cognitive measures in both SZ and AD. Disease and cognitive specificities were also tested in patients with mild cognitive impairment and showed intermediate overlap. SZ and AD have diverse etiologies and clinical courses; our findings suggest that white matter deficits may represent a key intersecting point for these 2 otherwise distinct diseases. Identifying mechanisms underlying this white matter deficit pattern may yield preventative and treatment targets for cognitive deficits in both SZ and AD patients.
Collapse
Affiliation(s)
- Peter Kochunov
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Artemis Zavaliangos-Petropulu
- Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California of USC, Marina del Rey, CA
| | - Neda Jahanshad
- Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California of USC, Marina del Rey, CA
| | - Paul M Thompson
- Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California of USC, Marina del Rey, CA
| | - Meghann C Ryan
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Joshua Chiappelli
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Shuo Chen
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Xiaoming Du
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Kathryn Hatch
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Bhim Adhikari
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Hemalatha Sampath
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Stephanie Hare
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Mark Kvarta
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Eric Goldwaser
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| | - Fude Yang
- Beijing Huilongguan Hospital, Peking University Huilongguan Clinical Medical School, Beijing, P. R. China
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Joanne E Curran
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX
| | - John Blangero
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX
| | - David C Glahn
- Department of Psychiatry, Boston Children’s Hospital, Harvard Medical School, Boston, MA
| | - Yunlong Tan
- Beijing Huilongguan Hospital, Peking University Huilongguan Clinical Medical School, Beijing, P. R. China
| | - L Elliot Hong
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
| |
Collapse
|
4
|
Mathias SR, Knowles EEM, Mollon J, Rodrigue A, Koenis MMC, Alexander-Bloch AF, Winkler AM, Olvera RL, Duggirala R, Göring HHH, Curran JE, Fox PT, Almasy L, Blangero J, Glahn DC. Minimal Relationship between Local Gyrification and General Cognitive Ability in Humans. Cereb Cortex 2020; 30:3439-3450. [PMID: 32037459 DOI: 10.1093/cercor/bhz319] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 11/26/2019] [Accepted: 11/29/2019] [Indexed: 12/30/2022] Open
Abstract
Previous studies suggest that gyrification is associated with superior cognitive abilities in humans, but the strength of this relationship remains unclear. Here, in two samples of related individuals (total N = 2882), we calculated an index of local gyrification (LGI) at thousands of cortical surface points using structural brain images and an index of general cognitive ability (g) using performance on cognitive tests. Replicating previous studies, we found that phenotypic and genetic LGI-g correlations were positive and statistically significant in many cortical regions. However, all LGI-g correlations in both samples were extremely weak, regardless of whether they were significant or nonsignificant. For example, the median phenotypic LGI-g correlation was 0.05 in one sample and 0.10 in the other. These correlations were even weaker after adjusting for confounding neuroanatomical variables (intracranial volume and local cortical surface area). Furthermore, when all LGIs were considered together, at least 89% of the phenotypic variance of g remained unaccounted for. We conclude that the association between LGI and g is too weak to have profound implications for our understanding of the neurobiology of intelligence. This study highlights potential issues when focusing heavily on statistical significance rather than effect sizes in large-scale observational neuroimaging studies.
Collapse
Affiliation(s)
- Samuel R Mathias
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Emma E M Knowles
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Josephine Mollon
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Amanda Rodrigue
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA
| | - Marinka M C Koenis
- Olin Neuropsychiatric Research Center, Hartford Hospital, Harford, CT 06106, USA
| | - Aaron F Alexander-Bloch
- Department of Child and Adolescent Psychiatry and Behavioral Science, Children's Hospital of Philadelphia, and Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
| | - Anderson M Winkler
- Section on Development and Affective Neuroscience, National Institute of Mental Health, Bethesda, MD 20892, USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
| | - Ravi Duggirala
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA
| | - Harald H H Göring
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA
| | - Joanne E Curran
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.,South Texas Veterans Health System, San Antonio, TX 78229, USA
| | - Laura Almasy
- Department of Genetics, University of Pennsylvania and Department of Biomedical and Health Informatics at Children's Hospital of Philadelphia, Philadelphia, PA19104, USA
| | - John Blangero
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
| | - David C Glahn
- Department of Psychiatry, Boston Children's Hospital, Boston, MA 02115, USA.,Harvard Medical School, Boston, MA 02115, USA.,Olin Neuropsychiatric Research Center, Hartford Hospital, Harford, CT 06106, USA
| |
Collapse
|
5
|
Mollon J, Curran JE, Mathias SR, Knowles EEM, Carlisle P, Fox PT, Olvera RL, Göring HHH, Rodrigue A, Almasy L, Duggirala R, Blangero J, Glahn DC. Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology. Diabetologia 2020; 63:977-986. [PMID: 32016567 PMCID: PMC7150650 DOI: 10.1007/s00125-020-05101-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Accepted: 01/15/2020] [Indexed: 01/02/2023]
Abstract
AIMS/HYPOTHESIS Type 2 diabetes is associated with cognitive impairments, but it is unclear whether common genetic factors influence both type 2 diabetes risk and cognition. METHODS Using data from 1892 Mexican-American individuals from extended pedigrees, including 402 with type 2 diabetes, we examined possible pleiotropy between type 2 diabetes and cognitive functioning, as measured by a comprehensive neuropsychological test battery. RESULTS Negative phenotypic correlations (ρp) were observed between type 2 diabetes and measures of attention (Continuous Performance Test [CPT d']: ρp = -0.143, p = 0.001), verbal memory (California Verbal Learning Test [CVLT] recall: ρp = -0.111, p = 0.004) and face memory (Penn Face Memory Test [PFMT]: ρp = -0.127, p = 0.002; PFMT Delayed: ρp = -0.148, p = 2 × 10-4), replicating findings of cognitive impairment in type 2 diabetes. Negative genetic correlations (ρg) were also observed between type 2 diabetes and measures of attention (CPT d': ρg = -0.401, p = 0.001), working memory (digit span backward test: ρg = -0.380, p = 0.005), and face memory (PFMT: ρg = -0.476, p = 2 × 10-4; PFMT Delayed: ρg = -0.376, p = 0.005), suggesting that the same genetic factors underlying risk for type 2 diabetes also influence poor cognitive performance in these domains. Performance in these domains was also associated with type 2 diabetes risk using an endophenotype ranking value approach. Specifically, on measures of attention (CPT d': β = -0.219, p = 0.005), working memory (digit span backward: β = -0.326, p = 0.035), and face memory (PFMT: β = -0.171, p = 0.023; PFMT Delayed: β = -0.215, p = 0.005), individuals with type 2 diabetes showed the lowest performance, while unaffected/unrelated individuals showed the highest performance, and those related to an individual with type 2 diabetes performed at an intermediate level. CONCLUSIONS/INTERPRETATION These findings suggest that cognitive impairment may be a useful endophenotype of type 2 diabetes and, therefore, help to elucidate the pathophysiological underpinnings of this chronic disease. DATA AVAILABILITY The data analysed in this study is available in dbGaP: www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001215.v2.p2.
Collapse
Affiliation(s)
- Josephine Mollon
- Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, 1 Autumn Street, BCH 3428, Boston, MA, 02115, USA.
| | - Joanne E Curran
- Department of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
- South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
| | - Samuel R Mathias
- Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, 1 Autumn Street, BCH 3428, Boston, MA, 02115, USA
| | - Emma E M Knowles
- Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, 1 Autumn Street, BCH 3428, Boston, MA, 02115, USA
| | - Phoebe Carlisle
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Rene L Olvera
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Harald H H Göring
- Department of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
- South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
| | - Amanda Rodrigue
- Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, 1 Autumn Street, BCH 3428, Boston, MA, 02115, USA
| | - Laura Almasy
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Ravi Duggirala
- Department of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
- South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
| | - John Blangero
- Department of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
- South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, USA
| | - David C Glahn
- Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, 1 Autumn Street, BCH 3428, Boston, MA, 02115, USA
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA
| |
Collapse
|
6
|
Alexander-Bloch AF, Mathias SR, Fox PT, Olvera RL, Göring HHH, Duggirala R, Curran JE, Blangero J, Glahn DC. Human Cortical Thickness Organized into Genetically-determined Communities across Spatial Resolutions. Cereb Cortex 2020; 29:106-118. [PMID: 29190330 DOI: 10.1093/cercor/bhx309] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Indexed: 12/13/2022] Open
Abstract
The cerebral cortex may be organized into anatomical genetic modules, communities of brain regions with shared genetic influences via pleiotropy. Such modules could represent novel phenotypes amenable to large-scale gene discovery. This modular structure was investigated with network analysis of in vivo MRI of extended pedigrees, revealing a "multiscale" structure where smaller and larger modules exist simultaneously and in partially overlapping fashion across spatial scales, in contrast to prior work suggesting a specific number of cortical thickness modules. Inter-regional genetic correlations, gene co-expression patterns and computational models indicate that two simple organizational principles account for a large proportion of the apparent complexity in the network of genetic correlations. First, regions are strongly genetically correlated with their homologs in the opposite cerebral hemisphere. Second, regions are strongly genetically correlated with nearby regions in the same hemisphere, with an initial steep decrease in genetic correlation with anatomical distance, followed by a more gradual decline. Understanding underlying organizational principles of genetic influence is a critical step towards a mechanistic model of how specific genes influence brain anatomy and mediate neuropsychiatric risk.
Collapse
Affiliation(s)
| | - Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA
| | - Peter T Fox
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, TX, USA.,University of Texas of the Rio Grande Valley, Brownsville, TX, USA
| | - Rene L Olvera
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, TX, USA.,University of Texas of the Rio Grande Valley, Brownsville, TX, USA
| | - Harold H H Göring
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, TX, USA.,University of Texas of the Rio Grande Valley, Brownsville, TX, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, TX, USA.,University of Texas of the Rio Grande Valley, Brownsville, TX, USA
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, TX, USA.,University of Texas of the Rio Grande Valley, Brownsville, TX, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, TX, USA.,University of Texas of the Rio Grande Valley, Brownsville, TX, USA
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA
| |
Collapse
|
7
|
Knowles EEM, Curran JE, Göring HHH, Mathias SR, Mollon J, Rodrigue A, Olvera RL, Leandro A, Duggirala R, Almasy L, Blangero J, Glahn DC. Family-based analyses reveal novel genetic overlap between cytokine interleukin-8 and risk for suicide attempt. Brain Behav Immun 2019; 80:292-299. [PMID: 30953777 PMCID: PMC7168352 DOI: 10.1016/j.bbi.2019.04.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Revised: 02/25/2019] [Accepted: 04/02/2019] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Suicide is major public health concern. It is imperative to find robust biomarkers so that at-risk individuals can be identified in a timely and reliable manner. Previous work suggests mechanistic links between increased cytokines and risk for suicide, but questions remain regarding the etiology of this association, as well as the roles of sex and BMI. METHODS Analyses were conducted using a randomly-ascertained extended-pedigree sample of 1882 Mexican-American individuals (60% female, mean age = 42.04, range = 18-97). Genetic correlations were calculated using a variance components approach between the cytokines TNF-α, IL-6 and IL-8, and Lifetime Suicide Attempt and Current Suicidal Ideation. The potentially confounding effects of sex and BMI were considered. RESULTS 159 individuals endorse a Lifetime Suicide Attempt. IL-8 and IL-6 shared significant genetic overlap with risk for suicide attempt (ρg = 0.49, pFDR = 7.67 × 10-03; ρg = 0.53, pFDR = 0.01), but for IL-6 this was attenuated when BMI was included as a covariate (ρg = 0.37, se = 0.23, pFDR = 0.12). Suicide attempts were significantly more common in females (pFDR = 0.01) and the genetic overlap between IL-8 and risk for suicide attempt was significant in females (ρg = 0.56, pFDR = 0.01), but not in males (ρg = 0.44, pFDR = 0.30). DISCUSSION These results demonstrate that: IL-8 shares genetic influences with risk for suicide attempt; females drove this effect; and BMI should be considered when assessing the association between IL-6 and suicide. This finding represents a significant advancement in knowledge by demonstrating that cytokine alterations are not simply a secondary manifestation of suicidal behavior, but rather, the pathophysiology of suicide attempts is, at least partly, underpinned by the same biological mechanisms responsible for regulating inflammatory response.
Collapse
Affiliation(s)
- E E M Knowles
- Department of Psychiatry, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - Harald H H Göring
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - Samuel R Mathias
- Department of Psychiatry, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
| | - Josephine Mollon
- Department of Psychiatry, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
| | - Amanda Rodrigue
- Department of Psychiatry, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Ana Leandro
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - Laura Almasy
- Department of Genetics at University of Pennsylvania and Department of Biomedical and Health Informatics at Children's Hospital of Philadelphia, PA, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - David C Glahn
- Department of Psychiatry, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| |
Collapse
|
8
|
Elsayed NM, Fields KM, Olvera RL, Williamson DE. The role of familial risk, parental psychopathology, and stress for first-onset depression during adolescence. J Affect Disord 2019; 253:232-239. [PMID: 31055129 PMCID: PMC6620141 DOI: 10.1016/j.jad.2019.04.084] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2018] [Revised: 02/13/2019] [Accepted: 04/21/2019] [Indexed: 01/22/2023]
Abstract
BACKGROUND Adolescence represents a critical developmental period during which the initial onset of depression emerges. Family risk for depression is a salient risk factor for the initial onset of Major Depressive Disorder (MDD). We examined the effects of familial risk, stress, and behavior on the risk of developing first-onset depression. METHODS Adolescents aged 12 to 15 with high (n = 166) or low (n = 159) familial risk for depression were assessed annually for up to five years. Stress was assessed using the Stressful Life Events Schedule and Childhood Trauma Questionnaire. The Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version was administered to the adolescents and their parents to assess lifetime psychiatric conditions and diagnose MDD onset. Survival and path analyses were used in tandem to determine the risk for first-onset depression as well as the contributions of additional direct and indirect pathways to onset. RESULTS High-risk adolescents were eight times more likely to develop first-onset depression compared with low-risk adolescents. The path analyses revealed that the presence of maternal behavioral disorders and increased recent life stress directly predicted an initial onset of MDD in high-risk adolescents. LIMITATIONS The small samples used in this study limit the generalizability of these findings. CONCLUSIONS Adolescents at high familial risk for depression had an increased risk for the emergence of first-onset depression during adolescence. Stress and maternal behavioral psychopathology directly contributed to depression onset independently of familial risk, while childhood trauma exerted an indirect effect on first-onset MDD through recent stress.
Collapse
Affiliation(s)
- Nourhan M. Elsayed
- Department of Psychological and Brain Sciences at Washington University in St. Louis
| | - Kristina M. Fields
- Department of Psychiatry at the University of Texas Health at San Antonio, San Antonio, Texas
| | - Rene L. Olvera
- Department of Psychiatry at the University of Texas Health at San Antonio, San Antonio, Texas
| | - Douglas E. Williamson
- Translational Center for Stress-Related Disorders in the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine and the Research Division of the Durham Veterans Affairs Medical Center, both in Durham, North Carolina
| |
Collapse
|
9
|
Rodrigue AL, Knowles EE, Mollon J, Mathias SR, Koenis MM, Peralta JM, Leandro AC, Fox PT, Sprooten E, Kochunov P, Olvera RL, Duggirala R, Almasy L, Curran JE, Blangero J, Glahn DC. Evidence for genetic correlation between human cerebral white matter microstructure and inflammation. Hum Brain Mapp 2019; 40:4180-4191. [PMID: 31187567 DOI: 10.1002/hbm.24694] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2019] [Revised: 05/20/2019] [Accepted: 05/27/2019] [Indexed: 12/23/2022] Open
Abstract
White matter microstructure is affected by immune system activity via the actions of circulating pro-inflammatory cytokines. Although white matter microstructure and inflammatory measures are significantly heritable, it is unclear if overlapping genetic factors influence these traits in humans. We conducted genetic correlation analyses of these traits using randomly ascertained extended pedigrees from the Genetics of Brain Structure and Function Study (N = 1862, 59% females, ages 18-97 years; 42 ± 15.7). White matter microstructure was assessed using fractional anisotropy (FA) calculated from diffusion tensor imaging (DTI). Circulating levels (pg/mL) of pro-inflammatory cytokines (IL-6, IL-8, and TNFα) phenotypically associated with white matter microstructure were quantified from blood serum. All traits were significantly heritable (h2 ranging from 0.41 to 0.66 for DTI measures and from 0.18 to 0.30 for inflammatory markers). Phenotypically, higher levels of circulating inflammatory markers were associated with lower FA values across the brain (r = -.03 to r = -.17). There were significant negative genetic correlations between most DTI measures and IL-8 and TNFα, although effects for TNFα were no longer significant when covarying for body mass index. Genetic correlations between DTI measures and IL-6 were not significant. Understanding the genetic correlation between specific inflammatory markers and DTI measures may help researchers focus questions related to inflammatory processes and brain structure.
Collapse
Affiliation(s)
- Amanda L Rodrigue
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Emma Em Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Josephine Mollon
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Marinka Mg Koenis
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Juan M Peralta
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Ana C Leandro
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health San Antonio, San Antonio, Texas
| | - Emma Sprooten
- Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.,Department of Cognitive Neuroscience, Radboudumc, Nijmegen, the Netherlands
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health San Antonio, San Antonio, Texas
| | - Ravindranath Duggirala
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Laura Almasy
- Department of Genetics, Perelman School of Medicine and the Penn-CHOP Lifespan Brain Institute, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Joanne E Curran
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - John Blangero
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut
| |
Collapse
|
10
|
Knowles EEM, Curran JE, Meikle PJ, Huynh K, Mathias SR, Göring HHH, VandeBerg JL, Mahaney MC, Jalbrzikowski M, Mosior MK, Michael LF, Olvera RL, Duggirala R, Almasy L, Glahn DC, Blangero J. Disentangling the genetic overlap between cholesterol and suicide risk. Neuropsychopharmacology 2018; 43:2556-2563. [PMID: 30082891 PMCID: PMC6224547 DOI: 10.1038/s41386-018-0162-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Revised: 07/12/2018] [Accepted: 07/13/2018] [Indexed: 01/03/2023]
Abstract
Suicide is major public health concern; one million individuals worldwide die by suicide each year of which there are many more attempts. Thus, it is imperative that robust and reliable indicators, or biomarkers, of suicide risk be identified so that individuals at risk can be identified and provided appropriate interventions as quickly as possible. Previous work has revealed a relationship between low levels of circulating cholesterol and suicide risk, implicating cholesterol level as one such potential biomarker, but the factors underlying this relationship remain unknown. In the present study, we applied a combination of bivariate polygenic and coefficient-of-relatedness analysis, followed by mediation analysis, in a large sample of Mexican-American individuals from extended pedigrees [N = 1897; 96 pedigrees (average size = 19.17 individuals, range = 2-189) 60% female; mean age = 42.58 years, range = 18-97 years, sd = 15.75 years] with no exclusion criteria for any given psychiatric disorder. We observed that total esterified cholesterol measured at the time of psychiatric assessment shared a significant genetic overlap with risk for suicide attempt (ρg = -0.64, p = 1.24 × 10-04). We also found that total unesterified cholesterol measured around 20 years prior to assessment varied as a function of genetic proximity to an affected individual (h2 = 0.21, se = 0.10, p = 8.73 × 10-04; βsuicide = -0.70, se = 0.25, p = 8.90 × 10-03). Finally, we found that the relationship between total unesterified cholesterol and suicide risk was significantly mediated by ABCA-1-specific cholesterol efflux capacity (βsuicide-efflux = -0.45, p = 0.039; βefflux-cholexterol = -0.34, p < 0.0001; βindirect = -0.15, p = 0.044). These findings suggest that the relatively well-delineated process of cholesterol metabolism and associated molecular pathways will be informative for understanding the neurobiological underpinnings of risk for suicide attempt.
Collapse
Affiliation(s)
- Emma E. M. Knowles
- 0000000419368710grid.47100.32Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
| | - Joanne E. Curran
- 0000 0004 5374 269Xgrid.449717.8South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, TX USA
| | - Peter J. Meikle
- 0000 0000 9760 5620grid.1051.5Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | - Kevin Huynh
- 0000 0000 9760 5620grid.1051.5Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | - Samuel R. Mathias
- 0000000419368710grid.47100.32Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
| | - Harald H. H. Göring
- 0000 0004 5374 269Xgrid.449717.8South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, TX USA
| | - John L. VandeBerg
- 0000 0004 5374 269Xgrid.449717.8South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, TX USA
| | - Michael C. Mahaney
- 0000 0004 5374 269Xgrid.449717.8South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, TX USA
| | - Maria Jalbrzikowski
- 0000 0004 1936 9000grid.21925.3dDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA USA
| | - Marian K. Mosior
- 0000 0000 2220 2544grid.417540.3Diabetes and Complications Therapeutic Area, Eli Lilly and Company, Indianapolis, IN USA
| | - Laura F. Michael
- 0000 0000 2220 2544grid.417540.3Diabetes and Complications Therapeutic Area, Eli Lilly and Company, Indianapolis, IN USA
| | - Rene L. Olvera
- 0000 0001 0629 5880grid.267309.9Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX USA
| | - Ravi Duggirala
- 0000 0004 5374 269Xgrid.449717.8South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, TX USA
| | - Laura Almasy
- 0000 0004 1936 8972grid.25879.31Department of Genetics, University of Pennsylvania, Philadelphia, PA USA ,0000 0001 0680 8770grid.239552.aDepartment of Biomedical and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA USA
| | - David C. Glahn
- 0000000419368710grid.47100.32Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA ,0000 0001 0626 2712grid.277313.3Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT USA
| | - John Blangero
- 0000 0004 5374 269Xgrid.449717.8South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, TX USA
| |
Collapse
|
11
|
Knowles EEM, Mathias SR, Mollon J, Rodrigue A, Koenis MMG, Dyer TD, Goring HHH, Curran JE, Olvera RL, Duggirala R, Almasy L, Blangero J, Glahn DC. A QTL on chromosome 3q23 influences processing speed in humans. Genes Brain Behav 2018; 18:e12530. [PMID: 30379395 DOI: 10.1111/gbb.12530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 09/24/2018] [Accepted: 10/18/2018] [Indexed: 10/28/2022]
Abstract
Processing speed is a psychological construct that refers to the speed with which an individual can perform any cognitive operation. Processing speed correlates strongly with general cognitive ability, declines sharply with age and is impaired across a number of neurological and psychiatric disorders. Thus, identifying genes that influence processing speed will likely improve understanding of the genetics of intelligence, biological aging and the etiologies of numerous disorders. Previous genetics studies of processing speed have relied on simple phenotypes (eg, mean reaction time) derived from single tasks. This strategy assumes, erroneously, that processing speed is a unitary construct. In the present study, we aimed to characterize the genetic architecture of processing speed by using a multidimensional model applied to a battery of cognitive tasks. Linkage and QTL-specific association analyses were performed on the factors from this model. The randomly ascertained sample comprised 1291 Mexican-American individuals from extended pedigrees. We found that performance on all three distinct processing-speed factors (Psychomotor Speed; Sequencing and Shifting and Verbal Fluency) were moderately and significantly heritable. We identified a genome-wide significant quantitative trait locus (QTL) on chromosome 3q23 for Psychomotor Speed (LOD = 4.83). Within this locus, we identified a plausible and interesting candidate gene for Psychomotor Speed (Z = 2.90, P = 1.86 × 10-03 ).
Collapse
Affiliation(s)
- Emma E M Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Josephine Mollon
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Amanda Rodrigue
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Marinka M G Koenis
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Thomas D Dyer
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, Texas
| | - Harald H H Goring
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, Texas
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, Texas
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, Texas
| | - Laura Almasy
- Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania.,Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - John Blangero
- South Texas Diabetes and Obesity Institute and Department of Human Genetics, University of Texas of the Rio Grande Valley School of Medicine, Brownsville, Texas
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut
| |
Collapse
|
12
|
Elsayed NM, Kim MJ, Fields KM, Olvera RL, Hariri AR, Williamson DE. Trajectories of Alcohol Initiation and Use During Adolescence: The Role of Stress and Amygdala Reactivity. J Am Acad Child Adolesc Psychiatry 2018; 57:550-560. [PMID: 30071976 PMCID: PMC6396321 DOI: 10.1016/j.jaac.2018.05.011] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2017] [Revised: 05/10/2018] [Accepted: 06/11/2018] [Indexed: 12/20/2022]
Abstract
OBJECTIVE Early alcohol use initiation predicts onset of alcohol use disorders in adulthood. However, little is known about developmental trajectories of alcohol use initiation and their putative biological and environmental correlates. METHOD Adolescents (N = 330) with high or low familial loading for depression were assessed annually for up to 6 years. Data were collected assessing affective symptoms, alcohol use, and stress at each assessment. Adolescents also participated in a functional magnetic resonance imaging protocol that included measurement of threat-related amygdala and reward-related ventral striatum activity. RESULTS Latent class analyses identified 2 trajectories of alcohol use initiation. Early initiators (n = 32) reported greater baseline alcohol use and rate of change of use compared with late initiators and/or current abstainers (n = 298). Early initiators reported higher baseline levels of stressful life events (p = .001) and exhibited higher amygdala (p = .001) but not ventral striatum activity compared with late initiators. Early initiators were 15.3 times more likely to have a full drink (p < .0001), 9.1 times more likely to experience intoxication (p < .0001), and 6.7 times more likely to develop an alcohol use disorder by 19 years of age compared with late initiators (p = .003). CONCLUSION Adolescents on a trajectory of early alcohol use initiation have higher levels of stress, have increased threat-related amygdala activity, are more likely to consume a full standard alcoholic drink, are more likely to experience early intoxication, and are at a heightened risk for the onset of an alcohol use disorder.
Collapse
Affiliation(s)
| | | | | | | | | | - Douglas E Williamson
- Duke University, the Durham Veterans Affairs Medical Center, Durham, NC, and the University of Texas Health at San Antonio
| |
Collapse
|
13
|
Hodgson K, Poldrack RA, Curran JE, Knowles EE, Mathias S, Göring HHH, Yao N, Olvera RL, Fox PT, Almasy L, Duggirala R, Barch DM, Blangero J, Glahn DC. Shared Genetic Factors Influence Head Motion During MRI and Body Mass Index. Cereb Cortex 2018; 27:5539-5546. [PMID: 27744290 DOI: 10.1093/cercor/bhw321] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2016] [Accepted: 01/01/2016] [Indexed: 11/13/2022] Open
Abstract
Head movements are typically viewed as a nuisance to functional magnetic resonance imaging (fMRI) analysis, and are particularly problematic for resting state fMRI. However, there is growing evidence that head motion is a behavioral trait with neural and genetic underpinnings. Using data from a large randomly ascertained extended pedigree sample of Mexican Americans (n = 689), we modeled the genetic structure of head motion during resting state fMRI and its relation to 48 other demographic and behavioral phenotypes. A replication analysis was performed using data from the Human Connectome Project, which uses an extended twin design (n = 864). In both samples, head motion was significantly heritable (h2 = 0.313 and 0.427, respectively), and phenotypically correlated with numerous traits. The most strongly replicated relationship was between head motion and body mass index, which showed evidence of shared genetic influences in both data sets. These results highlight the need to view head motion in fMRI as a complex neurobehavioral trait correlated with a number of other demographic and behavioral phenotypes. Given this, when examining individual differences in functional connectivity, the confounding of head motion with other traits of interest needs to be taken into consideration alongside the critical important of addressing head motion artifacts.
Collapse
Affiliation(s)
- Karen Hodgson
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA
| | - Russell A Poldrack
- Department of Psychology , Stanford University, Jordan Hall Building 01-420, 450 Serra Mall, Stanford, CA 94305, USA
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Emma E Knowles
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA
| | - Samuel Mathias
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA
| | - Harald H H Göring
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Nailin Yao
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Drive, San Antonio, TX 78229, USA
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - Deanna M Barch
- Psychological & Brain Sciences, Washington University in St. Louis, One Brookings Drive, St. Louis, MO63130-4899, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX 78520, USA
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, CT 06106, USA
| |
Collapse
|
14
|
Walss-Bass C, Suchting R, Olvera RL, Williamson DE. Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting. J Affect Disord 2018; 234:276-281. [PMID: 29554616 PMCID: PMC5895481 DOI: 10.1016/j.jad.2018.03.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2017] [Revised: 02/20/2018] [Accepted: 03/10/2018] [Indexed: 01/09/2023]
Abstract
BACKGROUND Immune system abnormalities have been repeatedly observed in several psychiatric disorders, including severe depression and anxiety. However, whether specific immune mediators play an early role in the etiopathogenesis of these disorders remains unknown. METHODS In a longitudinal design, component-wise gradient boosting was used to build models of depression, assessed by the Mood-Feelings Questionnaire-Child (MFQC), and anxiety, assessed by the Screen for Child Anxiety Related Emotional Disorders (SCARED) in 254 adolescents from a large set of candidate predictors, including sex, race, 39 inflammatory proteins, and the interactions between those proteins and time. Each model was reduced via backward elimination to maximize parsimony and generalizability. RESULTS Component-wise gradient boosting and model reduction found that female sex, growth- regulated oncogene (GRO), and transforming growth factor alpha (TGF-alpha) predicted depression, while female sex predicted anxiety. LIMITATIONS Differential onset of puberty as well as a lack of control for menstrual cycle may also have been responsible for differences between males and females in the present study. In addition, investigation of all possible nonlinear relationships between the predictors and the outcomes was beyond the computational capacity and scope of the present research. CONCLUSIONS This study highlights the need for novel statistical modeling to identify reliable biological predictors of aberrant psychological behavior.
Collapse
Affiliation(s)
- Consuelo Walss-Bass
- Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, TX USA
| | - Robert Suchting
- Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, TX, USA.
| | - Rene L. Olvera
- Division of Child, Adolescent and Adult Psychiatry, University of Texas Health Science Center at San Antonio, TX USA
| | - Douglas E. Williamson
- Division of Translational Neuroscience, Department of Psychiatry and Behavioral Sciences, Duke University and the Durham VA Medical Center Durham, NC USA
| |
Collapse
|
15
|
Mathias CW, Stanford MS, Liang Y, Goros M, Charles NE, Sheftall AH, Mullen J, Hill-Kapturczak N, Acheson A, Olvera RL, Dougherty DM. A test of the psychometric characteristics of the BIS-Brief among three groups of youth. Psychol Assess 2018; 30:847-856. [PMID: 29431454 DOI: 10.1037/pas0000531] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
The Barratt Impulsiveness Scale (BIS-11) is the most widely administered trait impulsiveness questionnaire. Recently a shorter, unidimensional version of the instrument was developed for adults (BIS-Brief). While psychometric characteristics of the BIS-Brief support its use among adults, it also may be more appropriate for youth samples than the complete BIS-11 because it less burdensome and omits items about activities not usually encountered by children and adolescents. This article describes a test of psychometric characteristics of the BIS-Brief among youth. To measure a sufficiently wide range of scores, analyses were conducted based on secondary data analysis of data sets pooled from 3 distinct youth cohorts aged 10-17: healthy controls (Control; n = 356); those who had a family history of substance use disorder (FH+; n = 302); and psychiatric inpatients (Patients; n = 322). Model fit for the BIS-Brief was good but varied somewhat depending on the respondent cohort. There was a strong correlation between test and re-test BIS-Brief both within a single day and at 6 months, and also a strong correlation between BIS-Brief and BIS-11 scores. Concurrent validity was supported by correlation with questionnaire measures, which tended to be more robustly associated with BIS-Brief than behavioral measures. Both BIS-Brief and BIS-11 forms were similarly associated with other convergent measures. In conclusion, the BIS-Brief is a shorter version of the BIS-11 that reduces participant burden and with psychometric properties that support its use among youth populations. (PsycINFO Database Record
Collapse
Affiliation(s)
- Charles W Mathias
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| | | | - Yuanyuan Liang
- Department of Epidemiology & Biostatistics, The University of Texas Health Science Center at San Antonio
| | - Martin Goros
- Department of Epidemiology & Biostatistics, The University of Texas Health Science Center at San Antonio
| | - Nora E Charles
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| | - Arielle H Sheftall
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| | - Jillian Mullen
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| | | | - Ashley Acheson
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| | - Rene L Olvera
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| | - Donald M Dougherty
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio
| |
Collapse
|
16
|
Knowles EEM, Meikle PJ, Huynh K, Göring HHH, Olvera RL, Mathias SR, Duggirala R, Almasy L, Blangero J, Curran JE, Glahn DC. Serum phosphatidylinositol as a biomarker for bipolar disorder liability. Bipolar Disord 2017; 19:107-115. [PMID: 28230325 PMCID: PMC5798864 DOI: 10.1111/bdi.12468] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2016] [Revised: 01/03/2017] [Accepted: 01/10/2017] [Indexed: 12/17/2022]
Abstract
OBJECTIVES Individuals with bipolar disorder (BPD) exhibit alterations in their phospholipid levels. It is unclear whether these alterations are a secondary consequence of illness state, or if phospholipids and illness risk overlap genetically. If the latter were true, then phospholipids might provide key insights into the pathophysiology of the illness. Therefore, we rank-ordered phospholipid classes by their genetic overlap with BPD risk in order to establish which class might be most informative in terms of increasing our understanding of illness pathophysiology. METHODS Analyses were conducted in a sample of 558 individuals, unselected for BPD, from 38 extended pedigrees (average family size=14.79, range=2-82). We calculated a coefficient of relatedness for all family members of nine individuals with BPD in the sample (N=185); this coefficient was set to be zero in unrelated individuals (N=373). Then, under an endophenotype ranking value (ERV) approach, this scalar index was tested against 13 serum-based phospholipid concentrations in order to rank-order lipid classes by their respective overlap with BPD risk. RESULTS The phosphatidylinositol class was significantly heritable (h2 =0.26, P=6.71 × 10-05 ). It was the top-ranked class, and was significantly associated with BPD risk after correction for multiple testing (β=-1.18, P=2.10 × 10-03 , ERV=0.49). CONCLUSIONS We identified a peripheral biomarker, serum-based phosphatidylinositol, which exhibits a significant association with BPD risk. Therefore, given that phosphatidylinositol and BPD risk share partially common etiology, it seems that this lipid class warrants further investigation, not only in terms of treatment, but also as a promising diagnostic and risk marker.
Collapse
Affiliation(s)
- Emma EM Knowles
- Department of Psychiatry, Yale University, School of Medicine, New Haven, CT, USA,Correspondence: Emma E. M. Knowles, Department of Psychiatry, Yale University, New Haven, CT, USA.,
| | - Peter J Meikle
- Baker Heart and Diabetes Institute, Melbourne, Vic., Australia
| | - Kevin Huynh
- Baker Heart and Diabetes Institute, Melbourne, Vic., Australia
| | - Harald HH Göring
- South Texas Diabetes and Obesity, Institute, University of Texas Rio Grande Valley, School of Medicine, Brownsville, TX, USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas, Health Science Center at San Antonio, San Antonio, TX, USA
| | - Samuel R Mathias
- Department of Psychiatry, Yale University, School of Medicine, New Haven, CT, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity, Institute, University of Texas Rio Grande Valley, School of Medicine, Brownsville, TX, USA
| | - Laura Almasy
- Department of Genetics, University of Pennsylvania and Department of Biomedical and Health Informatics at Children’s Hospital of Philadelphia, PA, USA
| | - John Blangero
- South Texas Diabetes and Obesity, Institute, University of Texas Rio Grande Valley, School of Medicine, Brownsville, TX, USA
| | - Joanne E Curran
- South Texas Diabetes and Obesity, Institute, University of Texas Rio Grande Valley, School of Medicine, Brownsville, TX, USA
| | - David C Glahn
- Department of Psychiatry, Yale University, School of Medicine, New Haven, CT, USA,Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| |
Collapse
|
17
|
Knowles EEM, Huynh K, Meikle PJ, Göring HHH, Olvera RL, Mathias SR, Duggirala R, Almasy L, Blangero J, Curran JE, Glahn DC. The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk. Eur Psychiatry 2017; 43:44-50. [PMID: 28365467 DOI: 10.1016/j.eurpsy.2017.02.479] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Revised: 01/27/2017] [Accepted: 02/06/2017] [Indexed: 01/23/2023] Open
Abstract
BACKGROUND The lipidome is rapidly garnering interest in the field of psychiatry. Recent studies have implicated lipidomic changes across numerous psychiatric disorders. In particular, there is growing evidence that the concentrations of several classes of lipids are altered in those diagnosed with MDD. However, for lipidomic abnormalities to be considered potential treatment targets for MDD (rather than secondary manifestations of the disease), a shared etiology between lipid concentrations and MDD should be demonstrated. METHODS In a sample of 567 individuals from 37 extended pedigrees (average size 13.57 people, range=3-80), we used mass spectrometry lipidomic measures to evaluate the genetic overlap between twenty-three biologically distinct lipid classes and a dimensional scale of MDD. RESULTS We found that the lipid class with the largest endophenotype ranking value (ERV, a standardized parametric measure of pleiotropy) were ether-phosphodatidylcholines (alkylphosphatidylcholine, PC(O) and alkenylphosphatidylcholine, PC(P) subclasses). Furthermore, we examined the cluster structure of the twenty-five species within the top-ranked lipid class, and the relationship of those clusters with MDD. This analysis revealed that species containing arachidonic acid generally exhibited the greatest degree of genetic overlap with MDD. CONCLUSIONS This study is the first to demonstrate a shared genetic etiology between MDD and ether-phosphatidylcholine species containing arachidonic acid, an omega-6 fatty acid that is a precursor to inflammatory mediators, such as prostaglandins. The study highlights the potential utility of the well-characterized linoleic/arachidonic acid inflammation pathway as a diagnostic marker and/or treatment target for MDD.
Collapse
Affiliation(s)
- E E M Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
| | - K Huynh
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - P J Meikle
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - H H H Göring
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - R L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - S R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - R Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - L Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - J Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - J E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - D C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| |
Collapse
|
18
|
Hibar DP, Adams HHH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beecham AH, Beiser A, Bernard M, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chen Q, Ching CRK, Chouraki V, Cuellar-Partida G, Crivello F, Den Braber A, Doan NT, Ehrlich S, Giddaluru S, Goldman AL, Gottesman RF, Grimm O, Griswold ME, Guadalupe T, Gutman BA, Hass J, Haukvik UK, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Jørgensen KN, Karbalai N, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liewald DCM, Lopez LM, Luciano M, Macare C, Marquand AF, Matarin M, Mather KA, Mattheisen M, McKay DR, Milaneschi Y, Muñoz Maniega S, Nho K, Nugent AC, Nyquist P, Loohuis LMO, Oosterlaan J, Papmeyer M, Pirpamer L, Pütz B, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Ropele S, Rose EJ, Royle NA, Rundek T, Sämann PG, Saremi A, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Trompet S, Vaidya D, Van der Grond J, Van der Lee SJ, Van der Meer D, Van Donkelaar MMJ, Van Eijk KR, Van Erp TGM, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Wolfers T, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Craen AJM, De Geus EJC, De Jager PL, De Zubicaray GI, Deary IJ, Debette S, DeCarli C, Delanty N, Depondt C, DeStefano A, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Enzinger C, Erk S, Espeseth T, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Fornage M, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HHH, Green RC, Gruber O, Gudnason V, Guelfi S, Håberg AK, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Huentelman M, Pol HEH, Ikeda M, Jack Jr CR, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BWJH, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schmidt H, Schofield PR, Sigursson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Tsolaki M, Tzourio C, Uitterlinden AG, Hernández MCV, Van der Brug M, van der Lugt A, van der Wee NJA, Van Haren NEM, van 't Ent D, Van Tol MJ, Vardarajan BN, Vellas B, Veltman DJ, Völzke H, Walter H, Wardlaw JM, Wassink TH, Weale ME, Weinberger DR, Weiner MW, Wen W, Westman E, White T, Wong TY, Wright CB, Zielke RH, Zonderman AB, Martin NG, Van Duijn CM, Wright MJ, Longstreth WT, Schumann G, Grabe HJ, Franke B, Launer LJ, Medland SE, Seshadri S, Thompson PM, Ikram MA. Novel genetic loci associated with hippocampal volume. Nat Commun 2017; 8:13624. [PMID: 28098162 PMCID: PMC5253632 DOI: 10.1038/ncomms13624] [Citation(s) in RCA: 183] [Impact Index Per Article: 26.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2016] [Accepted: 10/18/2016] [Indexed: 12/17/2022] Open
Abstract
The hippocampal formation is a brain structure integrally involved in episodic memory, spatial navigation, cognition and stress responsiveness. Structural abnormalities in hippocampal volume and shape are found in several common neuropsychiatric disorders. To identify the genetic underpinnings of hippocampal structure here we perform a genome-wide association study (GWAS) of 33,536 individuals and discover six independent loci significantly associated with hippocampal volume, four of them novel. Of the novel loci, three lie within genes (ASTN2, DPP4 and MAST4) and one is found 200 kb upstream of SHH. A hippocampal subfield analysis shows that a locus within the MSRB3 gene shows evidence of a localized effect along the dentate gyrus, subiculum, CA1 and fissure. Further, we show that genetic variants associated with decreased hippocampal volume are also associated with increased risk for Alzheimer's disease (rg=-0.155). Our findings suggest novel biological pathways through which human genetic variation influences hippocampal volume and risk for neuropsychiatric illness.
Collapse
Affiliation(s)
- Derrek P. Hibar
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Hieab H. H. Adams
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Neda Jahanshad
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Ganesh Chauhan
- INSERM Unit U1219, University of Bordeaux, 33076 Bordeaux, France
| | - Jason L. Stein
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
- Department of Genetics & UNC Neuroscience Center, University of North Carolina (UNC), Chapel Hill, North Carolina, 27599, USA
| | - Edith Hofer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
- Institute of Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Miguel E. Renteria
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Joshua C. Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, 1730 Minor Avenue/Suite 1360. Seattle, Washington 98101, USA
| | - Alejandro Arias-Vasquez
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - M. Kamran Ikram
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore, 169857, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore
- Memory Aging & Cognition Centre (MACC), National University Health System, Singapore, 119228, Singapore
- Department of Pharmacology, National University of Singapore, Singapore, 119077, Singapore
| | - Sylvane Desrivières
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Meike W. Vernooij
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Lucija Abramovic
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Saud Alhusaini
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4
- The Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
| | - Najaf Amin
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
| | - Micael Andersson
- Department of Integrative Medical Biology and Umeå Center for Functional Brain Imaging, Umeå University, 901 87 Umeå, Sweden
| | - Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois 60616, USA
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois 60616, USA
| | - Benjamin S. Aribisala
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Department of Computer Science, Lagos State University, Lagos, P.M.B. 01 LASU, Nigeria
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Nicola J. Armstrong
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Mathematics and Statistics, Murdoch University, Perth, Western Australia, 6150, Australia
| | - Lavinia Athanasiu
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
| | - Tomas Axelsson
- Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Box 1432, SE-751 44 Uppsala, Sweden
| | - Ashley H. Beecham
- Dr John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Alexa Beiser
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118 USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Manon Bernard
- Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8
| | - Susan H. Blanton
- Dr John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Marc M. Bohlken
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Marco P. Boks
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Janita Bralten
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Adam M. Brickman
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain; G.H. Sergievsky Center; Department of Neurology. Columbia University Medical Center, 639 West 1168th Street, New York, New York 10032, USA
| | - Owen Carmichael
- Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA
| | - M. Mallar Chakravarty
- Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada H4H 1R3
- Department of Psychiatry and Biomedical Engineering, McGill University, Montreal, Quebec, Canada H3A 2B4
| | - Qiang Chen
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
| | - Christopher R. K. Ching
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
- Interdepartmental Neuroscience Graduate Program, UCLA School of Medicine, Los Angeles, California 90095, USA
| | - Vincent Chouraki
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167—RID-AGE—Risk factors and molecular determinants of aging-related diseases, F-59000 Lille, France
| | | | - Fabrice Crivello
- IMN UMR5293, GIN, CNRS, CEA, University of Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux, France
| | - Anouk Den Braber
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Nhat Trung Doan
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
| | - Stefan Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, 01307 Dresden, Germany
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
| | - Sudheer Giddaluru
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 5021 Bergen, Norway
| | - Aaron L. Goldman
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
| | - Rebecca F. Gottesman
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
| | - Oliver Grimm
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, 68159 Mannheim, Germany
| | - Michael E. Griswold
- Department of Data Science, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
| | - Tulio Guadalupe
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD Nijmegen, The Netherlands
- International Max Planck Research School for Language Sciences, 6525 XD Nijmegen, The Netherlands
| | - Boris A. Gutman
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Johanna Hass
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, 01307 Dresden, Germany
| | - Unn K. Haukvik
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, 0319 Oslo, Norway
| | - David Hoehn
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
| | - Avram J. Holmes
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Department of Psychology, Yale University, New Haven, Connecticut 06520, USA
| | - Martine Hoogman
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Deborah Janowitz
- Department of Psychiatry, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Tianye Jia
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Kjetil N. Jørgensen
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, 0319 Oslo, Norway
| | | | - Dalia Kasperaviciute
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, SL9 0RJ, UK
- Department of Medicine, Imperial College London, London SW7 2AZ, UK
| | - Sungeun Kim
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Marieke Klein
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Bernd Kraemer
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, 69120, Germany
| | - Phil H. Lee
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts 02141, USA
- Lurie Center for Autism, Massachusetts General Hospital, Harvard Medical School, Lexington, Massachusetts, 02421, USA
| | - David C. M. Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Lorna M. Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Michelle Luciano
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Christine Macare
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Andre F. Marquand
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, 6525 EN, The Netherlands
| | - Mar Matarin
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, SL9 0RJ, UK
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Karen A. Mather
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Manuel Mattheisen
- Department of Biomedicine, Aarhus University, DK-8000 Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, DK-8000 Aarhus and Copenhagen, Denmark
- Center for integrated Sequencing, iSEQ, Aarhus University, DK-8000 Aarhus, Denmark
| | - David R. McKay
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut 06114, USA
| | - Yuri Milaneschi
- Department of Psychiatry, EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, 1081 HL Amsterdam, The Netherlands
| | - Susana Muñoz Maniega
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Kwangsik Nho
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Allison C. Nugent
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
| | - Paul Nyquist
- Department of Neurology, Department of Anesthesia/Critical Care Medicine, Department of Neurosurgery, Johns Hopkins, USA600 N. Wolfe St, Baltimore, Maryland 21287, USA
| | - Loes M. Olde Loohuis
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California 90095, USA
| | - Jaap Oosterlaan
- Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, 1081 HV, The Netherlands
| | - Martina Papmeyer
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
- Division of Systems Neuroscience of Psychopathology, Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, 3060, Switzerland
| | - Lukas Pirpamer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Benno Pütz
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
| | - Adaikalavan Ramasamy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
- The Jenner Institute Laboratories, University of Oxford, Oxford OX3 7DQ, UK
| | - Jennifer S. Richards
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 6525 GC, The Netherlands
| | - Shannon L. Risacher
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Roberto Roiz-Santiañez
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, 39008 Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, 39011, Spain
| | - Nanda Rommelse
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 6525 GC, The Netherlands
| | - Stefan Ropele
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Emma J. Rose
- Psychosis Research Group, Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College, Dublin, Dublin 2, Ireland
| | - Natalie A. Royle
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Tatjana Rundek
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | | | - Arvin Saremi
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Claudia L. Satizabal
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Victoria, 3502, Australia
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, 3502, Australia
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| | - Andrew J. Schork
- Multimodal Imaging Laboratory, Department of Neurosciences, University of California, San Diego, California 92093, USA
- Department of Cognitive Sciences, University of California, San Diego, California 92161, USA
| | - Li Shen
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Jean Shin
- Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8
| | - Elena Shumskaya
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, 6525 EN, The Netherlands
| | - Albert V. Smith
- Icelandic Heart Association, Kopavogur, 201, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland
| | - Emma Sprooten
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut 06114, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA
| | - Lachlan T. Strike
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, Australia
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Diana Tordesillas-Gutierrez
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, 39011, Spain
- Neuroimaging Unit, Technological Facilities. Valdecilla Biomedical Research Institute IDIVAL, Santander, Cantabria, 39011, Spain
| | | | - Daniah Trabzuni
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia
| | - Stella Trompet
- Department of Cardiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
| | - Dhananjay Vaidya
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Suite 8028, Baltimore, Maryland 21287, USA
| | - Jeroen Van der Grond
- Department of Radiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
| | - Sven J. Van der Lee
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
| | - Dennis Van der Meer
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Marjolein M. J. Van Donkelaar
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Kristel R. Van Eijk
- Brain Center Rudolf Magnus, Human Neurogenetics Unit, UMC Utrecht, 3584 CG Utrecht, The Netherlands
| | - Theo G. M. Van Erp
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California 92617, USA
| | - Daan Van Rooij
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Esther Walton
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, 01307 Dresden, Germany
- Department of Psychology, Georgia State University, Atlanta, Georgia 30302, USA
| | - Lars T. Westlye
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
- Department of Psychology, Georgia State University, Atlanta, Georgia 30302, USA
| | - Christopher D. Whelan
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
- The Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
| | - Beverly G. Windham
- NORMENT—KG Jebsen Centre, Department of Psychology, University of Oslo, 0317 Oslo, Norway
| | - Anderson M. Winkler
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
| | - Katharina Wittfeld
- Department of Psychiatry, University Medicine Greifswald, 17489 Greifswald, Germany
- FMRIB Centre, University of Oxford, Oxford OX3 9DU, UK
| | - Girma Woldehawariat
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
| | - Christiane Wolf
- German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 17487 Greifswald, Germany
| | - Thomas Wolfers
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Lisa R. Yanek
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Suite 8028, Baltimore, Maryland 21287, USA
| | - Jingyun Yang
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- University of Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Wuerzburg, 97080, Germany
| | - Alex Zijdenbos
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
| | - Marcel P. Zwiers
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, 6525 EN, The Netherlands
| | - Ingrid Agartz
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, 0319 Oslo, Norway
- Biospective Inc, Montreal, Quebec, Canada, 6100 Avenue Royalmount, Montréal, Québec, Canada H4P 2R2
| | - Laura Almasy
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville/Edinburg/San Antonio, Texas, 78250, USA
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - David Ames
- Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 29104, USA
- National Ageing Research Institute, Royal Melbourne Hospital, Melbourne, Victoria 3052, Australia
| | - Philippe Amouyel
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167—RID-AGE—Risk factors and molecular determinants of aging-related diseases, F-59000 Lille, France
| | - Ole A. Andreassen
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
| | - Sampath Arepalli
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Amelia A. Assareh
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Sandra Barral
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain; G.H. Sergievsky Center; Department of Neurology. Columbia University Medical Center, 639 West 1168th Street, New York, New York 10032, USA
| | - Mark E. Bastin
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Diane M. Becker
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Suite 8028, Baltimore, Maryland 21287, USA
| | - James T. Becker
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - David A. Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- University of Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Wuerzburg, 97080, Germany
| | - John Blangero
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Hans van Bokhoven
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Dorret I. Boomsma
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Departments of Psychiatry, Neurology, and Psychology, University of Pittsburgh, 3501 Forbes Ave., Suite 830, Pittsburgh, Pennsylvania 15213, USA
| | - Rachel M. Brouwer
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Han G. Brunner
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Dementia Collaborative Research Centre—Assessment and Better Care, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Randy L. Buckner
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Department of Clinical Genetics and GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands
| | - Jan K. Buitelaar
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 6525 GC, The Netherlands
| | - Kazima B. Bulayeva
- Department of Psychology, Center for Brain Science, Harvard University, Cambridge, Massachusetts 02138, USA
| | - Wiepke Cahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Vince D. Calhoun
- Department of Evolution and Genetics, Dagestan State University, Makhachkala 367000, Dagestan, Russia
- The Mind Research Network & LBERI, Albuquerque, New Mexico 87106, USA
| | - Dara M. Cannon
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
- Department of ECE, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | | | - Ching-Yu Cheng
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore, 169857, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, H91 TK33 Galway, Ireland
| | - Sven Cichon
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119077, Singapore
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland
- Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
| | - Mark R. Cookson
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Aiden Corvin
- Psychosis Research Group, Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College, Dublin, Dublin 2, Ireland
| | - Benedicto Crespo-Facorro
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, 39008 Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, 39011, Spain
| | - Joanne E. Curran
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Michael Czisch
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
| | - Anders M. Dale
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, 52425 Jülich, Germany
- Center for Multimodal Imaging and Genetics, University of California, San Diego, California 92093, USA
| | - Gareth E. Davies
- Departments of Neurosciences, Radiology, Psychiatry, and Cognitive Science, University of California, San Diego, California 92093, USA
| | | | - Eco J. C. De Geus
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Philip L. De Jager
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
- Program in Translational NeuroPsychiatric Genomics, Departments of Neurology & Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA
- Harvard Medical School, Boston, Massachusetts, 02115, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, 02142, USA
| | | | - Ian J. Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Stéphanie Debette
- INSERM Unit U1219, University of Bordeaux, 33076 Bordeaux, France
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Faculty of Health and Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Queensland 4059, Australia
| | - Charles DeCarli
- Department of Neurology, Bordeaux University Hospital, Bordeaux, 33076, France
| | - Norman Delanty
- The Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
- Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience, University of California at Davis, 4860 Y Street, Suite 3700, Sacramento, California 95817, USA
| | | | - Anita DeStefano
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118 USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Allissa Dillman
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Srdjan Djurovic
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, 1070 Brussels, Belgium
| | - Gary Donohoe
- Department of Medical Genetics, Oslo University Hospital, 0420 Oslo, Norway
- Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition & Genomics Centre (NICOG) & NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, H91 TK33, Galway, Ireland
| | - Wayne C. Drevets
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
| | - Ravi Duggirala
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Thomas D. Dyer
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Christian Enzinger
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Susanne Erk
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Thomas Espeseth
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
- Department of Psychology, Georgia State University, Atlanta, Georgia 30302, USA
| | - Iryna O. Fedko
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Guillén Fernández
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Luigi Ferrucci
- Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Department of Psychiatry and Psychotherapy, Charitéplatz 1, 10117 Berlin, Germany
| | - Simon E. Fisher
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD Nijmegen, The Netherlands
| | - Debra A. Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Intramural Research Program of the National Institute on Aging, Baltimore, Maryland, 21224, USA
| | - Ian Ford
- Department of Neurological Sciences & Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois 60616, USA
| | - Myriam Fornage
- Robertson Centre for Biostatistics, University of Glasgow, Glasgow, G41 4DQ, UK
| | - Tatiana M. Foroud
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA
| | - Peter T. Fox
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Clyde Francks
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD Nijmegen, The Netherlands
| | - Masaki Fukunaga
- University of Texas Health Science Center, San Antonio, Texas 78229, USA
| | - J. Raphael Gibbs
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - David C. Glahn
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut 06114, USA
| | - Randy L. Gollub
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Harald H. H. Göring
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Robert C. Green
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Division of Cerebral Integration, National Institute for Physiological Sciences, Aichi, 444-8585, Japan
| | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, 69120, Germany
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, 201, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland
| | - Sebastian Guelfi
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Asta K. Håberg
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
- Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, 7491, Norway
| | - Narelle K. Hansell
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, Australia
| | - John Hardy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Catharina A. Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Ryota Hashimoto
- Department of Radiology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, 7030, Norway
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
| | - Katrin Hegenscheid
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, 565-0871, Japan
| | - Andreas Heinz
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Stephanie Le Hellard
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 5021 Bergen, Norway
| | - Dena G. Hernandez
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Dirk J. Heslenfeld
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, 72076, Germany
| | - Beng-Choon Ho
- Department of Psychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - Pieter J. Hoekstra
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Wolfgang Hoffmann
- Institute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
- FMRIB Centre, University of Oxford, Oxford OX3 9DU, UK
| | - Albert Hofman
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115 USA
| | - Florian Holsboer
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
- Department of Psychiatry, University of Iowa, Iowa City, Iowa 52242, USA
| | - Georg Homuth
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115 USA
| | - Norbert Hosten
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, 565-0871, Japan
| | - Jouke-Jan Hottenga
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | | | - Hilleke E. Hulshoff Pol
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Masashi Ikeda
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Clifford R. Jack Jr
- Translational Genomics Research Institute, Neurogenomics Division, 445N Fifth Street, Phoenix, Arizona 85004, USA
| | - Mark Jenkinson
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
| | - Robert Johnson
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan
| | - Erik G. Jönsson
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Biospective Inc, Montreal, Quebec, Canada, 6100 Avenue Royalmount, Montréal, Québec, Canada H4P 2R2
| | - J. Wouter Jukema
- Department of Cardiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
| | - René S. Kahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Ryota Kanai
- Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland 21201, USA
- School of Psychology, University of Sussex, Brighton BN1 9QH, UK
| | - Iwona Kloszewska
- Institute of Cognitive Neuroscience, University College London, London WC1N 3AR, UK
| | - David S. Knopman
- Department of Neuroinformatics, Araya Brain Imaging, Tokyo, 102-0093, Japan
| | | | - John B. Kwok
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, 55905, USA
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, 21228, USA
| | - Stephen M. Lawrie
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Hervé Lemaître
- Neuroscience Research Australia, Sydney, New South Wales 2031, Australia
| | - Xinmin Liu
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
- School of Medical Sciences, UNSW, Sydney, New South Wales 2052, Australia
| | - Dan L. Longo
- INSERM UMR 1000 “Neuroimaging and Psychiatry”, Service Hospitalier Frédéric Joliot; University Paris-Sud, Université Paris-Saclay, University Paris Descartes, Maison de Solenn, Paris, 91400, France
| | - Oscar L. Lopez
- Columbia University Medical Center, New York, New York 10032, USA
| | - Simon Lovestone
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA
- Departments of Neurology and Psychiatry, University of Pittsburgh, 3501 Forbes Ave., Suite 830, Pittsburgh Pennsylvania 15213, USA
| | - Oliver Martinez
- Department of Neurology, Bordeaux University Hospital, Bordeaux, 33076, France
| | - Jean-Luc Martinot
- Neuroscience Research Australia, Sydney, New South Wales 2031, Australia
| | - Venkata S. Mattay
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
- Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK
| | - Colm McDonald
- Department of ECE, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Andrew M. McIntosh
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Francis J. McMahon
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
| | - Katie L. McMahon
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Patrizia Mecocci
- Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland 4072, Australia
| | - Ingrid Melle
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
| | - Andreas Meyer-Lindenberg
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, 68159 Mannheim, Germany
| | - Sebastian Mohnke
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Grant W. Montgomery
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Derek W. Morris
- Department of Medical Genetics, Oslo University Hospital, 0420 Oslo, Norway
| | - Thomas H. Mosley
- NORMENT—KG Jebsen Centre, Department of Psychology, University of Oslo, 0317 Oslo, Norway
| | - Thomas W. Mühleisen
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland
- Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
| | - Bertram Müller-Myhsok
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
- Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, 06132 Perugia, Italy
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Michael A. Nalls
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Matthias Nauck
- University of Liverpool, Institute of Translational Medicine, Liverpool L69 3BX, UK
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Thomas E. Nichols
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
- German Center for Cardiovascular Research (DZHK e.V.), partner site Greifswald, Greifswald, 17475, Germany
| | - Wiro J. Niessen
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
- Department of Statistics & WMG, University of Warwick, Coventry CV4 7AL, UK
- Department of Medical Informatics Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Markus M. Nöthen
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland
- Faculty of Applied Sciences, Delft University of Technology, Delft, 2628 CD, The Netherlands
| | - Lars Nyberg
- Department of Integrative Medical Biology and Umeå Center for Functional Brain Imaging, Umeå University, 901 87 Umeå, Sweden
| | - Kazutaka Ohi
- Department of Radiology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, 7030, Norway
| | - Rene L. Olvera
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Roel A. Ophoff
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California 90095, USA
| | | | - Tomas Paus
- Department of Genomics, Life & Brain Center, University of Bonn, 53127 Bonn, Germany
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada M6A 2E1
- Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada M5T 1R8
| | - Zdenka Pausova
- Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8
- Child Mind Institute, New York, New York, 10022, USA
| | - Brenda W. J. H. Penninx
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| | - G. Bruce Pike
- Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada T2N 4N1
| | - Steven G. Potkin
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California 92617, USA
| | - Bruce M. Psaty
- Department of Clinical Neuroscience, University of Calgary, Calgary, Alberta, Canada T2N 4N1
| | - Simone Reppermund
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Departments of Epidemiology, Medicine and Health Services, University of Washington, Seattle, WA, USA Group Health Research Institute, Group Health, 1730 Minor Avenue/Suite 1360, Seattle, Washington 98101, USA
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, 68159 Mannheim, Germany
| | - Joshua L. Roffman
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
| | | | - Jerome I. Rotter
- Department of Developmental Disability Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Mina Ryten
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
| | - Ralph L. Sacco
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Pediatrics at Harbor-UCLA Medical Center, Torrance, California 90502, USA
| | - Perminder S. Sachdev
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Andrew J. Saykin
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA
| | - Reinhold Schmidt
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Helena Schmidt
- Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia
| | - Peter R. Schofield
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, 55905, USA
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, 21228, USA
| | | | - Andrew Simmons
- Institute of Molecular Biology and Biochemistry, Medical University Graz, Harrachgasse 21/III, 8010 Graz, Austria
- Department of Neuroimaging, Institute of Psychiatry, King's College London, London SE5 8AF, UK
- Biomedical Research Centre for Mental Health, King's College London, London SE5 8AF, UK
| | - Andrew Singleton
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Sanjay M. Sisodiya
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, SL9 0RJ, UK
| | - Colin Smith
- Biomedical Research Unit for Dementia, King's College London, London SE5 8AF, UK
| | - Jordan W. Smoller
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts 02141, USA
| | - Hilkka Soininen
- MRC Edinburgh Brain Bank, University of Edinburgh, Academic Department of Neuropathology, Centre for Clinical Brain Sciences, Edinburgh, EH16 4SB UK
- Institute of Clinical Medicine, Neurology, University of Eastern Finland, FI-70211 Kuopio, Finland
| | - Vidar M. Steen
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 5021 Bergen, Norway
| | - David J. Stott
- Neurocentre Neurology, Kuopio University Hospital, FI-70211 Kuopio, Finland
| | - Jessika E. Sussmann
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Arthur W. Toga
- Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, G4 0SF, UK
| | - Bryan J. Traynor
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Juan Troncoso
- Laboratory of Neuro Imaging, Institute for Neuroimaging and Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033, USA
| | - Magda Tsolaki
- Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21205, USA
| | - Christophe Tzourio
- INSERM Unit U1219, University of Bordeaux, 33076 Bordeaux, France
- 3rd Department of Neurology, "G. Papanicolaou", Hospital, Aristotle University of Thessaloniki, Thessaloniki, 57010, Greece
| | - Andre G. Uitterlinden
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219, Bordeaux, F-33000, France
| | - Maria C. Valdés Hernández
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Marcel Van der Brug
- Department of Internal Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Aad van der Lugt
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | | | - Neeltje E. M. Van Haren
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Dennis van 't Ent
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Marie-Jose Van Tol
- Department of Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
| | - Badri N. Vardarajan
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain; G.H. Sergievsky Center; Department of Neurology. Columbia University Medical Center, 639 West 1168th Street, New York, New York 10032, USA
| | - Bruno Vellas
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, 9713 AW Groningen, the Netherlands
| | - Dick J. Veltman
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Henrik Walter
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Joanna M. Wardlaw
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Thomas H. Wassink
- Department of Internal Medicine and Geriatric Medicine, INSERM U1027, University of Toulouse, Toulouse, 31024, France
| | - Michael E. Weale
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
| | - Daniel R. Weinberger
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
- Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
| | - Michael W. Weiner
- Departments of Psychiatry, Neurology, Neuroscience and the Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Eric Westman
- Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center, University of California, San Francisco, California 94121, USA
| | - Tonya White
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, SE-141 57 Huddinge, Sweden
| | - Tien Y. Wong
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore, 169857, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, H91 TK33 Galway, Ireland
| | - Clinton B. Wright
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Pediatrics at Harbor-UCLA Medical Center, Torrance, California 90502, USA
| | - Ronald H. Zielke
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan
| | - Alan B. Zonderman
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, 3015 CE Rotterdam, The Netherlands
| | - Nicholas G. Martin
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Cornelia M. Van Duijn
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
| | - Margaret J. Wright
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, Australia
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - W. T. Longstreth
- Laboratory of Epidemiology & Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Gunter Schumann
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Hans J. Grabe
- Department of Psychiatry, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Barbara Franke
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Lenore J. Launer
- Departments of Neurology and Epidemiology, University of Washington, 325 Ninth Avenue, Seattle, Washington 98104-2420, USA
| | - Sarah E. Medland
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Sudha Seshadri
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Paul M. Thompson
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - M. Arfan Ikram
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
- Intramural Research Program, NIA, NIH, 7201 Wisconsin Ave, Suite 3C-309, Bethesda, Maryland 20892, USA
| |
Collapse
|
19
|
Hodgson K, Almasy L, Knowles EEM, Kent JW, Curran JE, Dyer TD, Göring HHH, Olvera RL, Woolsey MD, Duggirala R, Fox PT, Blangero J, Glahn DC. The genetic basis of the comorbidity between cannabis use and major depression. Addiction 2017; 112:113-123. [PMID: 27517884 PMCID: PMC5148647 DOI: 10.1111/add.13558] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2015] [Revised: 04/06/2016] [Accepted: 08/09/2016] [Indexed: 12/15/2022]
Abstract
BACKGROUND AND AIMS While the prevalence of major depression is elevated among cannabis users, the role of genetics in this pattern of comorbidity is not clear. This study aimed to estimate the heritability of cannabis use and major depression, quantify the genetic overlap between these two traits and localize regions of the genome that segregate in families with cannabis use and major depression. DESIGN Family-based univariate and bivariate genetic analysis. SETTING San Antonio, Texas, USA. PARTICIPANTS Genetics of Brain Structure and Function study (GOBS) participants: 1284 Mexican Americans from 75 large multi-generation families and an additional 57 genetically unrelated spouses. MEASUREMENTS Phenotypes of life-time history of cannabis use and major depression, measured using the semistructured MINI-Plus interview. Genotypes measured using ~1 M single nucleotide polymorphisms (SNPs) on Illumina BeadChips. A subselection of these SNPs were used to build multi-point identity-by-descent matrices for linkage analysis. FINDINGS Both cannabis use [h2 = 0.614, P = 1.00 × 10-6 , standard error (SE) = 0.151] and major depression (h2 = 0.349, P = 1.06 × 10-5 , SE = 0.100) are heritable traits, and there is significant genetic correlation between the two (ρg = 0.424, P = 0.0364, SE = 0.195). Genome-wide linkage scans identify a significant univariate linkage peak for major depression on chromosome 22 [logarithm of the odds (LOD) = 3.144 at 2 centimorgans (cM)], with a suggestive peak for cannabis use on chromosome 21 (LOD = 2.123 at 37 cM). A significant pleiotropic linkage peak influencing both cannabis use and major depression was identified on chromosome 11 using a bivariate model (LOD = 3.229 at 112 cM). Follow-up of this pleiotropic signal identified a SNP 20 kb upstream of NCAM1 (rs7932341) that shows significant bivariate association (P = 3.10 × 10-5 ). However, this SNP is rare (seven minor allele carriers) and does not drive the linkage signal observed. CONCLUSIONS There appears to be a significant genetic overlap between cannabis use and major depression among Mexican Americans, a pleiotropy that appears to be localized to a region on chromosome 11q23 that has been linked previously to these phenotypes.
Collapse
Affiliation(s)
- Karen Hodgson
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT,Correspondence to Karen Hodgson Ph.D., Department of Psychiatry, Yale School of Medicine, New Haven, CT
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
| | - Emma E. M. Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
| | - Jack W. Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Joanne E. Curran
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
| | - Thomas D. Dyer
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
| | - Harald H. H. Göring
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
| | - Rene L. Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Mary D. Woolsey
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
| | - Peter T. Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, South Texas Veterans Health System, 7400 Merton Minter, San Antonio, TX
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
| | - David C. Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT
| |
Collapse
|
20
|
Adams HHH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beiser A, Bernard M, Bis JC, Blanken LME, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chauhan G, Chen Q, Ching CRK, Cuellar-Partida G, Braber AD, Doan NT, Ehrlich S, Filippi I, Ge T, Giddaluru S, Goldman AL, Gottesman RF, Greven CU, Grimm O, Griswold ME, Guadalupe T, Hass J, Haukvik UK, Hilal S, Hofer E, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liao J, Liewald DCM, Lopez LM, Luciano M, Macare C, Marquand A, Matarin M, Mather KA, Mattheisen M, Mazoyer B, McKay DR, McWhirter R, Milaneschi Y, Mirza-Schreiber N, Muetzel RL, Maniega SM, Nho K, Nugent AC, Loohuis LMO, Oosterlaan J, Papmeyer M, Pappa I, Pirpamer L, Pudas S, Pütz B, Rajan KB, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Rose EJ, Royle NA, Rundek T, Sämann PG, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Thomson R, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Vaidya D, Van der Grond J, Van der Meer D, Van Donkelaar MMJ, Van Eijk KR, Van Erp TGM, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Woldehawariat G, Wolf C, Wolfers T, Xu B, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Aggarwal NT, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Chen C, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Geus EJC, De Jager PL, de Zubicaray GI, Delanty N, Depondt C, DeStefano AL, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Erk S, Espeseth T, Evans DA, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HHH, Grabe HJ, Green RC, Gruber O, Gudnason V, Guelfi S, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Hulshoff Pol HE, Ikeda M, Ikram MK, Jack CR, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Longstreth WT, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon KL, McMahon FJ, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BWJH, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schofield PR, Sigurdsson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Srikanth V, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Tiemeier H, Toga AW, Traynor BJ, Troncoso J, Turner JA, Tzourio C, Uitterlinden AG, Hernández MCV, Van der Brug M, Van der Lugt A, Van der Wee NJA, Van Duijn CM, Van Haren NEM, Van T Ent D, Van Tol MJ, Vardarajan BN, Veltman DJ, Vernooij MW, Völzke H, Walter H, Wardlaw JM, Wassink TH, Weale ME, Weinberger DR, Weiner MW, Wen W, Westman E, White T, Wong TY, Wright CB, Zielke HR, Zonderman AB, Deary IJ, DeCarli C, Schmidt H, Martin NG, De Craen AJM, Wright MJ, Launer LJ, Schumann G, Fornage M, Franke B, Debette S, Medland SE, Ikram MA, Thompson PM. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci 2016; 19:1569-1582. [PMID: 27694991 PMCID: PMC5227112 DOI: 10.1038/nn.4398] [Citation(s) in RCA: 149] [Impact Index Per Article: 18.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Accepted: 08/31/2016] [Indexed: 02/08/2023]
Abstract
Intracranial volume reflects the maximally attained brain size during development, and remains stable with loss of tissue in late life. It is highly heritable, but the underlying genes remain largely undetermined. In a genome-wide association study of 32,438 adults, we discovered five previously unknown loci for intracranial volume and confirmed two known signals. Four of the loci were also associated with adult human stature, but these remained associated with intracranial volume after adjusting for height. We found a high genetic correlation with child head circumference (ρgenetic = 0.748), which indicates a similar genetic background and allowed us to identify four additional loci through meta-analysis (Ncombined = 37,345). Variants for intracranial volume were also related to childhood and adult cognitive function, and Parkinson's disease, and were enriched near genes involved in growth pathways, including PI3K-AKT signaling. These findings identify the biological underpinnings of intracranial volume and their link to physiological and pathological traits.
Collapse
Affiliation(s)
- Hieab H H Adams
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Derrek P Hibar
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
| | - Vincent Chouraki
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, Lille, France
- Framingham Heart Study, Framingham, Massachusetts, USA
| | - Jason L Stein
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
- Department of Genetics and UNC Neuroscience Center, University of North Carolina (UNC), Chapel Hill, North Carolina, USA
| | - Paul A Nyquist
- Department of Neurology, Department of Anesthesia/Critical Care Medicine, Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA
| | | | - Stella Trompet
- Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Alejandro Arias-Vasquez
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Sudha Seshadri
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Framingham Heart Study, Framingham, Massachusetts, USA
| | - Sylvane Desrivières
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Ashley H Beecham
- Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Neda Jahanshad
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
| | - Katharina Wittfeld
- German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany
- Department of Psychiatry, University Medicine Greifswald, Greifswald, Germany
| | | | - Lucija Abramovic
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Saud Alhusaini
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada
- The Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Najaf Amin
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
| | - Micael Andersson
- Department of Integrative Medical Biology and Umeå center for Functional Brain Imaging, Umeå University, Umeå, Sweden
| | - Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, USA
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois, USA
| | - Benjamin S Aribisala
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Department of Computer Science, Lagos State University, Lagos, Nigeria
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
| | - Nicola J Armstrong
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Mathematics and Statistics, Murdoch University, Perth, Australia
| | - Lavinia Athanasiu
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
| | - Tomas Axelsson
- Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Alexa Beiser
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Framingham Heart Study, Framingham, Massachusetts, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA
| | - Manon Bernard
- Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - Joshua C Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
| | - Laura M E Blanken
- Generation R Study Group, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Susan H Blanton
- Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Marc M Bohlken
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Marco P Boks
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Janita Bralten
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Adam M Brickman
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
- G.H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA
- Department of Neurology, Columbia University Medical Center, New York, New York, USA
| | - Owen Carmichael
- Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
| | - M Mallar Chakravarty
- Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Canada
- Department of Psychiatry and Biomedical Engineering, McGill University, Montreal, Canada
| | | | - Qiang Chen
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
| | - Christopher R K Ching
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
- Interdepartmental Neuroscience Graduate Program, UCLA School of Medicine, Los Angeles, California, USA
| | | | - Anouk Den Braber
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Nhat Trung Doan
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Stefan Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Germany
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, North Carolina, USA
| | - Irina Filippi
- NSERM Unit 1000 ″Neuroimaging and Psychiatry″, University Paris Sud, University Paris Descartes, Paris, France
- Maison de Solenn, Adolescent Psychopathology and Medicine Department, APHP Hospital Cochin, Paris, France
| | - Tian Ge
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, North Carolina, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA
| | - Sudheer Giddaluru
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - Aaron L Goldman
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
| | - Rebecca F Gottesman
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Corina U Greven
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
- King's College London, Medical Research Council Social, Genetic and Developmental Psychiatry Centre, Institute of Psychology, Psychiatry and Neurosciene, London, UK
| | - Oliver Grimm
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
| | - Michael E Griswold
- Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Tulio Guadalupe
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
- International Max Planck Research School for Language Sciences, Nijmegen, the Netherlands
| | - Johanna Hass
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden, Germany
| | - Unn K Haukvik
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, Oslo, Norway
| | - Saima Hilal
- Department of Pharmacology, National University of Singapore, Singapore
- Memory Aging and Cognition Centre (MACC), National University Health System, Singapore
| | - Edith Hofer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Austria, Graz, Austria
- Institute of Medical Informatics, Statistics and Documentation, Medical University Graz, Austria, Graz, Austria
| | - David Hoehn
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Avram J Holmes
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Department of Psychology, Yale University, New Haven, Connecticut, USA
| | - Martine Hoogman
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Deborah Janowitz
- Department of Psychiatry, University Medicine Greifswald, Greifswald, Germany
| | - Tianye Jia
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Dalia Kasperaviciute
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, UK
- Department of Medicine, Imperial College London, London, UK
| | - Sungeun Kim
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Marieke Klein
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Bernd Kraemer
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany
| | - Phil H Lee
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA
- Lurie Center for Autism, Massachusetts General Hospital, Harvard Medical School, Lexington, Massachusetts, USA
| | - Jiemin Liao
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
| | - David C M Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Lorna M Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Michelle Luciano
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Christine Macare
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Andre Marquand
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands
| | - Mar Matarin
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, UK
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Karen A Mather
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Manuel Mattheisen
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus and Copenhagen, Denmark
- Center for integrated Sequencing, iSEQ, Aarhus University, Aarhus, Denmark
| | | | - David R McKay
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut, USA
| | - Rebekah McWhirter
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
| | - Yuri Milaneschi
- Department of Psychiatry, EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam, The Netherlands
| | - Nazanin Mirza-Schreiber
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Ryan L Muetzel
- Generation R Study Group, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Susana Muñoz Maniega
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Kwangsik Nho
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Allison C Nugent
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
| | - Loes M Olde Loohuis
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California, USA
| | - Jaap Oosterlaan
- Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, the Netherlands
| | - Martina Papmeyer
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
- Division of Systems Neuroscience of Psychopathology, Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland
| | - Irene Pappa
- Generation R Study Group, Erasmus Medical Center, Rotterdam, the Netherlands
- School of Pedagogical and Educational Sciences, Erasmus University Rotterdam, Rotterdam, the Netherlands
| | - Lukas Pirpamer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Austria, Graz, Austria
| | - Sara Pudas
- Department of Integrative Medical Biology and Umeå center for Functional Brain Imaging, Umeå University, Umeå, Sweden
| | - Benno Pütz
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Kumar B Rajan
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA
| | - Adaikalavan Ramasamy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Medical and Molecular Genetics, King's College London, London, UK
- The Jenner Institute Laboratories, University of Oxford, Oxford, UK
| | - Jennifer S Richards
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
| | - Shannon L Risacher
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Roberto Roiz-Santiañez
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, Spain
| | - Nanda Rommelse
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
| | - Emma J Rose
- Psychosis Research Group, Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin
| | - Natalie A Royle
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Tatjana Rundek
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Philipp G Sämann
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Claudia L Satizabal
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Framingham Heart Study, Framingham, Massachusetts, USA
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
| | - Andrew J Schork
- Multimodal Imaging Laboratory, Department of Neurosciences, University of California, San Diego, USA
- Department of Cognitive Sciences, University of California, San Diego, USA
| | - Li Shen
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Jean Shin
- Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - Elena Shumskaya
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands
| | - Albert V Smith
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Emma Sprooten
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut, USA
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Lachlan T Strike
- QIMR Berghofer Medical Research Institute, Brisbane, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Australia
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Russell Thomson
- School of Computing Engineering and Mathematics, Western Sydney University, Parramatta, Australia
| | - Diana Tordesillas-Gutierrez
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, Spain
- Neuroimaging Unit,Technological Facilities. Valdecilla Biomedical Research Institute IDIVAL, Santander, Cantabria, Spain
| | | | - Daniah Trabzuni
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Dhananjay Vaidya
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Jeroen Van der Grond
- Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Dennis Van der Meer
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Marjolein M J Van Donkelaar
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Kristel R Van Eijk
- Brain Center Rudolf Magnus, Human Neurogenetics Unit, UMC Utrecht, Utrecht, the Netherlands
| | - Theo G M Van Erp
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California, USA
| | - Daan Van Rooij
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Esther Walton
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden, Germany
| | - Lars T Westlye
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- NORMENT - KG Jebsen Centre, Department of Psychology, University of Oslo, Oslo, Norway
| | - Christopher D Whelan
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
- The Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Beverly G Windham
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Anderson M Winkler
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- FMRIB Centre, University of Oxford, Oxford, UK
| | - Girma Woldehawariat
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
| | - Christiane Wolf
- University of Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Wuerzburg, Germany
| | - Thomas Wolfers
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Bing Xu
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Lisa R Yanek
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Jingyun Yang
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Alex Zijdenbos
- Biospective Inc, Montreal, Quebec, Canada, Montréal, Québec, Canada
| | - Marcel P Zwiers
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands
| | - Ingrid Agartz
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, Oslo, Norway
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden
| | - Neelum T Aggarwal
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - David Ames
- National Ageing Research Institute, Royal Melbourne Hospital, Melbourne, Australia
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Australia
| | - Philippe Amouyel
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, Lille, France
| | - Ole A Andreassen
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
| | - Sampath Arepalli
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Amelia A Assareh
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Sandra Barral
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
| | - Mark E Bastin
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Diane M Becker
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - James T Becker
- Departments of Psychiatry, Neurology, and Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Hans van Bokhoven
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Dorret I Boomsma
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Dementia Collaborative Research Centre - Assessment and Better Care, UNSW, Sydney, Australia
| | - Rachel M Brouwer
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Han G Brunner
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Randy L Buckner
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Department of Psychology, Center for Brain Science, Harvard University, Cambridge, Massachusetts, USA
| | - Jan K Buitelaar
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
| | - Kazima B Bulayeva
- Department of Evolution and Genetics, Dagestan State University, Makhachkala, Dagestan, Russia
| | - Wiepke Cahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Vince D Calhoun
- The Mind Research Network and LBERI, Albuquerque, New Mexico, USA
- Department of ECE, University of New Mexico, Albuquerque, New Mexico, USA
| | - Dara M Cannon
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | | | - Christopher Chen
- Department of Pharmacology, National University of Singapore, Singapore
- Memory Aging and Cognition Centre (MACC), National University Health System, Singapore
| | - Ching-Yu Cheng
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Sven Cichon
- Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Mark R Cookson
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Aiden Corvin
- Psychosis Research Group, Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin
| | - Benedicto Crespo-Facorro
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, Spain
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Michael Czisch
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Anders M Dale
- Center for Multimodal Imaging and Genetics, University of California, San Diego, California, USA
- Department of Neurosciences, University of California, San Diego, California, USA
- Department of Radiology, University of California, San Diego, California, USA
- Department of Psychiatry, University of California, San Diego, California, USA
- Department of Cognitive Science, University of California, San Diego, California, USA
| | - Gareth E Davies
- Avera Institute for Human Genetics, Sioux Falls, South Dakota, USA
- Program in Translational NeuroPsychiatric Genomics, Departments of Neurology and Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA
| | - Eco J C De Geus
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Philip L De Jager
- Harvard Medical School, Boston, Massachusetts, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA
- Broad Institute, Cambridge, Massachusetts, USA
| | - Greig I de Zubicaray
- Faculty of Health and Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Australia
| | - Norman Delanty
- The Royal College of Surgeons in Ireland, Dublin 2, Ireland
- Neurology Division, Beaumont Hospital, Dublin, 9, Ireland
| | - Chantal Depondt
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium
| | - Anita L DeStefano
- Framingham Heart Study, Framingham, Massachusetts, USA
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - Allissa Dillman
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Srdjan Djurovic
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
| | - Gary Donohoe
- Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition and Genomics Centre (NICOG) and NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
| | - Wayne C Drevets
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
- Janssen Research and Development, LLC, Titusville, New Jersey, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Thomas D Dyer
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Susanne Erk
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Thomas Espeseth
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- NORMENT - KG Jebsen Centre, Department of Psychology, University of Oslo, Oslo, Norway
| | - Denis A Evans
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA
| | - Iryna O Fedko
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Guillén Fernández
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Luigi Ferrucci
- Intramural Research Program of the National Institute on Aging, Baltimore, Maryland, USA
| | - Simon E Fisher
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Ian Ford
- Robertson Center for Biostatistics, University of Glasgow, Glasgow, UK
| | - Tatiana M Foroud
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Peter T Fox
- University of Texas Health Science Center, San Antonio, Texas, USA
| | - Clyde Francks
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
| | - Masaki Fukunaga
- Division of Cerebral Integration, National Institute for Physiological Sciences, Aichi, Japan
| | - J Raphael Gibbs
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - David C Glahn
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut, USA
| | - Randy L Gollub
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, North Carolina, USA
- Harvard Medical School, Boston, Massachusetts, USA
| | - Harald H H Göring
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Hans J Grabe
- Department of Psychiatry, University Medicine Greifswald, Greifswald, Germany
| | - Robert C Green
- Harvard Medical School, Boston, Massachusetts, USA
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Sebastian Guelfi
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Narelle K Hansell
- QIMR Berghofer Medical Research Institute, Brisbane, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Australia
| | - John Hardy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Catharina A Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Ryota Hashimoto
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan
| | - Katrin Hegenscheid
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Stephanie Le Hellard
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - Dena G Hernandez
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
| | - Dirk J Heslenfeld
- Department of Psychology, VU University Amsterdam, Amsterdam, the Netherlands
| | - Beng-Choon Ho
- Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA
| | - Pieter J Hoekstra
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Wolfgang Hoffmann
- German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Albert Hofman
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
| | - Florian Holsboer
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
- HMNC Brain Health, Munich, Germany
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
| | - Norbert Hosten
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
| | - Jouke-Jan Hottenga
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Hilleke E Hulshoff Pol
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Masashi Ikeda
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan
| | - M Kamran Ikram
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Pharmacology, National University of Singapore, Singapore
- Memory Aging and Cognition Centre (MACC), National University Health System, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore
| | - Clifford R Jack
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Robert Johnson
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland, USA
| | - Erik G Jönsson
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- FMRIB Centre, University of Oxford, Oxford, UK
| | - J Wouter Jukema
- Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
| | - René S Kahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Ryota Kanai
- School of Psychology, University of Sussex, Brighton, UK
- Institute of Cognitive Neuroscience, University College London, London, UK
- Department of Neuroinformatics, Araya Brain Imaging, Tokyo, Japan
| | | | - David S Knopman
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA
| | - John B Kwok
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, UNSW, Sydney, Australia
| | - Stephen M Lawrie
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Hervé Lemaître
- NSERM Unit 1000 ″Neuroimaging and Psychiatry″, University Paris Sud, University Paris Descartes, Paris, France
- Maison de Solenn, Adolescent Psychopathology and Medicine Department, APHP Hospital Cochin, Paris, France
| | - Xinmin Liu
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
- Columbia University Medical Center, New York, New York, USA
| | - Dan L Longo
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
| | - W T Longstreth
- Department of Neurology, University of Washington, Seattle, Washington, USA
- Department of Epidemiology, University of Washington, Seattle, Washington, USA
| | - Oscar L Lopez
- Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Simon Lovestone
- Department of Psychiatry, University of Oxford, Oxford, UK
- NIHR Dementia Biomedical Research Unit, King's College London, London, UK
| | - Oliver Martinez
- Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, California, USA
| | - Jean-Luc Martinot
- NSERM Unit 1000 ″Neuroimaging and Psychiatry″, University Paris Sud, University Paris Descartes, Paris, France
- Maison de Solenn, Adolescent Psychopathology and Medicine Department, APHP Hospital Cochin, Paris, France
| | - Venkata S Mattay
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Colm McDonald
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Andrew M McIntosh
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Katie L McMahon
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
| | - Francis J McMahon
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
| | - Patrizia Mecocci
- Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Perugia, Italy
| | - Ingrid Melle
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
| | - Andreas Meyer-Lindenberg
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
| | - Sebastian Mohnke
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | | | - Derek W Morris
- Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition and Genomics Centre (NICOG) and NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
| | - Thomas H Mosley
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Thomas W Mühleisen
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Bertram Müller-Myhsok
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- University of Liverpool, Institute of Translational Medicine, Liverpool, UK
| | - Michael A Nalls
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Matthias Nauck
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
- German Center for Cardiovascular Research (DZHK e.V.), partner site Greifswald, Germany
| | - Thomas E Nichols
- FMRIB Centre, University of Oxford, Oxford, UK
- Department of Statistics and Warwick Manufacturing Group, University of Warwick, Coventry, UK
| | - Wiro J Niessen
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
- Department of Medical Informatics Erasmus MC, Rotterdam, the Netherlands
- Faculty of Applied Sciences, Delft University of Technology, Delft, the Netherlands
| | - Markus M Nöthen
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany
| | - Lars Nyberg
- Department of Integrative Medical Biology and Umeå center for Functional Brain Imaging, Umeå University, Umeå, Sweden
| | - Kazutaka Ohi
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Rene L Olvera
- University of Texas Health Science Center, San Antonio, Texas, USA
| | - Roel A Ophoff
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California, USA
| | - Massimo Pandolfo
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium
| | - Tomas Paus
- Rotman Research Institute, University of Toronto, Toronto, Canada
- Departments of Psychology and Psychiatry, University of Toronto, Canada
- Child Mind Institute, New York, New York, USA
| | - Zdenka Pausova
- Hospital for Sick Children, University of Toronto, Toronto, Canada
- Department of Physiology, University of Toronto, Toronto, Canada
- Department of Nutritional Sciences, University of Toronto, Toronto, Canada
| | - Brenda W J H Penninx
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
| | - G Bruce Pike
- Department of Radiology, University of Calgary, Calgary, Canada
- Department of Clinical Neuroscience, University of Calgary, Calgary, Canada
| | - Steven G Potkin
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California, USA
| | - Bruce M Psaty
- Department of Epidemiology, University of Washington, Seattle, Washington, USA
- Department of Medicine, University of Washington, Seattle, Washington, USA
- Department of Health Services, University of Washington, Seattle, Washington, USA
- Group Health Research Institute, Group Health, Seattle, Washington, USA
| | - Simone Reppermund
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Department of Developmental Disability Neuropsychiatry, School of Psychiatry, UNSW Medicine, Australia
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
| | - Joshua L Roffman
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
| | - Nina Romanczuk-Seiferth
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Jerome I Rotter
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Pediatrics at Harbor-UCLA Medical Center, Torrance, California, USA
| | - Mina Ryten
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Medical and Molecular Genetics, King's College London, London, UK
| | - Ralph L Sacco
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia
| | - Andrew J Saykin
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Reinhold Schmidt
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Austria, Graz, Austria
| | - Peter R Schofield
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, UNSW, Sydney, Australia
| | | | - Andy Simmons
- Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK
- Biomedical Research Centre for Mental Health, King's College London, London, UK
- Biomedical Research Unit for Dementia, King's College London, London, UK
| | - Andrew Singleton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Sanjay M Sisodiya
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, UK
| | - Colin Smith
- MRC Edinburgh Brain Bank, University of Edinburgh, Academic Department of Neuropathology, Centre for Clinical Brain Sciences, Edinburgh, UK
| | - Jordan W Smoller
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA
| | - Hilkka Soininen
- Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland
- Neurocentre Neurology, Kuopio University Hospital, Finland
| | - Velandai Srikanth
- Department of Medicine, Peninsula Health and Monash University, Melbourne, Australia
| | - Vidar M Steen
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - David J Stott
- Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, UK
| | - Jessika E Sussmann
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Arthur W Toga
- Laboratory of Neuro Imaging, Institute for Neuroimaging and Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA
| | - Bryan J Traynor
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Juan Troncoso
- Brain Resource Center, Johns Hopkins University, Baltimore, Maryland, USA
| | | | - Christophe Tzourio
- Institute for Neurodegenerative Disorders, UMR 5293, CEA, CNRS, Université de Bordeaux, France
| | - Andre G Uitterlinden
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Maria C Valdés Hernández
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | | | - Aad Van der Lugt
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Nic J A Van der Wee
- Department of Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands
| | | | - Neeltje E M Van Haren
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Dennis Van T Ent
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Marie-Jose Van Tol
- Neuroimaging Centre, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Badri N Vardarajan
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
| | - Dick J Veltman
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
| | - Meike W Vernooij
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Joanna M Wardlaw
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Thomas H Wassink
- Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
| | - Michael E Weale
- Department of Medical and Molecular Genetics, King's College London, London, UK
| | - Daniel R Weinberger
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
- Departments of Psychiatry, Neurology, Neuroscience and the Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Michael W Weiner
- Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center, University of California, San Francisco, California, USA
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Eric Westman
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
| | - Tonya White
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Tien Y Wong
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
- Department of Evolution and Genetics, Dagestan State University, Makhachkala, Dagestan, Russia
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Clinton B Wright
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - H Ronald Zielke
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland, USA
| | - Alan B Zonderman
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Charles DeCarli
- Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, California, USA
| | - Helena Schmidt
- Institute of Molecular Biology and Biochemistry, Medical University Graz, Graz, Austria
| | | | - Anton J M De Craen
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands
| | - Margaret J Wright
- Queensland Brain Institute, University of Queensland, Brisbane, Australia
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
| | - Lenore J Launer
- Intramural Research Program, NIA, NIH, Bethesda, Maryland, USA
| | - Gunter Schumann
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Myriam Fornage
- Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - Barbara Franke
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Stéphanie Debette
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
- Department of Neurology, Bordeaux University Hospital, Bordeaux, France
| | - Sarah E Medland
- QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - M Arfan Ikram
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
- Department of Neurology, Erasmus MC, Rotterdam, the Netherlands
| | - Paul M Thompson
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
| |
Collapse
|
21
|
Dougherty DM, Olvera RL, Acheson A, Hill-Kapturczak N, Ryan SR, Mathias CW. Acute effects of methylphenidate on impulsivity and attentional behavior among adolescents comorbid for ADHD and conduct disorder. J Adolesc 2016; 53:222-230. [PMID: 27816696 DOI: 10.1016/j.adolescence.2016.10.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2016] [Revised: 10/26/2016] [Accepted: 10/27/2016] [Indexed: 01/24/2023]
Abstract
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and Conduct Disorder (CD) experience deficits in neuropsychological measures of attention, inhibition, and reward processes. Methylphenidate treatment for ADHD and CD has acute effects on these processes. Some of these same aspects of performance are separately described in the Behavioral Model of Impulsivity, which uses a modified approach to measurement. This study characterized the acute effects of methylphenidate attention, initiation, inhibition, and reward processes described in this model of impulsivity. Thirty-one adolescents from the United States of America with comorbid ADHD and CD completed measures of impulsivity (response initiation, response inhibition, and consequence) and attention following placebo, 20 mg, and 40 mg of a long-acting dose of methylphenidate. Methylphenidate effects on attentional performance was more robust than on any of the measures of impulsivity. Adolescent performance from this behavioral perspective is interpreted in the context of divergence from previous neuropsychological tests of acute methylphenidate effects.
Collapse
Affiliation(s)
- Donald M Dougherty
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Rene L Olvera
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Ashley Acheson
- Psychiatry and Behavioral Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - Nathalie Hill-Kapturczak
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Stacy R Ryan
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - Charles W Mathias
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
| |
Collapse
|
22
|
Hodgson K, Almasy L, Knowles EEM, Kent JW, Curran JE, Dyer TD, Göring HHH, Olvera RL, Fox PT, Pearlson GD, Krystal JH, Duggirala R, Blangero J, Glahn DC. Genome-wide significant loci for addiction and anxiety. Eur Psychiatry 2016; 36:47-54. [PMID: 27318301 DOI: 10.1016/j.eurpsy.2016.03.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2016] [Revised: 03/10/2016] [Accepted: 03/10/2016] [Indexed: 10/21/2022] Open
Abstract
BACKGROUND Psychiatric comorbidity is common among individuals with addictive disorders, with patients frequently suffering from anxiety disorders. While the genetic architecture of comorbid addictive and anxiety disorders remains unclear, elucidating the genes involved could provide important insights into the underlying etiology. METHODS Here we examine a sample of 1284 Mexican-Americans from randomly selected extended pedigrees. Variance decomposition methods were used to examine the role of genetics in addiction phenotypes (lifetime history of alcohol dependence, drug dependence or chronic smoking) and various forms of clinically relevant anxiety. Genome-wide univariate and bivariate linkage scans were conducted to localize the chromosomal regions influencing these traits. RESULTS Addiction phenotypes and anxiety were shown to be heritable and univariate genome-wide linkage scans revealed significant quantitative trait loci for drug dependence (14q13.2-q21.2, LOD=3.322) and a broad anxiety phenotype (12q24.32-q24.33, LOD=2.918). Significant positive genetic correlations were observed between anxiety and each of the addiction subtypes (ρg=0.550-0.655) and further investigation with bivariate linkage analyses identified significant pleiotropic signals for alcohol dependence-anxiety (9q33.1-q33.2, LOD=3.054) and drug dependence-anxiety (18p11.23-p11.22, LOD=3.425). CONCLUSIONS This study confirms the shared genetic underpinnings of addiction and anxiety and identifies genomic loci involved in the etiology of these comorbid disorders. The linkage signal for anxiety on 12q24 spans the location of TMEM132D, an emerging gene of interest from previous GWAS of anxiety traits, whilst the bivariate linkage signal identified for anxiety-alcohol on 9q33 peak coincides with a region where rare CNVs have been associated with psychiatric disorders. Other signals identified implicate novel regions of the genome in addiction genetics.
Collapse
Affiliation(s)
- K Hodgson
- Department of psychiatry, Yale University, School of Medicine, New Haven, CT, USA.
| | - L Almasy
- South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - E E M Knowles
- Department of psychiatry, Yale University, School of Medicine, New Haven, CT, USA
| | - J W Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - J E Curran
- South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - T D Dyer
- South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - H H H Göring
- South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - R L Olvera
- Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA
| | - P T Fox
- Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, USA; South Texas Veterans Health System, 7400, Merton Minter, San Antonio, TX, USA
| | - G D Pearlson
- Department of psychiatry, Yale University, School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA; Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA
| | - J H Krystal
- Department of psychiatry, Yale University, School of Medicine, New Haven, CT, USA; Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA; Clinical Neuroscience Division, VA National Center for PTSD, VA Connecticut Healthcare System, West Haven, CT, USA; Psychiatry Services, Yale-New Haven Hospital, New Haven, CT, USA
| | - R Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - J Blangero
- South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA
| | - D C Glahn
- Department of psychiatry, Yale University, School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| |
Collapse
|
23
|
Mathias CW, Charles NE, Liang Y, Acheson A, Lake SL, Ryan SR, Olvera RL, Dougherty DM. Pubertal Maturation Compression and Behavioral Impulsivity among Boys at Increased Risk for Substance Use. Addict Disord Their Treat 2016; 15:61-73. [PMID: 27199616 PMCID: PMC4868185 DOI: 10.1097/adt.0000000000000077] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
OBJECTIVES While early onset of puberty among girls has been related to substance use involvement and other adverse outcomes, less research has examined pubertal development and outcomes in boys. Further, research on puberty has not been conducted in the context of other risk factors for substance use involvement such as impulsivity. To address these gaps, this study characterized boys' pubertal development from preadolescence to mid-adolescence and related it to substance use risk and behavioral impulsivity. METHODS A sample of 153 boys completed the Pubertal Development Scale to assess perception of their pubertal development relative to same age peers from ages 10 to 16 years, at 6-month intervals. Group-based trajectory modeling identified three distinct patterns of pubertal development: boys with more slowly developing boys with either earlier (n = 54) or later (n = 43) pubertal timing, and boys with faster tempo of pubertal development (n = 56). The groups were compared on demographic and substance use risk characteristics, as well as behavioral measures of impulsivity. RESULTS Boys who had the accelerated progression through puberty had the highest proportion of family histories of substance use disorder and perform more impulsively on reward choice measures. CONCLUSIONS Outcomes are consistent within the Maturation Compression Hypothesis and social neuroscience models of adolescent developmental risk.
Collapse
Affiliation(s)
- Charles W. Mathias
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Nora E. Charles
- Department of Psychology, The University of Southern Mississippi, Hattiesburg, MS
| | - Yuanyuan Liang
- Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Ashley Acheson
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX
- Research Imaging Institute, The University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Sarah L. Lake
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Stacy R. Ryan
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Rene L. Olvera
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Donald M. Dougherty
- Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX
| |
Collapse
|
24
|
Kulkarni H, Mamtani M, Peralta J, Almeida M, Dyer TD, Goring HH, Johnson MP, Duggirala R, Mahaney MC, Olvera RL, Almasy L, Glahn DC, Williams-Blangero S, Curran JE, Blangero J. Soluble Forms of Intercellular and Vascular Cell Adhesion Molecules Independently Predict Progression to Type 2 Diabetes in Mexican American Families. PLoS One 2016; 11:e0151177. [PMID: 27007680 PMCID: PMC4805238 DOI: 10.1371/journal.pone.0151177] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Accepted: 02/24/2016] [Indexed: 12/16/2022] Open
Abstract
Objective While the role of type 2 diabetes (T2D) in inducing endothelial dysfunction is fairly well-established the etiological role of endothelial dysfunction in the onset of T2D is still a matter of debate. In the light of conflicting evidence in this regard, we conducted a prospective study to determine the association of circulating levels of soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vessel cell adhesion molecule 1 (sVCAM-1) with incident T2D. Methods Data from this study came from 1,269 Mexican Americans of whom 821 initially T2D-free individuals were longitudinally followed up in the San Antonio Family Heart Study. These individuals were followed for 9752.95 person-years for development of T2D. Prospective association of sICAM-1 and sVCAM-1 with incident T2D was studied using Kaplan-Meier survival plots and mixed effects Cox proportional hazards modeling to account for relatedness among study participants. Incremental value of adhesion molecule biomarkers was studied using integrated discrimination improvement (IDI) and net reclassification improvement (NRI) indexes. Results Decreasing median values for serum concentrations of sICAM-1 and sVCAM-1 were observed in the following groups in this order: individuals with T2D at baseline, individuals who developed T2D during follow-up, individuals with prediabetes at baseline and normal glucose tolerant (NGT) individuals who remained T2D-free during follow-up. Top quartiles for sICAM-1 and sVCAM-1 were strongly and significantly associated with homeostatic model of assessment—insulin resistance (HOMA-IR). Mixed effects Cox proportional hazards modeling revealed that after correcting for important clinical confounders, high sICAM-1 and sVCAM-1 concentrations were associated with 2.52 and 1.99 times faster progression to T2D as compared to low concentrations, respectively. Individuals with high concentrations for both sICAM-1 and sVCAM-1 progressed to T2D 3.42 times faster than those with low values for both sICAM-1 and sVCAM-1. The results were similar in women in reproductive age group and the remainder of the cohort. Inclusion of sICAM-1 and sVCAM-1 in predictive models significantly improved reclassification and discrimination. The majority of these results were seen even when the analyses were restricted to NGT individuals. Conclusion Serum concentrations of sICAM-1 and sVCAM-1 independently and additively predict future T2D and represent important candidate biomarkers of T2D.
Collapse
Affiliation(s)
- Hemant Kulkarni
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
- * E-mail:
| | - Manju Mamtani
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Juan Peralta
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Marcio Almeida
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Thomas D. Dyer
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Harald H. Goring
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Matthew P. Johnson
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Ravindranath Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Michael C. Mahaney
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Rene L. Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - David C. Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States of America
- Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, United States of America
| | - Sarah Williams-Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - Joanne E. Curran
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, United States of America
| |
Collapse
|
25
|
Knowles EEM, Kent JW, McKay DR, Sprooten E, Mathias SR, Curran JE, Carless MA, de Almeida MAA, Harald HHG, Dyer TD, Olvera RL, Fox PT, Duggirala R, Almasy L, Blangero J, Glahn DC. Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression. J Affect Disord 2016; 191:123-31. [PMID: 26655122 PMCID: PMC4715913 DOI: 10.1016/j.jad.2015.11.012] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2015] [Revised: 10/27/2015] [Accepted: 11/09/2015] [Indexed: 12/28/2022]
Abstract
Major depressive disorder (MDD) is a common and potentially life-threatening mood disorder. Identifying genetic markers for depression might provide reliable indicators of depression risk, which would, in turn, substantially improve detection, enabling earlier and more effective treatment. The aim of this study was to identify rare variants for depression, modeled as a continuous trait, using linkage and post-hoc association analysis. The sample comprised 1221 Mexican-American individuals from extended pedigrees. A single dimensional scale of MDD was derived using confirmatory factor analysis applied to all items from the Past Major Depressive Episode section of the Mini-International Neuropsychiatric Interview. Scores on this scale of depression were subjected to linkage analysis followed by QTL region-specific association analysis. Linkage analysis revealed a single genome-wide significant QTL (LOD=3.43) on 10q26.13, QTL-specific association analysis conducted in the entire sample revealed a suggestive variant within an intron of the gene LHPP (rs11245316, p=7.8×10(-04); LD-adjusted Bonferroni-corrected p=8.6×10(-05)). This region of the genome has previously been implicated in the etiology of MDD; the present study extends our understanding of the involvement of this region by highlighting a putative gene of interest (LHPP).
Collapse
Affiliation(s)
- Emma E M Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA.
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - D Reese McKay
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| | - Emma Sprooten
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| | - Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - Melanie A Carless
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Marcio A A de Almeida
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - H H Goring Harald
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - Tom D Dyer
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, Texas Center San Antonio, San Antonio, TX, United States
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, TX, United States; South Texas Veterans' Healthcare System, 7400 Merton Minter, San Antonio, TX 78229, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX, United States
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA
| |
Collapse
|
26
|
Abstract
BACKGROUND Depression and diabetes commonly co-occur; however, the strength of the physiological effects of diabetes as mediating factors towards depression is uncertain. METHOD We analyzed extensive clinical, epidemiological and laboratory data from n = 2081 Mexican Americans aged 35-64 years, recruited from the community as part of the Cameron County Hispanic Cohort (CCHC) divided into three groups: Diagnosed (self-reported) diabetes (DD, n = 335), Undiagnosed diabetes (UD, n = 227) and No diabetes (ND, n = 1519). UD participants denied being diagnosed with diabetes, but on testing met the 2010 American Diabetes Association and World Health Organization definitions of diabetes. Depression was measured using the Center for Epidemiological Studies - Depression (CES-D) scale. Weighted data were analyzed using dimensional and categorical outcomes using univariate and multivariate models. RESULTS The DD group had significantly higher CES-D scores than both the ND and UD (p ⩽ 0.001) groups, whereas the ND and UD groups did not significantly differ from each other. The DD subjects were more likely to meet the CES-D cut-off score for depression compared to both the ND and UD groups (p = 0.001), respectively. The UD group was also less likely to meet the cut-off score for depression than the ND group (p = 0.003). Our main findings remained significant in models that controlled for socio-demographic and clinical confounders. CONCLUSIONS Meeting clinical criteria for diabetes was not sufficient for increased depressive symptoms. Our findings suggest that the 'knowing that one is ill' is associated with depressive symptoms in diabetic subjects.
Collapse
Affiliation(s)
- Rene L. Olvera
- The University of Texas Health Science Center at San Antonio, Department of Psychiatry, Division of Genetic Epidemiology, San Antonio, TX., U.S.A
| | | | - Douglas E. Williamson
- The University of Texas Health Science Center at San Antonio, Department of Psychiatry, Division of Genetic Epidemiology, San Antonio, TX., U.S.A
| | | | | |
Collapse
|
27
|
Sprooten E, Gupta CN, Knowles EEM, McKay DR, Mathias SR, Curran JE, Kent JW, Carless MA, Almeida MA, Dyer TD, Göring HHH, Olvera RL, Kochunov P, Fox PT, Duggirala R, Almasy L, Calhoun VD, Blangero J, Turner JA, Glahn DC. Genome-wide significant linkage of schizophrenia-related neuroanatomical trait to 12q24. Am J Med Genet B Neuropsychiatr Genet 2015; 168:678-86. [PMID: 26440917 PMCID: PMC4639444 DOI: 10.1002/ajmg.b.32360] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2014] [Accepted: 07/31/2015] [Indexed: 11/08/2022]
Abstract
The insula and medial prefrontal cortex (mPFC) share functional, histological, transcriptional, and developmental characteristics, and they serve higher cognitive functions of theoretical relevance to schizophrenia and related disorders. Meta-analyses and multivariate analysis of structural magnetic resonance imaging (MRI) scans indicate that gray matter density and volume reductions in schizophrenia are the most consistent and pronounced in a network primarily composed of the insula and mPFC. We used source-based morphometry, a multivariate technique optimized for structural MRI, in a large sample of randomly ascertained pedigrees (N = 887) to derive an insula-mPFC component and to investigate its genetic determinants. Firstly, we replicated the insula-mPFC gray matter component as an independent source of gray matter variation in the general population, and verified its relevance to schizophrenia in an independent case-control sample. Secondly, we showed that the neuroanatomical variation defined by this component is largely determined by additive genetic variation (h(2) = 0.59), and genome-wide linkage analysis resulted in a significant linkage peak at 12q24 (LOD = 3.76). This region has been of significant interest to psychiatric genetics as it contains the Darier's disease locus and other proposed susceptibility genes (e.g., DAO, NOS1), and it has been linked to affective disorders and schizophrenia in multiple populations. Thus, in conjunction with previous clinical studies, our data imply that one or more psychiatric risk variants at 12q24 are co-inherited with reductions in mPFC and insula gray matter concentration. © 2015 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Emma Sprooten
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
,Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, CT
| | | | - Emma EM Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
,Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, CT
| | - D Reese McKay
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
,Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, CT
| | - Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
,Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, CT
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Melanie A Carless
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Marcio A Almeida
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Thomas D Dyer
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Harald HH Göring
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, TX
| | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Vince D. Calhoun
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
,The Mind Research Network, Albuquerque, NM
,Department of Psychiatry, University of New Mexico, Albuquerque, NM
,Department of Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
| | - Jessica A Turner
- The Mind Research Network, Albuquerque, NM
,Department of Psychology and Neuroscience Institute, Georgia State University, Atlanta, GA
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
,Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, CT
| |
Collapse
|
28
|
Mathias SR, Knowles EEM, Kent JW, McKay DR, Curran JE, de Almeida MAA, Dyer TD, Göring HHH, Olvera RL, Duggirala R, Fox PT, Almasy L, Blangero J, Glahn DC. Recurrent major depression and right hippocampal volume: A bivariate linkage and association study. Hum Brain Mapp 2015; 37:191-202. [PMID: 26485182 DOI: 10.1002/hbm.23025] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2015] [Accepted: 10/02/2015] [Indexed: 01/04/2023] Open
Abstract
Previous work has shown that the hippocampus is smaller in the brains of individuals suffering from major depressive disorder (MDD) than those of healthy controls. Moreover, right hippocampal volume specifically has been found to predict the probability of subsequent depressive episodes. This study explored the utility of right hippocampal volume as an endophenotype of recurrent MDD (rMDD). We observed a significant genetic correlation between the two traits in a large sample of Mexican American individuals from extended pedigrees (ρg = -0.34, p = 0.013). A bivariate linkage scan revealed a significant pleiotropic quantitative trait locus on chromosome 18p11.31-32 (LOD = 3.61). Bivariate association analysis conducted under the linkage peak revealed a variant (rs574972) within an intron of the gene SMCHD1 meeting the corrected significance level (χ(2) = 19.0, p = 7.4 × 10(-5)). Univariate association analyses of each phenotype separately revealed that the same variant was significant for right hippocampal volume alone, and also revealed a suggestively significant variant (rs12455524) within the gene DLGAP1 for rMDD alone. The results implicate right-hemisphere hippocampal volume as a possible endophenotype of rMDD, and in so doing highlight a potential gene of interest for rMDD risk.
Collapse
Affiliation(s)
- Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut
| | - Emma E M Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - D Reese McKay
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Marcio A A de Almeida
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Thomas D Dyer
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Harald H H Göring
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas.,South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas.,South Texas Veterans Health System, San Antonio, Texas
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio, Texas.,University of Texas of the Rio Grande Valley, Brownsville, Texas
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.,Olin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut
| |
Collapse
|
29
|
Olvera RL, Williamson DE, Fisher-Hoch SP, Vatcheva KP, McCormick JB. Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans. J Clin Psychiatry 2015; 76:e1300-5. [PMID: 26528653 PMCID: PMC5836315 DOI: 10.4088/jcp.14m09118] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/07/2014] [Accepted: 10/23/2014] [Indexed: 02/08/2023]
Abstract
INTRODUCTION We examined the prevalence of depression, obesity, and metabolic syndrome and associations between them in a population-based representative cohort of Mexican Americans living on the United States-Mexico border. METHOD The sample in this cross-sectional analysis consisted of 1,768 Mexican American adults (≥ 18 years of age) assessed between the years 2004 and 2010, with whom we tested our central hypothesis of a significant relationship between obesity and depression. Depression was measured using the Center for Epidemiologic Studies-Depression scale (CES-D) with a cutoff score of ≥ 16 for depression and a cutoff score of ≥ 27 for severe depression. We categorized body mass index (BMI) values as obese (≥ 30kg/m(2)) and later subdivided the obese subjects into obese (30-39 kg/m(2)[inclusive]) and morbidly obese (≥ 40 kg/m(2)). Metabolic syndrome was defined using the American Heart Association definition requiring at least 3 of the following: increased waist circumference, elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol, elevated blood pressure, and elevated fasting glucose. Weighted data were analyzed to establish prevalence of depression, obesity, and metabolic syndrome. Univariate and multivariable weighted regression models were used to test potential associations between these disorders. RESULTS Using weighted prevalence, we observed high rates of depression (30%), obesity (52%), and metabolic syndrome (45%). Univariate models revealed female gender (P = .0004), low education (P = .003), low HDL level (P = .009), and increased waist circumference (P = .03) were associated with depression. Female gender (P = .01), low education (P = .003), and morbid obesity (P = .002) were risk factors for severe depression and remained significant in multivariable models. CONCLUSIONS In this large cohort of Mexican Americans, obesity, female gender, and low education were identified risk factors for depression. These indicators may serve as targets for early detection, prevention, and intervention in this population.
Collapse
Affiliation(s)
- Rene L. Olvera
- The University of Texas Health Science Center at San Antonio, Department of Psychiatry, San Antonio, TX., U.S.A
| | - Douglas E. Williamson
- The University of Texas Health Science Center at San Antonio, Department of Psychiatry, San Antonio, TX., U.S.A
| | - Susan P. Fisher-Hoch
- University of Texas Health Science Center Houston, School of Public Health, Division of Epidemiology, Brownsville TX., U.S.A
| | - Kristina P Vatcheva
- University of Texas Health Science Center Houston, School of Public Health, Division of Epidemiology, Brownsville TX., U.S.A
| | - Joseph B. McCormick
- University of Texas Health Science Center Houston, School of Public Health, Division of Epidemiology, Brownsville TX., U.S.A
| |
Collapse
|
30
|
Vatcheva KP, Fisher-Hoch SP, Rahbar MH, Lee M, Olvera RL, Mccormick JB. ASSOCIATION OF TOTAL AND DIFFERENTIAL WHITE BLOOD CELL COUNTS TO DEVELOPMENT OF TYPE 2 DIABETES IN MEXICAN AMERICANS IN CAMERON COUNTY HISPANIC COHORT. Diabetes Res 2015; 1:103-112. [PMID: 28090128 PMCID: PMC5226365 DOI: 10.17140/droj-1-117] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
OBJECTIVE To evaluate the relationship between total and differential White Blood Cell (WBC) counts with time to transition to type 2 diabetes in Mexican Americans using prospective data from the Cameron County Hispanic Cohort (CCHC). RESULTS Multivariable Cox proportional hazards regression models revealed that obese Mexican-American cohort participants whose total WBC or granulocyte count increased over time had 1.39 and 1.35 times higher risk respectively of transition to type 2 diabetes when compared to overweight participants. The granulocyte or total WBC count in participants with BMI≥35 were significant risk factors for transition to type 2 diabetes. CONCLUSIONS Increased total WBC and WBC differential counts, particularly lymphocytes and granulocytes, are associated with risk of transition to type 2 diabetes in obese Mexican Americans, after adjusting for other potential confounders. Screening and monitoring the WBC counts, including lymphocytes and granulocytes can help with monitoring potential transition to type 2 diabetes.
Collapse
Affiliation(s)
- Kristina P. Vatcheva
- Division of Epidemiology, University of Texas Health Science Center-Houston, School of Public Health, Brownsville Campus, Brownsville, TX
| | - Susan P. Fisher-Hoch
- Division of Epidemiology, University of Texas Health Science Center-Houston, School of Public Health, Brownsville Campus, Brownsville, TX
| | - Mohammad H. Rahbar
- Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Division of Clinical and Translational Sciences, Department of Internal Medicine, University of Texas Medical School at Houston, and Center for Clinical and Translational Sciences at The University of Texas Health Science Center at Houston, Room 1100.05 UT Professional Building, 6410 Fannin Street, Houston, TX
| | - MinJae Lee
- Division of Clinical and Translational Sciences, Department of Internal Medicine, University of Texas Medical School, Biostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences (CCTS), The University of Texas Health Science Center at Houston, Room 1100.06 UT Professional Building, 6410 Fannin Street, Houston, TX
| | - Rene L. Olvera
- Division of Genetic Epidemiology, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX
| | - Joseph B. Mccormick
- Division of Epidemiology, University of Texas Health Science Center-Houston, School of Public Health, Brownsville Campus, Brownsville, TX
| |
Collapse
|
31
|
Ramage AE, Lin AL, Olvera RL, Fox PT, Williamson DE. Resting-state regional cerebral blood flow during adolescence: associations with initiation of substance use and prediction of future use disorders. Drug Alcohol Depend 2015; 149:40-8. [PMID: 25682478 PMCID: PMC4361292 DOI: 10.1016/j.drugalcdep.2015.01.012] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2014] [Revised: 01/09/2015] [Accepted: 01/12/2015] [Indexed: 11/28/2022]
Abstract
BACKGROUND Adolescence is a period of developmental flux when brain systems are vulnerable to influences of early substance use, which in turn relays increased risk for substance use disorders. Our study intent was to assess adolescent regional cerebral blood flow (rCBF) as it relates to current and future alcohol use. The aim was to identify brain-based predictors for initiation of alcohol use and onset of future substance use disorders. METHODS Quantitative rCBF was assessed in 100 adolescents (age 12-15). Prospective behavioral assessments were conducted annually over a three-year follow-up period to characterize onset of alcohol initiation, future drinking patterns and use disorders. Comparisons amongst use groups (i.e., current-, future-, and non-alcohol using adolescents) identified rCBF associated with initiation of alcohol use. Regression by future drinking patterns identified rCBF predictive of heavier drinking. Survival analysis determined whether or not baseline rCBF predicted later development of use disorders. RESULTS Baseline rCBF was decreased to the parietal cortex and increased to mesolimbic regions in adolescents currently using alcohol as well as those who would use alcohol in the future. Higher baseline rCBF to the left fusiform gyrus and lower rCBF to the right inferior parietal cortex and left cerebellum was associated with future drinking patterns as well as predicted the onset of alcohol and substance use disorders in this cohort. CONCLUSIONS Variations in resting rCBF to regions within reward and default mode or control networks appear to represent trait markers of alcohol use initiation and are predictive of future development of use disorders.
Collapse
Affiliation(s)
- Amy E. Ramage
- Research Imaging Institute, University of Texas Health Science Center at San Antonio,Department of Psychiatry, University of Texas Health Science Center at San Antonio
| | - Ai-Ling Lin
- Research Imaging Institute, University of Texas Health Science Center at San Antonio,Department of Psychiatry, University of Texas Health Science Center at San Antonio,Cellular & Structural Biology, University of Texas Health Science Center at San Antonio
| | - Rene L. Olvera
- Research Imaging Institute, University of Texas Health Science Center at San Antonio,Department of Psychiatry, University of Texas Health Science Center at San Antonio
| | - Peter T. Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio,Neurology, University of Texas Health Science Center at San Antonio,Radiology, University of Texas Health Science Center at San Antonio
| | - Douglas E. Williamson
- Research Imaging Institute, University of Texas Health Science Center at San Antonio,Department of Psychiatry, University of Texas Health Science Center at San Antonio,Epidemiology & Biostatistics, University of Texas Health Science Center at San Antonio
| |
Collapse
|
32
|
Kochunov P, Jahanshad N, Marcus D, Winkler A, Sprooten E, Nichols TE, Wright SN, Hong LE, Patel B, Behrens T, Jbabdi S, Andersson J, Lenglet C, Yacoub E, Moeller S, Auerbach E, Ugurbil K, Sotiropoulos SN, Brouwer RM, Landman B, Lemaitre H, den Braber A, Zwiers MP, Ritchie S, van Hulzen K, Almasy L, Curran J, deZubicaray GI, Duggirala R, Fox P, Martin NG, McMahon KL, Mitchell B, Olvera RL, Peterson C, Starr J, Sussmann J, Wardlaw J, Wright M, Boomsma DI, Kahn R, de Geus EJC, Williamson DE, Hariri A, van 't Ent D, Bastin ME, McIntosh A, Deary IJ, Hulshoff Pol HE, Blangero J, Thompson PM, Glahn DC, Van Essen DC. Heritability of fractional anisotropy in human white matter: a comparison of Human Connectome Project and ENIGMA-DTI data. Neuroimage 2015; 111:300-11. [PMID: 25747917 DOI: 10.1016/j.neuroimage.2015.02.050] [Citation(s) in RCA: 134] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2014] [Revised: 01/10/2015] [Accepted: 02/23/2015] [Indexed: 01/23/2023] Open
Abstract
The degree to which genetic factors influence brain connectivity is beginning to be understood. Large-scale efforts are underway to map the profile of genetic effects in various brain regions. The NIH-funded Human Connectome Project (HCP) is providing data valuable for analyzing the degree of genetic influence underlying brain connectivity revealed by state-of-the-art neuroimaging methods. We calculated the heritability of the fractional anisotropy (FA) measure derived from diffusion tensor imaging (DTI) reconstruction in 481 HCP subjects (194/287 M/F) consisting of 57/60 pairs of mono- and dizygotic twins, and 246 siblings. FA measurements were derived using (Enhancing NeuroImaging Genetics through Meta-Analysis) ENIGMA DTI protocols and heritability estimates were calculated using the SOLAR-Eclipse imaging genetic analysis package. We compared heritability estimates derived from HCP data to those publicly available through the ENIGMA-DTI consortium, which were pooled together from five-family based studies across the US, Europe, and Australia. FA measurements from the HCP cohort for eleven major white matter tracts were highly heritable (h(2)=0.53-0.90, p<10(-5)), and were significantly correlated with the joint-analytical estimates from the ENIGMA cohort on the tract and voxel-wise levels. The similarity in regional heritability suggests that the additive genetic contribution to white matter microstructure is consistent across populations and imaging acquisition parameters. It also suggests that the overarching genetic influence provides an opportunity to define a common genetic search space for future gene-discovery studies. Uniquely, the measurements of additive genetic contribution performed in this study can be repeated using online genetic analysis tools provided by the HCP ConnectomeDB web application.
Collapse
Affiliation(s)
- Peter Kochunov
- Maryland Psychiatric Research Center, University of MD School of Medicine, Baltimore USA.
| | - Neda Jahanshad
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Department of Neurology Keck School of Medicine, University of Southern CA, Marina del Rey, USA
| | - Daniel Marcus
- Department of Radiology, Washington University School of Medicine, St. Louis, USA
| | | | - Emma Sprooten
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, USA
| | | | - Susan N Wright
- Maryland Psychiatric Research Center, University of MD School of Medicine, Baltimore USA
| | - L Elliot Hong
- Maryland Psychiatric Research Center, University of MD School of Medicine, Baltimore USA
| | - Binish Patel
- Maryland Psychiatric Research Center, University of MD School of Medicine, Baltimore USA
| | | | | | | | - Christophe Lenglet
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA
| | - Essa Yacoub
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA
| | - Steen Moeller
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA
| | - Eddie Auerbach
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA
| | - Kamil Ugurbil
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA
| | | | | | | | | | | | | | | | | | - Laura Almasy
- Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Joanne Curran
- Texas Biomedical Research Institute, San Antonio, TX, USA
| | | | - Ravi Duggirala
- Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Peter Fox
- University of Texas Health Science Center San Antonio, San Antonio, TX, USA
| | | | | | | | - Rene L Olvera
- University of Texas Health Science Center San Antonio, San Antonio, TX, USA
| | | | | | | | | | | | | | - Rene Kahn
- University Medical Center Utrecht, Utrecht, The Netherlands
| | | | | | | | | | | | | | | | | | - John Blangero
- Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Paul M Thompson
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Department of Neurology Keck School of Medicine, University of Southern CA, Marina del Rey, USA
| | - David C Glahn
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, USA
| | - David C Van Essen
- Anatomy & Neurobiology Department, Washington University in St. Louis, St. Louis, USA
| |
Collapse
|
33
|
Spieker EA, Kochunov P, Rowland LM, Sprooten E, Winkler AM, Olvera RL, Almasy L, Duggirala R, Fox PT, Blangero J, Glahn DC, Curran JE. Shared genetic variance between obesity and white matter integrity in Mexican Americans. Front Genet 2015; 6:26. [PMID: 25763009 PMCID: PMC4327744 DOI: 10.3389/fgene.2015.00026] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2014] [Accepted: 01/19/2015] [Indexed: 01/01/2023] Open
Abstract
Obesity is a chronic metabolic disorder that may also lead to reduced white matter integrity, potentially due to shared genetic risk factors. Genetic correlation analyses were conducted in a large cohort of Mexican American families in San Antonio (N = 761, 58% females, ages 18–81 years; 41.3 ± 14.5) from the Genetics of Brain Structure and Function Study. Shared genetic variance was calculated between measures of adiposity [(body mass index (BMI; kg/m2) and waist circumference (WC; in)] and whole-brain and regional measurements of cerebral white matter integrity (fractional anisotropy). Whole-brain average and regional fractional anisotropy values for 10 major white matter tracts were calculated from high angular resolution diffusion tensor imaging data (DTI; 1.7 × 1.7 × 3 mm; 55 directions). Additive genetic factors explained intersubject variance in BMI (heritability, h2 = 0.58), WC (h2 = 0.57), and FA (h2 = 0.49). FA shared significant portions of genetic variance with BMI in the genu (ρG = −0.25), body (ρG = −0.30), and splenium (ρG = −0.26) of the corpus callosum, internal capsule (ρG = −0.29), and thalamic radiation (ρG = −0.31) (all p's = 0.043). The strongest evidence of shared variance was between BMI/WC and FA in the superior fronto-occipital fasciculus (ρG = −0.39, p = 0.020; ρG = −0.39, p = 0.030), which highlights region-specific variation in neural correlates of obesity. This may suggest that increase in obesity and reduced white matter integrity share common genetic risk factors.
Collapse
Affiliation(s)
- Elena A Spieker
- Department of Family Medicine, Madigan Army Medical Center Tacoma, WA, USA ; Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine Baltimore, MD, USA
| | - Peter Kochunov
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine Baltimore, MD, USA ; Department of Physics, University of Maryland Baltimore, MD, USA ; South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - Laura M Rowland
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine Baltimore, MD, USA
| | - Emma Sprooten
- Department of Psychiatry, Yale University New Haven, CT, USA ; Olin Neuropsychiatry Research Center, Institute of Living Hartford, CT, USA
| | - Anderson M Winkler
- Department of Psychiatry, Yale University New Haven, CT, USA ; Department of Clinical Neurosciences, Oxford Centre for Functional MRI of the Brain, University of Oxford Oxford, UK
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - David C Glahn
- Department of Psychiatry, Yale University New Haven, CT, USA ; Olin Neuropsychiatry Research Center, Institute of Living Hartford, CT, USA ; Research Imaging Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio San Antonio, TX, USA
| |
Collapse
|
34
|
Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, Bralten J, Brown AA, Chakravarty MM, Chen Q, Ching CRK, Cuellar-Partida G, den Braber A, Giddaluru S, Goldman AL, Grimm O, Guadalupe T, Hass J, Woldehawariat G, Holmes AJ, Hoogman M, Janowitz D, Jia T, Kim S, Klein M, Kraemer B, Lee PH, Olde Loohuis LM, Luciano M, Macare C, Mather KA, Mattheisen M, Milaneschi Y, Nho K, Papmeyer M, Ramasamy A, Risacher SL, Roiz-Santiañez R, Rose EJ, Salami A, Sämann PG, Schmaal L, Schork AJ, Shin J, Strike LT, Teumer A, van Donkelaar MMJ, van Eijk KR, Walters RK, Westlye LT, Whelan CD, Winkler AM, Zwiers MP, Alhusaini S, Athanasiu L, Ehrlich S, Hakobjan MMH, Hartberg CB, Haukvik UK, Heister AJGAM, Hoehn D, Kasperaviciute D, Liewald DCM, Lopez LM, Makkinje RRR, Matarin M, Naber MAM, McKay DR, Needham M, Nugent AC, Pütz B, Royle NA, Shen L, Sprooten E, Trabzuni D, van der Marel SSL, van Hulzen KJE, Walton E, Wolf C, Almasy L, Ames D, Arepalli S, Assareh AA, Bastin ME, Brodaty H, Bulayeva KB, Carless MA, Cichon S, Corvin A, Curran JE, Czisch M, de Zubicaray GI, Dillman A, Duggirala R, Dyer TD, Erk S, Fedko IO, Ferrucci L, Foroud TM, Fox PT, Fukunaga M, Gibbs JR, Göring HHH, Green RC, Guelfi S, Hansell NK, Hartman CA, Hegenscheid K, Heinz A, Hernandez DG, Heslenfeld DJ, Hoekstra PJ, Holsboer F, Homuth G, Hottenga JJ, Ikeda M, Jack CR, Jenkinson M, Johnson R, Kanai R, Keil M, Kent JW, Kochunov P, Kwok JB, Lawrie SM, Liu X, Longo DL, McMahon KL, Meisenzahl E, Melle I, Mohnke S, Montgomery GW, Mostert JC, Mühleisen TW, Nalls MA, Nichols TE, Nilsson LG, Nöthen MM, Ohi K, Olvera RL, Perez-Iglesias R, Pike GB, Potkin SG, Reinvang I, Reppermund S, Rietschel M, Romanczuk-Seiferth N, Rosen GD, Rujescu D, Schnell K, Schofield PR, Smith C, Steen VM, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Turner JA, Valdés Hernández MC, van 't Ent D, van der Brug M, van der Wee NJA, van Tol MJ, Veltman DJ, Wassink TH, Westman E, Zielke RH, Zonderman AB, Ashbrook DG, Hager R, Lu L, McMahon FJ, Morris DW, Williams RW, Brunner HG, Buckner RL, Buitelaar JK, Cahn W, Calhoun VD, Cavalleri GL, Crespo-Facorro B, Dale AM, Davies GE, Delanty N, Depondt C, Djurovic S, Drevets WC, Espeseth T, Gollub RL, Ho BC, Hoffmann W, Hosten N, Kahn RS, Le Hellard S, Meyer-Lindenberg A, Müller-Myhsok B, Nauck M, Nyberg L, Pandolfo M, Penninx BWJH, Roffman JL, Sisodiya SM, Smoller JW, van Bokhoven H, van Haren NEM, Völzke H, Walter H, Weiner MW, Wen W, White T, Agartz I, Andreassen OA, Blangero J, Boomsma DI, Brouwer RM, Cannon DM, Cookson MR, de Geus EJC, Deary IJ, Donohoe G, Fernández G, Fisher SE, Francks C, Glahn DC, Grabe HJ, Gruber O, Hardy J, Hashimoto R, Hulshoff Pol HE, Jönsson EG, Kloszewska I, Lovestone S, Mattay VS, Mecocci P, McDonald C, McIntosh AM, Ophoff RA, Paus T, Pausova Z, Ryten M, Sachdev PS, Saykin AJ, Simmons A, Singleton A, Soininen H, Wardlaw JM, Weale ME, Weinberger DR, Adams HHH, Launer LJ, Seiler S, Schmidt R, Chauhan G, Satizabal CL, Becker JT, Yanek L, van der Lee SJ, Ebling M, Fischl B, Longstreth WT, Greve D, Schmidt H, Nyquist P, Vinke LN, van Duijn CM, Xue L, Mazoyer B, Bis JC, Gudnason V, Seshadri S, Ikram MA, Martin NG, Wright MJ, Schumann G, Franke B, Thompson PM, Medland SE. Common genetic variants influence human subcortical brain structures. Nature 2015; 520:224-9. [PMID: 25607358 DOI: 10.1038/nature14101] [Citation(s) in RCA: 551] [Impact Index Per Article: 61.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2014] [Accepted: 11/19/2014] [Indexed: 12/11/2022]
Abstract
The highly complex structure of the human brain is strongly shaped by genetic influences. Subcortical brain regions form circuits with cortical areas to coordinate movement, learning, memory and motivation, and altered circuits can lead to abnormal behaviour and disease. To investigate how common genetic variants affect the structure of these brain regions, here we conduct genome-wide association studies of the volumes of seven subcortical regions and the intracranial volume derived from magnetic resonance images of 30,717 individuals from 50 cohorts. We identify five novel genetic variants influencing the volumes of the putamen and caudate nucleus. We also find stronger evidence for three loci with previously established influences on hippocampal volume and intracranial volume. These variants show specific volumetric effects on brain structures rather than global effects across structures. The strongest effects were found for the putamen, where a novel intergenic locus with replicable influence on volume (rs945270; P = 1.08 × 10(-33); 0.52% variance explained) showed evidence of altering the expression of the KTN1 gene in both brain and blood tissue. Variants influencing putamen volume clustered near developmental genes that regulate apoptosis, axon guidance and vesicle transport. Identification of these genetic variants provides insight into the causes of variability in human brain development, and may help to determine mechanisms of neuropsychiatric dysfunction.
Collapse
Affiliation(s)
- Derrek P Hibar
- Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA
| | - Jason L Stein
- 1] Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA. [2] Neurogenetics Program, Department of Neurology, UCLA School of Medicine, Los Angeles, California 90095, USA
| | | | - Alejandro Arias-Vasquez
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Department of Psychiatry, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [3] Department of Cognitive Neuroscience, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [4] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Sylvane Desrivières
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Neda Jahanshad
- Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA
| | - Roberto Toro
- 1] Laboratory of Human Genetics and Cognitive Functions, Institut Pasteur, Paris 75015, France. [2] Centre Nationale de Recherche Scientifique (CNRS) Unité de Recherche Associée (URA) 2182 Genes, Synapses and Cognition, Institut Pasteur, Paris 75015, France. [3] Université Paris Diderot, Sorbonne Paris Cité, Paris 75015, France
| | - Katharina Wittfeld
- 1] German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald 17487, Germany. [2] Department of Psychiatry, University Medicine Greifswald, Greifswald 17489, Germany
| | - Lucija Abramovic
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Micael Andersson
- Umeå Centre for Functional Brain Imaging (UFBI), Umeå University, Umeå 901 87, Sweden
| | - Benjamin S Aribisala
- 1] Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK. [2] Department of Computer Science, Lagos State University, Lagos, Nigeria. [3] Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Nicola J Armstrong
- 1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia. [2] School of Mathematics and Statistics, University of Sydney, Sydney 2006, Australia
| | - Manon Bernard
- The Hospital for Sick Children, University of Toronto, Toronto M5G 1X8, Canada
| | - Marc M Bohlken
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Marco P Boks
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Janita Bralten
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Department of Cognitive Neuroscience, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [3] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Andrew A Brown
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway
| | - M Mallar Chakravarty
- 1] Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal H4H 1R3, Canada. [2] Department of Psychiatry and Biomedical Engineering, McGill University, Montreal H3A 2B4, Canada
| | - Qiang Chen
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
| | - Christopher R K Ching
- 1] Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA. [2] Interdepartmental Neuroscience Graduate Program, UCLA School of Medicine, Los Angeles, California 90095, USA
| | | | - Anouk den Braber
- Biological Psychology, Neuroscience Campus Amsterdam &EMGO Institute for Health and Care Research, VU University &VU Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Sudheer Giddaluru
- 1] NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway. [2] Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway
| | - Aaron L Goldman
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
| | - Oliver Grimm
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim 68159, Germany
| | - Tulio Guadalupe
- 1] Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525 XD, The Netherlands. [2] International Max Planck Research School for Language Sciences, Nijmegen 6525 XD, The Netherlands
| | - Johanna Hass
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden 01307 Germany
| | - Girma Woldehawariat
- Human Genetics Branch and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, Bethesda, Maryland 20892, USA
| | - Avram J Holmes
- 1] Department of Psychology, Yale University, New Haven, Connecticut 06511, USA. [2] Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA
| | - Martine Hoogman
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Deborah Janowitz
- Department of Psychiatry, University Medicine Greifswald, Greifswald 17489, Germany
| | - Tianye Jia
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Sungeun Kim
- 1] Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [2] Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [3] Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Marieke Klein
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Bernd Kraemer
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Goettingen 37075, Germany
| | - Phil H Lee
- 1] Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [2] Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [3] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts 02141, USA. [4] Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Loes M Olde Loohuis
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California 90095, USA
| | - Michelle Luciano
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Christine Macare
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Karen A Mather
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia
| | - Manuel Mattheisen
- 1] Department of Biomedicine, Aarhus University, Aarhus DK-8000, Denmark. [2] The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus and Copenhagen DK-8000, Denmark. [3] Center for integrated Sequencing, iSEQ, Aarhus University, Aarhus DK-8000, Denmark
| | - Yuri Milaneschi
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam 1081 HL, The Netherlands
| | - Kwangsik Nho
- 1] Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [2] Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [3] Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Martina Papmeyer
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Adaikalavan Ramasamy
- 1] Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK. [2] Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Shannon L Risacher
- 1] Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [2] Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Roberto Roiz-Santiañez
- 1] Department of Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander 39008, Spain. [2] Cibersam (Centro Investigación Biomédica en Red Salud Mental), Madrid 28029, Spain
| | - Emma J Rose
- 1] Neuropsychiatric Genetics Research Group and Department of Psychiatry, Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 2, Ireland. [2] Center for Translational Research on Adversity, Neurodevelopment and Substance Abuse (C-TRANS), Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21045, USA
| | - Alireza Salami
- 1] Umeå Centre for Functional Brain Imaging (UFBI), Umeå University, Umeå 901 87, Sweden. [2] Aging Research Center, Karolinska Institutet and Stockholm University, 11330 Stockholm, Sweden
| | | | - Lianne Schmaal
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam 1081 HL, The Netherlands
| | - Andrew J Schork
- 1] Multimodal Imaging Laboratory, Department of Neurosciences, University of California, San Diego, California 92093, USA. [2] Department of Cognitive Sciences, University of California, San Diego, California 92161, USA
| | - Jean Shin
- The Hospital for Sick Children, University of Toronto, Toronto M5G 1X8, Canada
| | - Lachlan T Strike
- 1] QIMR Berghofer Medical Research Institute, Brisbane 4006, Australia. [2] School of Psychology, University of Queensland, Brisbane 4072, Australia. [3] Centre for Advanced Imaging, University of Queensland, Brisbane 4072, Australia
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald D-17475, Germany
| | - Marjolein M J van Donkelaar
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Kristel R van Eijk
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Raymond K Walters
- 1] Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. [2] Medical and Population Genetics Program, Broad Institute of Harvard and MIT, Boston, Massachusetts 02142, USA
| | - Lars T Westlye
- 1] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway. [2] Department of Psychology, University of Oslo, Oslo 0373, Norway
| | - Christopher D Whelan
- Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA
| | - Anderson M Winkler
- 1] The Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK. [2] Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06511, USA
| | - Marcel P Zwiers
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Saud Alhusaini
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal H3A 2B4, Canada
| | - Lavinia Athanasiu
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway
| | - Stefan Ehrlich
- 1] Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden 01307 Germany. [2] Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [3] The Athinoula A.Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
| | - Marina M H Hakobjan
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Cecilie B Hartberg
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] Department of Psychiatric Research and Development, Diakonhjemmet Hospital, Oslo 0319, Norway
| | - Unn K Haukvik
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway
| | - Angelien J G A M Heister
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - David Hoehn
- Max Planck Institute of Psychiatry, Munich 80804, Germany
| | - Dalia Kasperaviciute
- 1] UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, London WC1N 3BG, UK. [2] Department of Medicine, Imperial College London, London W12 0NN, UK
| | - David C M Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Lorna M Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Remco R R Makkinje
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Mar Matarin
- Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Marlies A M Naber
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - D Reese McKay
- 1] Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06511, USA. [2] Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut 06106, USA
| | - Margaret Needham
- Neuropsychiatric Genetics Research Group and Department of Psychiatry, Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 2, Ireland
| | - Allison C Nugent
- Human Genetics Branch and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, Bethesda, Maryland 20892, USA
| | - Benno Pütz
- Max Planck Institute of Psychiatry, Munich 80804, Germany
| | - Natalie A Royle
- 1] Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK. [2] Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK. [3] Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Li Shen
- 1] Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [2] Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [3] Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Emma Sprooten
- 1] Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK. [2] Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06511, USA. [3] Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut 06106, USA
| | - Daniah Trabzuni
- 1] Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. [2] Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia
| | - Saskia S L van der Marel
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Kimm J E van Hulzen
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Esther Walton
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden 01307 Germany
| | | | - Laura Almasy
- 1] Texas Biomedical Research Institute, San Antonio, Texas 78245, USA. [2] University of Texas Health Science Center, San Antonio, Texas 78229, USA
| | - David Ames
- 1] National Ageing Research Institute, Royal Melbourne Hospital, Melbourne 3052, Australia. [2] Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne 3101, Australia
| | - Sampath Arepalli
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Amelia A Assareh
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia
| | - Mark E Bastin
- 1] Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK. [2] Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK. [3] Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK. [4] Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia
| | - Kazima B Bulayeva
- N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia
| | | | - Sven Cichon
- 1] Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel 4055, Switzerland. [2] Institute of Human Genetics, University of Bonn, Bonn, D-53127, Germany. [3] Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, D-52425, Germany. [4] Department of Genomics, Life &Brain Center, University of Bonn, Bonn D-53127, Germany
| | - Aiden Corvin
- Neuropsychiatric Genetics Research Group and Department of Psychiatry, Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 2, Ireland
| | - Joanne E Curran
- Texas Biomedical Research Institute, San Antonio, Texas 78245, USA
| | - Michael Czisch
- Max Planck Institute of Psychiatry, Munich 80804, Germany
| | | | - Allissa Dillman
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Ravi Duggirala
- Texas Biomedical Research Institute, San Antonio, Texas 78245, USA
| | - Thomas D Dyer
- 1] Texas Biomedical Research Institute, San Antonio, Texas 78245, USA. [2] University of Texas Health Science Center, San Antonio, Texas 78229, USA
| | - Susanne Erk
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin 10117, Germany
| | - Iryna O Fedko
- Biological Psychology, Neuroscience Campus Amsterdam &EMGO Institute for Health and Care Research, VU University &VU Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Luigi Ferrucci
- Clinical Research Branch, National Institute on Aging, Baltimore, Maryland 20892, USA
| | - Tatiana M Foroud
- 1] Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [2] Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Peter T Fox
- 1] University of Texas Health Science Center, San Antonio, Texas 78229, USA. [2] South Texas Veterans Health Care System, San Antonio, Texas 78229, USA
| | - Masaki Fukunaga
- Biofunctional Imaging, Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan
| | - J Raphael Gibbs
- 1] Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. [2] Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne 3101, Australia
| | | | - Robert C Green
- 1] Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Sebastian Guelfi
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | | | - Catharina A Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
| | - Katrin Hegenscheid
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald 17475, Germany
| | - Andreas Heinz
- Department of Genomics, Life &Brain Center, University of Bonn, Bonn D-53127, Germany
| | - Dena G Hernandez
- 1] Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. [2] Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne 3101, Australia
| | - Dirk J Heslenfeld
- Departments of Cognitive and Clinical Neuropsychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - Pieter J Hoekstra
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
| | | | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17489, Germany
| | - Jouke-Jan Hottenga
- Biological Psychology, Neuroscience Campus Amsterdam &EMGO Institute for Health and Care Research, VU University &VU Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Masashi Ikeda
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan
| | | | | | - Robert Johnson
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland 21201, USA
| | - Ryota Kanai
- 1] School of Psychology, University of Sussex, Brighton BN1 9QH, UK. [2] Institute of Cognitive Neuroscience, University College London, London WC1N 3AR, UK
| | - Maria Keil
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Goettingen 37075, Germany
| | - Jack W Kent
- Texas Biomedical Research Institute, San Antonio, Texas 78245, USA
| | - Peter Kochunov
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21201, USA
| | - John B Kwok
- 1] Neuroscience Research Australia, Sydney 2031, Australia. [2] School of Medical Sciences, UNSW, Sydney 2052, Australia
| | - Stephen M Lawrie
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Xinmin Liu
- 1] Human Genetics Branch and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, Bethesda, Maryland 20892, USA. [2] Department of Pathology and Cell Biology, Columbia University Medical Center, New York 10032, USA
| | - Dan L Longo
- Lymphocyte Cell Biology Unit, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA
| | - Katie L McMahon
- Centre for Advanced Imaging, University of Queensland, Brisbane 4072, Australia
| | - Eva Meisenzahl
- Department of Psychiatry, Ludwig-Maximilians-Universität, Munich 80336, Germany
| | - Ingrid Melle
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway
| | - Sebastian Mohnke
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin 10117, Germany
| | | | - Jeanette C Mostert
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Thomas W Mühleisen
- 1] Institute of Human Genetics, University of Bonn, Bonn, D-53127, Germany. [2] Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, D-52425, Germany. [3] Department of Genomics, Life &Brain Center, University of Bonn, Bonn D-53127, Germany
| | - Michael A Nalls
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Thomas E Nichols
- 1] FMRIB Centre, University of Oxford, Oxford OX3 9DU, UK. [2] Department of Statistics &WMG, University of Warwick, Coventry CV4 7AL, UK
| | - Lars G Nilsson
- Umeå Centre for Functional Brain Imaging (UFBI), Umeå University, Umeå 901 87, Sweden
| | - Markus M Nöthen
- 1] Institute of Human Genetics, University of Bonn, Bonn, D-53127, Germany. [2] Department of Genomics, Life &Brain Center, University of Bonn, Bonn D-53127, Germany
| | - Kazutaka Ohi
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
| | - Rene L Olvera
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Rocio Perez-Iglesias
- 1] Cibersam (Centro Investigación Biomédica en Red Salud Mental), Madrid 28029, Spain. [2] Institute of Psychiatry, King's College London, London SE5 8AF, UK
| | - G Bruce Pike
- 1] Department of Neurology, University of Calgary, Calgary T2N 2T9, Canada. [2] Department of Clinical Neuroscience, University of Calgary, Calgary T2N 2T9, Canada
| | - Steven G Potkin
- Psychiatry and Human Behavior, University of California, Irvine, California 92617, USA
| | - Ivar Reinvang
- Department of Psychology, University of Oslo, Oslo 0373, Norway
| | - Simone Reppermund
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim 68159, Germany
| | - Nina Romanczuk-Seiferth
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin 10117, Germany
| | - Glenn D Rosen
- 1] Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Dan Rujescu
- Department of Psychiatry, Ludwig-Maximilians-Universität, Munich 80336, Germany
| | - Knut Schnell
- Department of General Psychiatry, Heidelberg University Hospital, Heidelberg 69115, Germany
| | - Peter R Schofield
- 1] Neuroscience Research Australia, Sydney 2031, Australia. [2] School of Medical Sciences, UNSW, Sydney 2052, Australia
| | - Colin Smith
- Department of Neuropathology, MRC Sudden Death Brain Bank Project, University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Vidar M Steen
- 1] NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway. [2] Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway
| | - Jessika E Sussmann
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia
| | - Arthur W Toga
- Laboratory of Neuro Imaging, Institute for Neuroimaging and Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033, USA
| | - Bryan J Traynor
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Juan Troncoso
- Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21287, USA
| | - Jessica A Turner
- Psychology Department and Neuroscience Institute, Georgia State University, Atlanta, Georgia 30302, USA
| | | | - Dennis van 't Ent
- Biological Psychology, Neuroscience Campus Amsterdam &EMGO Institute for Health and Care Research, VU University &VU Medical Center, Amsterdam 1081 BT, The Netherlands
| | | | - Nic J A van der Wee
- Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands
| | - Marie-Jose van Tol
- Neuroimaging Centre, University of Groningen, University Medical Center Groningen, Groningen 9713 AW, The Netherlands
| | - Dick J Veltman
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam 1081 HL, The Netherlands
| | - Thomas H Wassink
- Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
| | - Eric Westman
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm SE-141 83, Sweden
| | - Ronald H Zielke
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland 21201, USA
| | - Alan B Zonderman
- Behavioral Epidemiology Section, National Institute on Aging Intramural Research Program, Baltimore, Maryland 20892, USA
| | - David G Ashbrook
- Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK
| | - Reinmar Hager
- Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK
| | - Lu Lu
- 1] Center for Integrative and Translational Genomics, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. [2] Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. [3] Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College of Nantong University, Nantong 226001, China
| | - Francis J McMahon
- Human Genetics Branch and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, Bethesda, Maryland 20892, USA
| | - Derek W Morris
- 1] Neuropsychiatric Genetics Research Group and Department of Psychiatry, Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 2, Ireland. [2] Cognitive Genetics and Therapy Group, School of Psychology &Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland
| | - Robert W Williams
- 1] Center for Integrative and Translational Genomics, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. [2] Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
| | - Han G Brunner
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands. [3] Department of Clinical Genetics, Maastricht University Medical Center, Maastricht 6200 MD, The Netherlands
| | - Randy L Buckner
- 1] Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [2] Department of Psychology, Center for Brain Science, Harvard University, Boston, Massachusetts 02138, USA
| | - Jan K Buitelaar
- 1] Department of Cognitive Neuroscience, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands. [3] Karakter Child and Adolescent Psychiatry, Radboud university medical center, Nijmegen 6500 HB, The Netherlands
| | - Wiepke Cahn
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Vince D Calhoun
- 1] The Mind Research Network &LBERI, Albuquerque, New Mexico 87106, USA. [2] Department of ECE, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Gianpiero L Cavalleri
- Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA
| | - Benedicto Crespo-Facorro
- 1] Department of Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander 39008, Spain. [2] Cibersam (Centro Investigación Biomédica en Red Salud Mental), Madrid 28029, Spain
| | - Anders M Dale
- 1] Center for Translational Imaging and Personalized Medicine, University of California, San Diego, California 92093, USA. [2] Departments of Neurosciences, Radiology, Psychiatry, and Cognitive Science, University of California, San Diego, California 92093, USA
| | - Gareth E Davies
- Avera Institute for Human Genetics, Sioux Falls, South Dakota, 57108, USA
| | - Norman Delanty
- 1] Molecular and Cellular Therapeutics, The Royal College of Surgeons, Dublin 2, Ireland. [2] Neurology Division, Beaumont Hospital, Dublin 9, Ireland
| | - Chantal Depondt
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, Brussels 1070, Belgium
| | - Srdjan Djurovic
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] Department of Medical Genetics, Oslo University Hospital, Oslo 0450, Norway
| | - Wayne C Drevets
- 1] Human Genetics Branch and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, Bethesda, Maryland 20892, USA. [2] Janssen Research &Development, Johnson &Johnson, Titusville, New Jersey 08560, USA
| | - Thomas Espeseth
- 1] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway. [2] Department of Psychology, University of Oslo, Oslo 0373, Norway
| | - Randy L Gollub
- 1] Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [2] The Athinoula A.Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. [3] Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Beng-Choon Ho
- Department of Psychiatry, University of Iowa, Iowa City, Iowa 52242, USA
| | - Wolfgang Hoffmann
- 1] German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald 17487, Germany. [2] Institute for Community Medicine, University Medicine Greifswald, Greifswald D-17475, Germany
| | - Norbert Hosten
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald 17475, Germany
| | - René S Kahn
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Stephanie Le Hellard
- 1] NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway. [2] Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway
| | - Andreas Meyer-Lindenberg
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim 68159, Germany
| | - Bertram Müller-Myhsok
- 1] Max Planck Institute of Psychiatry, Munich 80804, Germany. [2] Munich Cluster for Systems Neurology (SyNergy), Munich 81377, Germany. [3] University of Liverpool, Institute of Translational Medicine, Liverpool L69 3BX, UK
| | - Matthias Nauck
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald 17475, Germany
| | - Lars Nyberg
- Umeå Centre for Functional Brain Imaging (UFBI), Umeå University, Umeå 901 87, Sweden
| | - Massimo Pandolfo
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, Brussels 1070, Belgium
| | - Brenda W J H Penninx
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam 1081 HL, The Netherlands
| | - Joshua L Roffman
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA
| | - Sanjay M Sisodiya
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, London WC1N 3BG, UK
| | - Jordan W Smoller
- 1] Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [2] Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. [3] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts 02141, USA. [4] Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Hans van Bokhoven
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Neeltje E M van Haren
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald D-17475, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin 10117, Germany
| | - Michael W Weiner
- Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center, University of California, San Francisco, California 94121, USA
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia
| | - Tonya White
- 1] Department of Child and Adolescent Psychiatry, Erasmus University Medical Centre, Rotterdam 3000 CB, The Netherlands. [2] Department of Radiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands
| | - Ingrid Agartz
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] Department of Psychiatric Research and Development, Diakonhjemmet Hospital, Oslo 0319, Norway. [3] Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm SE-171 76, Sweden
| | - Ole A Andreassen
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0424, Norway
| | - John Blangero
- 1] Texas Biomedical Research Institute, San Antonio, Texas 78245, USA. [2] University of Texas Health Science Center, San Antonio, Texas 78229, USA
| | - Dorret I Boomsma
- Biological Psychology, Neuroscience Campus Amsterdam &EMGO Institute for Health and Care Research, VU University &VU Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Rachel M Brouwer
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Dara M Cannon
- 1] Human Genetics Branch and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, Bethesda, Maryland 20892, USA. [2] Clinical Neuroimaging Laboratory, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Mark R Cookson
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Eco J C de Geus
- Biological Psychology, Neuroscience Campus Amsterdam &EMGO Institute for Health and Care Research, VU University &VU Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Gary Donohoe
- 1] Neuropsychiatric Genetics Research Group and Department of Psychiatry, Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 2, Ireland. [2] Cognitive Genetics and Therapy Group, School of Psychology &Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland
| | - Guillén Fernández
- 1] Department of Cognitive Neuroscience, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Simon E Fisher
- 1] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands. [2] Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525 XD, The Netherlands
| | - Clyde Francks
- 1] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands. [2] Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen 6525 XD, The Netherlands
| | - David C Glahn
- 1] Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06511, USA. [2] Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut 06106, USA
| | - Hans J Grabe
- 1] Department of Psychiatry, University Medicine Greifswald, Greifswald 17489, Germany. [2] Department of Psychiatry and Psychotherapy, HELIOS Hospital Stralsund 18435, Germany
| | - Oliver Gruber
- 1] Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Goettingen 37075, Germany. [2] Max Planck Institute of Psychiatry, Munich 80804, Germany
| | - John Hardy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Ryota Hashimoto
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka 565-0871, Japan
| | - Hilleke E Hulshoff Pol
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands
| | - Erik G Jönsson
- 1] NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo N-0316, Norway. [2] Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm SE-171 76, Sweden
| | | | - Simon Lovestone
- 1] Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK. [2] NIHR Dementia Biomedical Research Unit, King's College London, London SE5 8AF, UK
| | - Venkata S Mattay
- 1] Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA. [2] Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Patrizia Mecocci
- Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Perugia 06156, Italy
| | - Colm McDonald
- Clinical Neuroimaging Laboratory, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Andrew M McIntosh
- 1] Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK. [2] Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Roel A Ophoff
- 1] Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands. [2] Center for Neurobehavioral Genetics, University of California, Los Angeles, California 90095, USA
| | - Tomas Paus
- 1] Rotman Research Institute, University of Toronto, Toronto M6A 2E1, Canada. [2] Departments of Psychology and Psychiatry, University of Toronto, Toronto M5T 1R8, Canada
| | - Zdenka Pausova
- 1] The Hospital for Sick Children, University of Toronto, Toronto M5G 1X8, Canada. [2] Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto M5S 3E2, Canada
| | - Mina Ryten
- 1] Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. [2] Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
| | - Perminder S Sachdev
- 1] Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia. [2] Neuropsychiatric Institute, Prince of Wales Hospital, Sydney 2031, Australia
| | - Andrew J Saykin
- 1] Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [2] Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. [3] Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin 10117, Germany
| | - Andy Simmons
- 1] Department of Neuroimaging, Institute of Psychiatry, King's College London, London SE5 8AF, UK. [2] Biomedical Research Centre for Mental Health, King's College London, London SE5 8AF, UK. [3] Biomedical Research Unit for Dementia, King's College London, London SE5 8AF, UK
| | - Andrew Singleton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Hilkka Soininen
- 1] Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio FI-70211, Finland. [2] Neurocentre Neurology, Kuopio University Hospital, Kuopio FI-70211, Finland
| | - Joanna M Wardlaw
- 1] Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK. [2] Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK. [3] Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK. [4] Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Michael E Weale
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
| | - Daniel R Weinberger
- 1] Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA. [2] Departments of Psychiatry, Neurology, Neuroscience and the Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Hieab H H Adams
- 1] Department of Radiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands. [2] Department of Epidemiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands
| | - Lenore J Launer
- Laboratory of Epidemiology and Population Sciences, Intramural Research Program, National Institute on Aging, Bethesda, Maryland 20892, USA
| | - Stephan Seiler
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Graz 8010, Austria
| | - Reinhold Schmidt
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Graz 8010, Austria
| | - Ganesh Chauhan
- INSERM U897, University of Bordeaux, Bordeaux 33076, France
| | - Claudia L Satizabal
- 1] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118, USA. [2] Framingham Heart Study, Framingham, Massachusetts 01702, USA
| | - James T Becker
- 1] Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA. [2] Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA. [3] Department of Psychology, Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - Lisa Yanek
- General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
| | - Sven J van der Lee
- Department of Epidemiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands
| | - Maritza Ebling
- 1] The Athinoula A.Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. [2] Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
| | - Bruce Fischl
- 1] The Athinoula A.Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. [2] Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. [3] Computer Science and AI Lab, Massachusetts Institute of Technology, Boston, Massachusetts 02141, USA
| | - W T Longstreth
- Department of Neurology University of Washington, Seattle, Washington 98195, USA
| | - Douglas Greve
- 1] The Athinoula A.Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. [2] Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
| | - Helena Schmidt
- Institute of Molecular Biology and Biochemistry, Medical University Graz, 8010 Graz, Austria
| | - Paul Nyquist
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Louis N Vinke
- 1] The Athinoula A.Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. [2] Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
| | - Cornelia M van Duijn
- Department of Epidemiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands
| | - Luting Xue
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118, USA
| | - Bernard Mazoyer
- Groupe d'Imagerie Neurofonctionnelle, UMR5296 CNRS, CEA and University of Bordeaux, Bordeaux 33076, France
| | - Joshua C Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington 98101, USA
| | - Vilmundur Gudnason
- Icelandic Heart Association, University of Iceland, Faculty of Medicine, Reykjavik 101, Iceland
| | - Sudha Seshadri
- 1] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118, USA. [2] Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Arfan Ikram
- 1] Department of Radiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands. [2] Department of Epidemiology, Erasmus University Medical Centre, Rotterdam 3015 CN, The Netherlands
| | | | | | | | | | | | | | - Margaret J Wright
- 1] QIMR Berghofer Medical Research Institute, Brisbane 4006, Australia. [2] School of Psychology, University of Queensland, Brisbane 4072, Australia
| | - Gunter Schumann
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Barbara Franke
- 1] Department of Human Genetics, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [2] Department of Psychiatry, Radboud university medical center, Nijmegen 6500 HB, The Netherlands. [3] Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6500 GL, The Netherlands
| | - Paul M Thompson
- Imaging Genetics Center, Institute for Neuroimaging &Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90292, USA
| | - Sarah E Medland
- QIMR Berghofer Medical Research Institute, Brisbane 4006, Australia
| |
Collapse
|
35
|
Glahn DC, Williams JT, McKay DR, Knowles EE, Sprooten E, Mathias SR, Curran JE, Kent JW, Carless MA, Göring HHH, Dyer TD, Woolsey MD, Winkler AM, Olvera RL, Kochunov P, Fox PT, Duggirala R, Almasy L, Blangero J. Discovering schizophrenia endophenotypes in randomly ascertained pedigrees. Biol Psychiatry 2015; 77:75-83. [PMID: 25168609 PMCID: PMC4261014 DOI: 10.1016/j.biopsych.2014.06.027] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2014] [Revised: 06/08/2014] [Accepted: 06/15/2014] [Indexed: 01/21/2023]
Abstract
BACKGROUND Although case-control approaches are beginning to disentangle schizophrenia's complex polygenic burden, other methods will likely be necessary to fully identify and characterize risk genes. Endophenotypes, traits genetically correlated with an illness, can help characterize the impact of risk genes by providing genetically relevant traits that are more tractable than the behavioral symptoms that classify mental illness. Here, we present an analytic approach for discovering and empirically validating endophenotypes in extended pedigrees with very few affected individuals. Our approach indexes each family member's risk as a function of shared genetic kinship with an affected individual, often referred to as the coefficient of relatedness. To demonstrate the utility of this approach, we search for neurocognitive and neuroanatomic endophenotypes for schizophrenia in large unselected multigenerational pedigrees. METHODS A fixed-effects test within the variance component framework was performed on neurocognitive and cortical surface area traits in 1606 Mexican-American individuals from large, randomly ascertained extended pedigrees who participated in the Genetics of Brain Structure and Function study. As affecteds were excluded from analyses, results were not influenced by disease state or medication usage. RESULTS Despite having sampled just 6 individuals with schizophrenia, our sample provided 233 individuals at various levels of genetic risk for the disorder. We identified three neurocognitive measures (digit-symbol substitution, facial memory, and emotion recognition) and six medial temporal and prefrontal cortical surfaces associated with liability for schizophrenia. CONCLUSIONS With our novel analytic approach, one can discover and rank endophenotypes for schizophrenia, or any heritable disease, in randomly ascertained pedigrees.
Collapse
Affiliation(s)
- David C Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut.
| | - Jeff T Williams
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - D Reese McKay
- Department of Psychiatry, Yale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut
| | - Emma E Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut
| | - Emma Sprooten
- Department of Psychiatry, Yale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut
| | - Samuel R Mathias
- Department of Psychiatry, Yale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - Melanie A Carless
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - Harald H H Göring
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - Thomas D Dyer
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - Mary D Woolsey
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, Texas
| | - Anderson M Winkler
- Centre for Functional MRI of the Brain, University of Oxford, Oxford, United Kingdom
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, Texas
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, Texas; State Key Laboratory for Brain and Cognitive Sciences, University of Hong Kong
| | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas
| |
Collapse
|
36
|
McKay DR, Knowles EEM, Winkler AAM, Sprooten E, Kochunov P, Olvera RL, Curran JE, Kent JW, Carless MA, Göring HHH, Dyer TD, Duggirala R, Almasy L, Fox PT, Blangero J, Glahn DC. Influence of age, sex and genetic factors on the human brain. Brain Imaging Behav 2014; 8:143-52. [PMID: 24297733 DOI: 10.1007/s11682-013-9277-5] [Citation(s) in RCA: 63] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
We report effects of age, age(2), sex and additive genetic factors on variability in gray matter thickness, surface area and white matter integrity in 1,010 subjects from the Genetics of Brain Structure and Function Study. Age was more strongly associated with gray matter thickness and fractional anisotropy of water diffusion in white matter tracts, while sex was more strongly associated with gray matter surface area. Widespread heritability of neuroanatomic traits was observed, suggesting that brain structure is under strong genetic control. Furthermore, our findings indicate that neuroimaging-based measurements of cerebral variability are sensitive to genetic mediation. Fundamental studies of genetic influence on the brain will help inform gene discovery initiatives in both clinical and normative samples.
Collapse
Affiliation(s)
- D Reese McKay
- Department of Psychiatry, Yale University School of Medicine, 300 George St., New Haven, CT, 06511, USA,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Dougherty DM, Charles NE, Mathias CW, Ryan SR, Olvera RL, Liang Y, Acheson A. Delay discounting differentiates pre-adolescents at high and low risk for substance use disorders based on family history. Drug Alcohol Depend 2014; 143:105-11. [PMID: 25096271 PMCID: PMC4161645 DOI: 10.1016/j.drugalcdep.2014.07.012] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2014] [Revised: 07/10/2014] [Accepted: 07/10/2014] [Indexed: 11/25/2022]
Abstract
BACKGROUND Youth with family histories of substance use disorders (FH+) are at increased risk for developing substance use disorders relative to those without such histories (FH-). FH+ individuals show deficits in impulse control that parallel those in individuals with substance use disorders. Elucidating how specific components of impulse control are affected in FH+ pre-adolescents would advance our understanding of how deficits in impulse control relate to risk of substance use disorders. METHOD A total of 386 children (305 FH+, 81 FH-; ages 10-12) with no histories of regular alcohol or other drug use were compared on measures of delay discounting (Kirby), response inhibition (GoStop Impulsivity Paradigm), and response initiation impulsivity (Immediate Memory Task). The independent associations between these three behavioral measures of impulsivity and FH status were analyzed using logistic regression models. RESULT FH+ pre-adolescents performed more impulsively on measures of delay discounting and response inhibition impulsivity, but there were no significant group differences on response initiation impulsivity. When the behavioral impulsivity measures were examined simultaneously, delay discounting was most robustly associated with FH status. CONCLUSIONS These results identify deficits in impulse control present in FH+ pre-adolescents before the onset of regular substance use, and suggest that increased delay discounting may be an important behavioral phenotype for pre-adolescents at risk for substance use involvement.
Collapse
Affiliation(s)
- Donald M. Dougherty
- Department of Psychiatry The University of Texas Health Science Center at San Antonio San Antonio, TX,Corresponding author: Donald M. Dougherty Professor and Director of the Division of Neurobehavioral Research Department of Psychiatry, the University of Texas Health Science Center at San Antonio NRLC MC 7793 7703 Floyd Curl Drive San Antonio, TX 78229-3900, USA Phone (210) 567-2745; Fax (210) 567-2748
| | - Nora E. Charles
- Department of Psychiatry The University of Texas Health Science Center at San Antonio San Antonio, TX
| | - Charles W. Mathias
- Department of Psychiatry The University of Texas Health Science Center at San Antonio San Antonio, TX
| | - Stacy R. Ryan
- Department of Psychiatry The University of Texas Health Science Center at San Antonio San Antonio, TX
| | - Rene L. Olvera
- Department of Psychiatry The University of Texas Health Science Center at San Antonio San Antonio, TX
| | - Yuanyuan Liang
- Department of Epidemiology and Biostatistics The University of Texas Health Science Center at San Antonio San Antonio, TX
| | - Ashley Acheson
- Department of Psychiatry The University of Texas Health Science Center at San Antonio San Antonio, TX,Research Imaging Institute The University of Texas Health Science Center at San Antonio San Antonio, TX
| |
Collapse
|
38
|
Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, Almasy L, Almeida J, Alpert K, Andreasen NC, Andreassen OA, Apostolova LG, Appel K, Armstrong NJ, Aribisala B, Bastin ME, Bauer M, Bearden CE, Bergmann Ø, Binder EB, Blangero J, Bockholt HJ, Bøen E, Bois C, Boomsma DI, Booth T, Bowman IJ, Bralten J, Brouwer RM, Brunner HG, Brohawn DG, Buckner RL, Buitelaar J, Bulayeva K, Bustillo JR, Calhoun VD, Cannon DM, Cantor RM, Carless MA, Caseras X, Cavalleri GL, Chakravarty MM, Chang KD, Ching CRK, Christoforou A, Cichon S, Clark VP, Conrod P, Coppola G, Crespo-Facorro B, Curran JE, Czisch M, Deary IJ, de Geus EJC, den Braber A, Delvecchio G, Depondt C, de Haan L, de Zubicaray GI, Dima D, Dimitrova R, Djurovic S, Dong H, Donohoe G, Duggirala R, Dyer TD, Ehrlich S, Ekman CJ, Elvsåshagen T, Emsell L, Erk S, Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher SE, Foroud T, Fox PT, Francks C, Frangou S, Frey EM, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn DC, Godlewska B, Goldstein RZ, Gollub RL, Grabe HJ, Grimm O, Gruber O, Guadalupe T, Gur RE, Gur RC, Göring HHH, Hagenaars S, Hajek T, Hall GB, Hall J, Hardy J, Hartman CA, Hass J, Hatton SN, Haukvik UK, Hegenscheid K, Heinz A, Hickie IB, Ho BC, Hoehn D, Hoekstra PJ, Hollinshead M, Holmes AJ, Homuth G, Hoogman M, Hong LE, Hosten N, Hottenga JJ, Hulshoff Pol HE, Hwang KS, Jack CR, Jenkinson M, Johnston C, Jönsson EG, Kahn RS, Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok JBJ, Lagopoulos J, Laje G, Landen M, Landman BA, Lauriello J, Lawrie SM, Lee PH, Le Hellard S, Lemaître H, Leonardo CD, Li CS, Liberg B, Liewald DC, Liu X, Lopez LM, Loth E, Lourdusamy A, Luciano M, Macciardi F, Machielsen MWJ, MacQueen GM, Malt UF, Mandl R, Manoach DS, Martinot JL, Matarin M, Mather KA, Mattheisen M, Mattingsdal M, Meyer-Lindenberg A, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery GW, Morris DW, Moses EK, Mueller BA, Muñoz Maniega S, Mühleisen TW, Müller-Myhsok B, Mwangi B, Nauck M, Nho K, Nichols TE, Nilsson LG, Nugent AC, Nyberg L, Olvera RL, Oosterlaan J, Ophoff RA, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z, Pearlson GD, Penninx BW, Peterson CP, Pfennig A, Phillips M, Pike GB, Poline JB, Potkin SG, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher SL, Roffman JL, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose EJ, Royle NA, Rujescu D, Ryten M, Sachdev PS, Salami A, Satterthwaite TD, Savitz J, Saykin AJ, Scanlon C, Schmaal L, Schnack HG, Schork AJ, Schulz SC, Schür R, Seidman L, Shen L, Shoemaker JM, Simmons A, Sisodiya SM, Smith C, Smoller JW, Soares JC, Sponheim SR, Sprooten E, Starr JM, Steen VM, Strakowski S, Strike L, Sussmann J, Sämann PG, Teumer A, Toga AW, Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee NJ, van Eijk K, van Erp TGM, van Haren NEM, van ‘t Ent D, van Tol MJ, Valdés Hernández MC, Veltman DJ, Versace A, Völzke H, Walker R, Walter H, Wang L, Wardlaw JM, Weale ME, Weiner MW, Wen W, Westlye LT, Whalley HC, Whelan CD, White T, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Zilles D, Zwiers MP, Thalamuthu A, Schofield PR, Freimer NB, Lawrence NS, Drevets W. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014; 8:153-82. [PMID: 24399358 PMCID: PMC4008818 DOI: 10.1007/s11682-013-9269-5] [Citation(s) in RCA: 491] [Impact Index Per Article: 49.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.
Collapse
Affiliation(s)
- Paul M. Thompson
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Jason L. Stein
- Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095 Netherlands
| | - Sarah E. Medland
- QIMR Berghofer Medical Research Institute, Quantitative Genetics, Brisbane, Australia
| | - Derrek P. Hibar
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Alejandro Arias Vasquez
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Miguel E. Renteria
- QIMR Berghofer Medical Research Institute, Quantitative Genetics, Brisbane, Australia
| | - Roberto Toro
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 ‘Genes, synapses and cognition’, Institut Pasteur, Paris, France
- Sorbonne Paris Cité, Human Genetics and Cognitive Functions, Université Paris Diderot, Paris, France
| | - Neda Jahanshad
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Gunter Schumann
- MRC-SGDP Centre, Institute of Psychiatry, King’s College London, London, UK
| | - Barbara Franke
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Margaret J. Wright
- QIMR Berghofer Medical Research Institute, Neuroimaging Genetics, Brisbane, Australia
| | - Nicholas G. Martin
- QIMR Berghofer Medical Research Institute, Genetic Epidemiology, Brisbane, Australia
| | - Ingrid Agartz
- Department of Clinical Neuroscience, Karolinska Institutet and Hospital, Stockholm, Sweden
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Martin Alda
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia Canada
| | - Saud Alhusaini
- Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland
- Department of Neurology and NeuroSurgery, McGill University, Montreal, Quebec Canada
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | - Jorge Almeida
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA USA
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia Canada
| | - Kathryn Alpert
- Departments of Psychiatry and Behavioral Sciences and Radiology, Northwestern University, Chicago, IL USA
| | | | - Ole A. Andreassen
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Liana G. Apostolova
- Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA
| | - Katja Appel
- Department of Psychiatry and Psychotherapy, University of Greifswald, Greifswald, Germany
| | - Nicola J. Armstrong
- School of Mathematics and Statistics, University of Sydney, Sydney, Australia
| | - Benjamin Aribisala
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Scotland, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
| | - Mark E. Bastin
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK
| | - Michael Bauer
- Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Dresden, Germany
| | - Carrie E. Bearden
- Department of Psychiatry and Biobehavioral Sciences and the Center for Neurobehavioral Genetics, The Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA USA
- Department of Psychology, UCLA, Los Angeles, CA USA
| | - Ørjan Bergmann
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | | | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | | | - Erlend Bøen
- Department of Psychosomatic Medicine, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Catherine Bois
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Dorret I. Boomsma
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
| | - Tom Booth
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
| | - Ian J. Bowman
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Janita Bralten
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands
| | - Rachel M. Brouwer
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Han G. Brunner
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - David G. Brohawn
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA USA
| | - Randy L. Buckner
- Massachusetts General Hospital, Boston, MA USA
- Center for Brain Science, Harvard University, Cambridge, MA USA
| | - Jan Buitelaar
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands
| | - Kazima Bulayeva
- N. I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkin str. 3, Moscow, 119991 Russia
| | - Juan R. Bustillo
- Department of Psychiatry, University of New Mexico, Albuquerque, NM USA
| | - Vince D. Calhoun
- The Mind Research Network, Albuquerque, NM USA
- Department of Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM USA
| | - Dara M. Cannon
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, University Road, Galway, Ireland
| | - Rita M. Cantor
- Center for Neurobehavioral Genetics, University of California, Los Angeles, CA USA
| | - Melanie A. Carless
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | - Xavier Caseras
- MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
| | - Gianpiero L. Cavalleri
- Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - M. Mallar Chakravarty
- The Kimel Family Translational Imaging Genetics Laboratory, The Centre for Addiction and Mental Health, Toronto, ON Canada
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON Canada
| | - Kiki D. Chang
- Department of Psychiatry, Stanford University School of Medicine, Stanford, CA USA
| | - Christopher R. K. Ching
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Andrea Christoforou
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Department of Clinical Medicine, University of Bergen, Bergen, Norway
| | - Sven Cichon
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Institute for Neuroscience and Medicine (INM-1), Centre Jülich, Jülich, Germany
- Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
| | - Vincent P. Clark
- Department of Psychology, University of New Mexico, Albuquerque, NM USA
| | - Patricia Conrod
- CHU Sainte Justine University Hospital Research Center, Montreal, QC Canada
- Addictions Department, King’s Health Partners, King’s College London, London, UK
| | - Giovanni Coppola
- Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA
- Department of Psychiatry and Biobehavioral Sciences and the Center for Neurobehavioral Genetics, The Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA USA
| | - Benedicto Crespo-Facorro
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IFIMAV, School of Medicine, University of Cantabria, Santander, Spain
- Centro Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain
| | - Joanne E. Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | | | - Ian J. Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
| | - Eco J. C. de Geus
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
| | - Anouk den Braber
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
| | | | - Chantal Depondt
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, 1070 Brussels, Belgium
| | - Lieuwe de Haan
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
| | | | - Danai Dima
- MRC-SGDP Centre, Institute of Psychiatry, King’s College London, London, UK
| | - Rali Dimitrova
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Srdjan Djurovic
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
| | - Hongwei Dong
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Gary Donohoe
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, University Road, Galway, Ireland
- Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute for Molecular Medicine and Trinity College Institute for Neuroscience, Trinity College, Dublin, Ireland
| | | | - Thomas D. Dyer
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | - Stefan Ehrlich
- MGH/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA USA
- University Hospital C.G. Carus, Department of Child and Adolescent Psychiatry, Dresden University of Technology, Dresden, Germany
| | - Carl Johan Ekman
- Department of Clinical Neuroscience, Karolinska Institutet and Hospital, Stockholm, Sweden
| | - Torbjørn Elvsåshagen
- Department of Psychosomatic Medicine, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Louise Emsell
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, University Road, Galway, Ireland
| | - Susanne Erk
- Department of Psychiatry and Psychotherapy, Charité, Universitaetsmedizin Berlin, Charitè Campus Mitte, Berlin, Germany
| | - Thomas Espeseth
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Psychology, University of Oslo, Oslo, Norway
| | - Jesen Fagerness
- Massachusetts General Hospital, Boston, MA USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA USA
| | - Scott Fears
- Center for Neurobehavioral Genetics, University of California, Los Angeles, CA USA
- Department of Psychiatry and Biobehavioral Sciences and the Center for Neurobehavioral Genetics, The Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA USA
| | - Iryna Fedko
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
| | - Guillén Fernández
- Department of Cognitive Neuroscience, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands
| | - Simon E. Fisher
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
- Max Planck Institute for Psycholinguistics, 6500 AH Nijmegen, The Netherlands
| | - Tatiana Foroud
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN USA
| | - Peter T. Fox
- Research Imaging Institute, UT Health Science Center at San Antonio, San Antonio, TX USA
- South Texas Veterans Health Care Center, San Antonio, TX USA
- South Texas Veterans Health Care System, San Antonio, TX USA
| | - Clyde Francks
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
- Max Planck Institute for Psycholinguistics, 6500 AH Nijmegen, The Netherlands
| | - Sophia Frangou
- Psychosis Research Unit, Mount Sinai School of Medicine, New York, NY USA
| | - Eva Maria Frey
- Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany
| | - Thomas Frodl
- Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany
- Department of Psychiatry and Psychotherapy, Trinity College, University Dublin, Dublin, Germany
| | - Vincent Frouin
- Neurospin, Commissariat à l’Energie Atomique, Paris, France
| | - Hugh Garavan
- Department of Psychiatry, UHC University of Vermont, Bergen, VT USA
| | - Sudheer Giddaluru
- Dr Einar Martens Research Group for Biological Psychiatry, Department of Clinical Medicine, University of Bergen, Bergen, Norway
- Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - David C. Glahn
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT USA
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
| | | | - Rita Z. Goldstein
- Department of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Randy L. Gollub
- MGH/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
| | - Hans J. Grabe
- Department of Psychiatry and Psychotherapy, University of Greifswald, Greifswald, Germany
- German Center for Neurodegenerative Diseases (DZNE), University of Greifswald, Greifswald, Germany
- Department of Psychiatry and Psychotherapy, Helios Hospital Stralsund, Stralsund, Germany
| | - Oliver Grimm
- Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - Oliver Gruber
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry, Georg August University, Goettingen, Germany
| | - Tulio Guadalupe
- Max Planck Institute for Psycholinguistics, 6500 AH Nijmegen, The Netherlands
| | - Raquel E. Gur
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA USA
| | - Ruben C. Gur
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA USA
- Philadelphia Veterans Administration Medical Center, Philadelphia, PA USA
| | - Harald H. H. Göring
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | - Saskia Hagenaars
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Tomas Hajek
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia Canada
| | - Geoffrey B. Hall
- Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, ON Canada
| | - Jeremy Hall
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
- Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
| | - John Hardy
- Department of Molecular Neuroscience, UCL Institute, London, UK
| | - Catharina A. Hartman
- Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Johanna Hass
- University Hospital C.G. Carus, Department of Child and Adolescent Psychiatry, Dresden University of Technology, Dresden, Germany
| | - Sean N. Hatton
- The Brain and Mind Research Institute, University of Sydney, Sydney, Australia
| | - Unn K. Haukvik
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
| | - Katrin Hegenscheid
- Department of Diagnostic Radiology and Neuroradiology, University of Greifswald, Greifswald, Germany
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Charité, Universitaetsmedizin Berlin, Charitè Campus Mitte, Berlin, Germany
| | - Ian B. Hickie
- The Brain and Mind Research Institute, University of Sydney, Sydney, Australia
| | - Beng-Choon Ho
- Department of Psychiatry, University of Iowa, Iowa City, IA USA
| | - David Hoehn
- Max Planck Institute of Psychiatry, Munich, Germany
| | - Pieter J. Hoekstra
- Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Marisa Hollinshead
- MGH/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA USA
- Center for Brain Science, Harvard University, Cambridge, MA USA
| | - Avram J. Holmes
- MGH/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
- Center for Brain Science, Harvard University, Cambridge, MA USA
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany
| | - Martine Hoogman
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - L. Elliot Hong
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD USA
| | - Norbert Hosten
- Department of Diagnostic Radiology and Neuroradiology, University of Greifswald, Greifswald, Germany
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
| | | | - Kristy S. Hwang
- Oakland University William Beaumont School of Medicine, Rochester Hills, MI USA
| | | | - Mark Jenkinson
- Oxford Centre for Functional MRI of the Brain (FMRIB), University of Oxford, Oxford, UK
| | - Caroline Johnston
- National Institute of Health Research Biomedical Research Centre for Mental Health, South London and Maudsley National Health Service Foundation Trust, London, UK
- King’s College London, Institute of Psychiatry, London, UK
| | - Erik G. Jönsson
- Department of Clinical Neuroscience, Karolinska Institutet and Hospital, Stockholm, Sweden
| | - René S. Kahn
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Dalia Kasperaviciute
- Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK
| | - Sinead Kelly
- Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute for Molecular Medicine and Trinity College Institute for Neuroscience, Trinity College, Dublin, Ireland
| | - Sungeun Kim
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN USA
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD USA
| | - Laura Koenders
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
| | - Bernd Krämer
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry, Georg August University, Goettingen, Germany
| | - John B. J. Kwok
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, University of New South Wales, Sydney, Australia
- School of Medical Sciences, University of New South Wales, Kensington, NSW Australia
| | - Jim Lagopoulos
- The Brain and Mind Research Institute, University of Sydney, Sydney, Australia
| | - Gonzalo Laje
- Maryland Institute for Neuroscience and Development (MIND), Chevy Chase, MD USA
| | - Mikael Landen
- Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | | | - John Lauriello
- Department of Psychiatry, University of Missouri, Columbia, MO USA
| | - Stephen M. Lawrie
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Phil H. Lee
- Broad Institute of Harvard and MIT, Boston, MA USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA USA
| | - Stephanie Le Hellard
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Department of Clinical Medicine, University of Bergen, Bergen, Norway
| | - Herve Lemaître
- Research Unit 1000, Neuroimaging and Psychiatry, INSERM-CEA-Faculté de Médecine Paris Sud University-Paris Descartes University, Maison de Solenn Paris, SHFJ Orsay, Paris, France
| | - Cassandra D. Leonardo
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Chiang-shan Li
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
| | - Benny Liberg
- Department of Clinical Neuroscience, Karolinska Institutet and Hospital, Stockholm, Sweden
| | - David C. Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
| | - Xinmin Liu
- Mood and Anxiety Disorders Section, Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Dept of Health and Human Services, Bethesda, MD USA
- Taub Institute for Research on Alzheimer Disease and the Aging Brain, Columbia University Medical Center, New York, NY USA
| | - Lorna M. Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Department of Psychology, The University of Edinburgh, Edinburgh, UK
| | - Eva Loth
- MRC-SGDP Centre, Institute of Psychiatry, King’s College London, London, UK
| | | | - Michelle Luciano
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
| | - Fabio Macciardi
- Department of Psychiatry and Human Behavior, University of California, Irvine, CA USA
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
| | | | - Glenda M. MacQueen
- Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta Canada
| | - Ulrik F. Malt
- Department of Psychosomatic Medicine, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - René Mandl
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Dara S. Manoach
- MGH/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
| | - Jean-Luc Martinot
- Research Unit 1000, Neuroimaging and Psychiatry, INSERM-CEA-Faculté de Médecine Paris Sud University-Paris Descartes University, Maison de Solenn Paris, SHFJ Orsay, Paris, France
| | - Mar Matarin
- Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK
| | - Karen A. Mather
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, Sydney, New South Wales Australia
| | - Manuel Mattheisen
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- Department of Genomic Mathematics, University of Bonn, Bonn, Germany
| | - Morten Mattingsdal
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Research Unit, Sorlandet Hospital HF, Kristiansand, Norway
| | - Andreas Meyer-Lindenberg
- Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - Colm McDonald
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, University Road, Galway, Ireland
| | - Andrew M. McIntosh
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Francis J. McMahon
- Mood and Anxiety Disorders Section, Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Dept of Health and Human Services, Bethesda, MD USA
| | - Katie L. McMahon
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
| | | | - Ingrid Melle
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Yuri Milaneschi
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
- Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, MD USA
| | - Sebastian Mohnke
- Department of Psychiatry and Psychotherapy, Charité, Universitaetsmedizin Berlin, Charitè Campus Mitte, Berlin, Germany
| | - Grant W. Montgomery
- Genetic Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia
| | - Derek W. Morris
- Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute for Molecular Medicine and Trinity College Institute for Neuroscience, Trinity College, Dublin, Ireland
| | - Eric K. Moses
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
- Centre for Genetic Origins of Health and Disease, The University of Western Australia, Perth, Australia
| | - Bryon A. Mueller
- Department of Psychiatry, University of Minnesota Medical Center, Minneapolis, MN USA
| | - Susana Muñoz Maniega
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Scotland, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
| | - Thomas W. Mühleisen
- Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Institute for Neuroscience and Medicine (INM-1), Centre Jülich, Jülich, Germany
| | - Bertram Müller-Myhsok
- Max Planck Institute of Psychiatry, Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Benson Mwangi
- Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston, TX USA
- University of Texas Center of Excellence on Mood Disorders, Department of Psychiatry, UT Medical School, Houston, TX USA
| | - Matthias Nauck
- Institute of Clinical Chemistry and Laboratory Medicine, University of Greifswald, Greifswald, Germany
| | - Kwangsik Nho
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN USA
| | - Thomas E. Nichols
- Department of Statistics & Warwick Manufacturing Group, The University of Warwick, Coventry, UK
| | - Lars-Göran Nilsson
- Department of Psychology, Stockholm University, Stockholm, Sweden
- Stockholm Brain Institute, Stockholm, Sweden
| | - Allison C. Nugent
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD USA
| | - Lars Nyberg
- Umeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden
| | - Rene L. Olvera
- Department of Psychiatry, UT Health Science Center at San Antonio, San Antonio, TX USA
| | - Jaap Oosterlaan
- Department of Clinical Neuropsychology, VU University, Amsterdam, The Netherlands
| | - Roel A. Ophoff
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
- Center for Neurobehavioral Genetics, University of California, Los Angeles, CA USA
| | - Massimo Pandolfo
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, 1070 Brussels, Belgium
| | | | - Martina Papmeyer
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Tomas Paus
- Rotman Research Institute, University of Toronto, Toronto, ON Canada
| | - Zdenka Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, ON Canada
| | - Godfrey D. Pearlson
- Department of Psychiatry and Psychotherapy, University of Greifswald, Greifswald, Germany
- Departments of Psychiatry and Neurobiology, Yale University School of Medicine, New Haven, CT USA
| | - Brenda W. Penninx
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
| | - Charles P. Peterson
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
| | - Andrea Pfennig
- Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Dresden, Germany
| | - Mary Phillips
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA USA
| | - G. Bruce Pike
- Department of Radiology, University of Calgary, Calgary, Alberta Canada
| | - Jean-Baptiste Poline
- Hellen Wills Neuroscience Institute, Brain Imaging Center, University of California at Berkeley, Berkeley, CA USA
| | - Steven G. Potkin
- Department of Psychiatry and Human Behavior, University of California, Irvine, CA USA
| | - Benno Pütz
- Max Planck Institute of Psychiatry, Munich, Germany
| | - Adaikalavan Ramasamy
- Department of Medical and Molecular Genetics, King’s College London, London, UK
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Jerod Rasmussen
- Department of Psychiatry and Human Behavior, University of California, Irvine, CA USA
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - Mark Rijpkema
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Shannon L. Risacher
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN USA
| | - Joshua L. Roffman
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
| | - Roberto Roiz-Santiañez
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IFIMAV, School of Medicine, University of Cantabria, Santander, Spain
- Centro Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain
| | - Nina Romanczuk-Seiferth
- Department of Psychiatry and Psychotherapy, Charité, Universitaetsmedizin Berlin, Charitè Campus Mitte, Berlin, Germany
| | - Emma J. Rose
- Transdisciplinary and Translational Prevention Program, RTI International, Baltimore, MD USA
| | - Natalie A. Royle
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
| | - Dan Rujescu
- Department of Psychiatry, University of Halle, Halle, Germany
| | - Mina Ryten
- Department of Molecular Neuroscience, UCL Institute, London, UK
- Department of Medical and Molecular Genetics, King’s College London, London, UK
| | - Perminder S. Sachdev
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, Sydney, New South Wales Australia
- Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, New South Wales Australia
| | - Alireza Salami
- Umeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden
- Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
| | | | - Jonathan Savitz
- Laureate Institute for Brain Research, Tulsa, OK USA
- Faculty of Community Medicine, University of Tulsa, Tulsa, OK USA
| | - Andrew J. Saykin
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN USA
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN USA
| | - Cathy Scanlon
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, University Road, Galway, Ireland
| | - Lianne Schmaal
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
| | - Hugo G. Schnack
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | | | - S. Charles Schulz
- Department of Psychiatry, University of Minnesota Medical Center, Minneapolis, MN USA
| | - Remmelt Schür
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Larry Seidman
- Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA USA
- Department of Psychiatry, Harvard Medical School, Harvard University, Cambridge, MA USA
| | - Li Shen
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN USA
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN USA
| | | | - Andrew Simmons
- Department of Neuroimaging, Institute of Psychiatry, King’s College London, London, UK
- NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Trust and Institute of Psychiatry, King’s College London, London, UK
| | - Sanjay M. Sisodiya
- Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK
| | - Colin Smith
- Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK
| | - Jordan W. Smoller
- Broad Institute of Harvard and MIT, Boston, MA USA
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA USA
| | - Jair C. Soares
- Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston, TX USA
| | - Scott R. Sponheim
- Department of Psychiatry, University of Minnesota Medical Center, Minneapolis, MN USA
- Minneapolis VA Health Care System, Minneapolis, MN USA
| | - Emma Sprooten
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
| | - John M. Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK
| | - Vidar M. Steen
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Department of Clinical Medicine, University of Bergen, Bergen, Norway
| | - Stephen Strakowski
- Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH USA
| | - Lachlan Strike
- Genetic Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia
| | - Jessika Sussmann
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | | | - Alexander Teumer
- Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany
| | - Arthur W. Toga
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
| | - Diana Tordesillas-Gutierrez
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IFIMAV, School of Medicine, University of Cantabria, Santander, Spain
- Centro Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain
| | - Daniah Trabzuni
- Department of Molecular Neuroscience, UCL Institute, London, UK
- Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Sarah Trost
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry, Georg August University, Goettingen, Germany
| | - Jessica Turner
- The Mind Research Network, Albuquerque, NM USA
- Department of Psychology and Neuroscience Institute, Georgia State University, Atlanta, GA USA
| | | | - Nic J. van der Wee
- Department of Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands
| | - Kristel van Eijk
- Department of Psychiatry, Rudolf Magnus Institute, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Theo G. M. van Erp
- Department of Psychiatry and Human Behavior, University of California, Irvine, CA USA
| | | | - Dennis van ‘t Ent
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
| | - Marie-Jose van Tol
- Behavioural and Cognitive Neuroscience Neuroimaging Center, University Medical Center Groningen, Groningen, The Netherlands
| | - Maria C. Valdés Hernández
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
| | - Dick J. Veltman
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
| | - Amelia Versace
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA USA
| | - Henry Völzke
- Institute for Community Medicine, University of Greifswald, Greifswald, Germany
| | - Robert Walker
- Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Charité, Universitaetsmedizin Berlin, Charitè Campus Mitte, Berlin, Germany
- Berlin School of Mind and Brain, Humboldt University Berlin, Berlin, Germany
| | - Lei Wang
- Departments of Psychiatry and Behavioral Sciences and Radiology, Northwestern University, Chicago, IL USA
| | - Joanna M. Wardlaw
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Scotland, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
| | - Michael E. Weale
- Department of Medical and Molecular Genetics, King’s College London, London, UK
| | - Michael W. Weiner
- Departments of Radiology, Medicine, Psychiatry, University of California, San Francisco, CA USA
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, Sydney, New South Wales Australia
| | - Lars T. Westlye
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Psychology, University of Oslo, Oslo, Norway
| | - Heather C. Whalley
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Christopher D. Whelan
- Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Tonya White
- Department of Child and Adolescent Psychiatry, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Anderson M. Winkler
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
- Oxford Centre for Functional MRI of the Brain (FMRIB), University of Oxford, Oxford, UK
| | - Katharina Wittfeld
- German Center for Neurodegenerative Diseases (DZNE), University of Greifswald, Greifswald, Germany
| | - Girma Woldehawariat
- Mood and Anxiety Disorders Section, Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Dept of Health and Human Services, Bethesda, MD USA
| | | | - David Zilles
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry, Georg August University, Goettingen, Germany
| | - Marcel P. Zwiers
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
- Radboud University NijmegenDonders Institute for Brain, Cognition and Behavior, Centre for Cognitive Neuroimaging, Nijmegen, The Netherlands
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing, Psychiatry, University of New South Wales (UNSW), Sydney, Australia
| | - Peter R. Schofield
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, University of New South Wales, Sydney, Australia
| | - Nelson B. Freimer
- Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA USA
| | | | - Wayne Drevets
- Janssen Research & Development, of Johnson & Johnson, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560 USA
| | - the Alzheimer’s Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group
- Imaging Genetics Center, Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, 2001 N. Soto Street, Los Angeles, CA 90033 USA
- Genetic Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia
- Broad Institute of Harvard and MIT, Boston, MA USA
- Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 ‘Genes, synapses and cognition’, Institut Pasteur, Paris, France
- Sorbonne Paris Cité, Human Genetics and Cognitive Functions, Université Paris Diderot, Paris, France
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT USA
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT USA
- Department of Psychiatry and Psychotherapy, University of Greifswald, Greifswald, Germany
- NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX USA
- Department of Psychiatry, University of Iowa, Iowa City, IA USA
- Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Scotland, UK
- Brain Research Imaging Centre, The University of Edinburgh, Edinburgh, UK
- Max Planck Institute of Psychiatry, Munich, Germany
- The Mind Research Network, Albuquerque, NM USA
- Department of Biological Psychology, VU University, Neuroscience Campus, Amsterdam, The Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands
- Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
- Massachusetts General Hospital, Boston, MA USA
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands
- N. I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkin str. 3, Moscow, 119991 Russia
- Department of Psychiatry, University of New Mexico, Albuquerque, NM USA
- Department of Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM USA
- Clinical Neuroimaging Laboratory, National University of Ireland Galway, University Road, Galway, Ireland
- Center for Neurobehavioral Genetics, University of California, Los Angeles, CA USA
- The Kimel Family Translational Imaging Genetics Laboratory, The Centre for Addiction and Mental Health, Toronto, ON Canada
- Dr Einar Martens Research Group for Biological Psychiatry, Department of Clinical Medicine, University of Bergen, Bergen, Norway
- Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
- Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Institute for Neuroscience and Medicine (INM-1), Centre Jülich, Jülich, Germany
- Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
- Department of Psychiatry, Marqués de Valdecilla University Hospital, IFIMAV, School of Medicine, University of Cantabria, Santander, Spain
- Centro Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain
- Department of Psychology, The University of Edinburgh, Edinburgh, UK
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, 1070 Brussels, Belgium
- School of Psychology, University of Queensland, Brisbane, QLD 4072 Australia
- Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
- Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute for Molecular Medicine and Trinity College Institute for Neuroscience, Trinity College, Dublin, Ireland
- MGH/HMS Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA USA
- University Hospital C.G. Carus, Department of Child and Adolescent Psychiatry, Dresden University of Technology, Dresden, Germany
- Department of Psychiatry and Psychotherapy, Charité, Universitaetsmedizin Berlin, Charitè Campus Mitte, Berlin, Germany
- Department of Psychology, University of Oslo, Oslo, Norway
- Max Planck Institute for Psycholinguistics, 6500 AH Nijmegen, The Netherlands
- Research Imaging Institute, UT Health Science Center at San Antonio, San Antonio, TX USA
- South Texas Veterans Health Care Center, San Antonio, TX USA
- Neurospin, Commissariat à l’Energie Atomique, Paris, France
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA USA
- German Center for Neurodegenerative Diseases (DZNE), University of Greifswald, Greifswald, Germany
- Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
- Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry, Georg August University, Goettingen, Germany
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
- Department of Molecular Neuroscience, UCL Institute, London, UK
- Department of Diagnostic Radiology and Neuroradiology, University of Greifswald, Greifswald, Germany
- Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany
- National Institute of Health Research Biomedical Research Centre for Mental Health, South London and Maudsley National Health Service Foundation Trust, London, UK
- King’s College London, Institute of Psychiatry, London, UK
- Department of Clinical Neuroscience, Karolinska Institutet and Hospital, Stockholm, Sweden
- Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN USA
- Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN USA
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA USA
- Mood and Anxiety Disorders Section, Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Dept of Health and Human Services, Bethesda, MD USA
- Taub Institute for Research on Alzheimer Disease and the Aging Brain, Columbia University Medical Center, New York, NY USA
- MRC-SGDP Centre, Institute of Psychiatry, King’s College London, London, UK
- Department of Psychiatry and Human Behavior, University of California, Irvine, CA USA
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, Sydney, New South Wales Australia
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- Department of Genomic Mathematics, University of Bonn, Bonn, Germany
- Research Unit, Sorlandet Hospital HF, Kristiansand, Norway
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
- Ludwig-Maximilians-University (LMU), Munich, Germany
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
- Centre for Genetic Origins of Health and Disease, The University of Western Australia, Perth, Australia
- Department of Psychiatry, University of Minnesota Medical Center, Minneapolis, MN USA
- Department of Psychology, Stockholm University, Stockholm, Sweden
- Umeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden
- Department of Psychiatry, UT Health Science Center at San Antonio, San Antonio, TX USA
- Rotman Research Institute, University of Toronto, Toronto, ON Canada
- The Hospital for Sick Children, University of Toronto, Toronto, ON Canada
- Department of Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands
- Department of Medical and Molecular Genetics, King’s College London, London, UK
- Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, New South Wales Australia
- Laureate Institute for Brain Research, Tulsa, OK USA
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN USA
- Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA USA
- Department of Neuroimaging, Institute of Psychiatry, King’s College London, London, UK
- NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Trust and Institute of Psychiatry, King’s College London, London, UK
- Minneapolis VA Health Care System, Minneapolis, MN USA
- Behavioural and Cognitive Neuroscience Neuroimaging Center, University Medical Center Groningen, Groningen, The Netherlands
- Institute for Community Medicine, University of Greifswald, Greifswald, Germany
- Departments of Radiology, Medicine, Psychiatry, University of California, San Francisco, CA USA
- Department of Child and Adolescent Psychiatry, Erasmus University Medical Centre, Rotterdam, The Netherlands
- Radboud University NijmegenDonders Institute for Brain, Cognition and Behavior, Centre for Cognitive Neuroimaging, Nijmegen, The Netherlands
- Oxford Centre for Functional MRI of the Brain (FMRIB), University of Oxford, Oxford, UK
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, University of New South Wales, Sydney, Australia
- Center for Brain Science, Harvard University, Cambridge, MA USA
- The Brain and Mind Research Institute, University of Sydney, Sydney, Australia
- Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK
- Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK
- Department Early Psychosis, Academic Psychiatric Centre, AMC, UvA, Amsterdam, Netherlands
- EMGO + Institute, VU University Medical Center, Amsterdam, The Netherlands
- Cognitive Science Department, UC San Diego, La Jolla, CA USA
- Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
- Department of Clinical Neuropsychology, VU University, Amsterdam, The Netherlands
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Neurology and NeuroSurgery, McGill University, Montreal, Quebec Canada
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA USA
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia Canada
- Department of Psychiatry, University of Oxford, Oxford, UK
- Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston, TX USA
- University of Texas Center of Excellence on Mood Disorders, Department of Psychiatry, UT Medical School, Houston, TX USA
- Department of Psychiatry and Biobehavioral Sciences and the Center for Neurobehavioral Genetics, The Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA USA
- Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, MD USA
- Berlin School of Mind and Brain, Humboldt University Berlin, Berlin, Germany
- Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Dresden, Germany
- Department of Psychiatry and Psychotherapy, Helios Hospital Stralsund, Stralsund, Germany
- Department of Psychiatry, Harvard Medical School, Harvard University, Cambridge, MA USA
- Department of Psychiatry, Brown University, Providence, RI USA
- Psychosis Research Unit, Mount Sinai School of Medicine, New York, NY USA
- Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH USA
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA USA
- Philadelphia Veterans Administration Medical Center, Philadelphia, PA USA
- Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany
- Department of Psychiatry and Psychotherapy, Trinity College, University Dublin, Dublin, Germany
- Stockholm Brain Institute, Stockholm, Sweden
- Department of Psychology and Neuroscience Institute, Georgia State University, Atlanta, GA USA
- Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, ON Canada
- Department of Psychology, University of New Mexico, Albuquerque, NM USA
- Department of Psychosomatic Medicine, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN USA
- Department of Radiology, University of Calgary, Calgary, Alberta Canada
- Department of Statistics & Warwick Manufacturing Group, The University of Warwick, Coventry, UK
- Departments of Psychiatry and Behavioral Sciences and Radiology, Northwestern University, Chicago, IL USA
- Electrical Engineering, Vanderbilt University, Nashville, TN USA
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD USA
- Institute of Clinical Chemistry and Laboratory Medicine, University of Greifswald, Greifswald, Germany
- Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON Canada
- Faculty of Community Medicine, University of Tulsa, Tulsa, OK USA
- Maryland Institute for Neuroscience and Development (MIND), Chevy Chase, MD USA
- Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta Canada
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK
- Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
- School of Medical Sciences, University of New South Wales, Kensington, NSW Australia
- Oakland University William Beaumont School of Medicine, Rochester Hills, MI USA
- CHU Sainte Justine University Hospital Research Center, Montreal, QC Canada
- Addictions Department, King’s Health Partners, King’s College London, London, UK
- South Texas Veterans Health Care System, San Antonio, TX USA
- Research Unit 1000, Neuroimaging and Psychiatry, INSERM-CEA-Faculté de Médecine Paris Sud University-Paris Descartes University, Maison de Solenn Paris, SHFJ Orsay, Paris, France
- Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
- Department of Psychiatry, Rudolf Magnus Institute, University Medical Center Utrecht, Utrecht, The Netherlands
- School of Mathematics and Statistics, University of Sydney, Sydney, Australia
- School of Medicine, University of Nottingham, Nottingham, UK
- Department of Psychiatry, Stanford University School of Medicine, Stanford, CA USA
- Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
- Hellen Wills Neuroscience Institute, Brain Imaging Center, University of California at Berkeley, Berkeley, CA USA
- Department of Psychiatry, University of Missouri, Columbia, MO USA
- Departments of Psychiatry and Neurobiology, Yale University School of Medicine, New Haven, CT USA
- Mayo Clinic, Rochester, MN USA
- Transdisciplinary and Translational Prevention Program, RTI International, Baltimore, MD USA
- Department of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Psychiatry, University of Halle, Halle, Germany
- Advanced Biomedical Informatics Group, llc., Iowa City, IA USA
- Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095 Netherlands
- QIMR Berghofer Medical Research Institute, Quantitative Genetics, Brisbane, Australia
- QIMR Berghofer Medical Research Institute, Genetic Epidemiology, Brisbane, Australia
- QIMR Berghofer Medical Research Institute, Neuroimaging Genetics, Brisbane, Australia
- Department of Psychology, UCLA, Los Angeles, CA USA
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
- Dr. E. Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
- Department of Psychiatry, UHC University of Vermont, Bergen, VT USA
- Centre for Healthy Brain Ageing, Psychiatry, University of New South Wales (UNSW), Sydney, Australia
- Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA USA
- School of Psychology, University of Exeter, Exeter, UK
- Janssen Research & Development, of Johnson & Johnson, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560 USA
| |
Collapse
|
39
|
Chouinard-Decorte F, McKay DR, Reid A, Khundrakpam B, Zhao L, Karama S, Rioux P, Sprooten E, Knowles E, Kent JW, Curran JE, Göring HHH, Dyer TD, Olvera RL, Kochunov P, Duggirala R, Fox PT, Almasy L, Blangero J, Bellec P, Evans AC, Glahn DC. Heritable changes in regional cortical thickness with age. Brain Imaging Behav 2014; 8:208-16. [PMID: 24752552 PMCID: PMC4205107 DOI: 10.1007/s11682-014-9296-x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2013] [Accepted: 02/05/2014] [Indexed: 01/15/2023]
Abstract
It is now well established that regional indices of brain structure such as cortical thickness, surface area or grey matter volume exhibit spatially variable patterns of heritability. However, a recent study found these patterns to change with age during development, a result supported by gene expression studies. Changes in heritability have not been investigated in adulthood so far and could have important implications in the study of heritability and genetic correlations in the brain as well as in the discovery of specific genes explaining them. Herein, we tested for genotype by age (G ×A) interactions, an extension of genotype by environment interactions, through adulthood and healthy aging in 902 subjects from the Genetics of Brain Structure (GOBS) study. A "jackknife" based method for the analysis of stable cortical thickness clusters (JASC) and scale selection is also introduced. Although additive genetic variance remained constant throughout adulthood, we found evidence for incomplete pleiotropy across age in the cortical thickness of paralimbic and parieto-temporal areas. This suggests that different genetic factors account for cortical thickness heritability at different ages in these regions.
Collapse
Affiliation(s)
- Francois Chouinard-Decorte
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
| | - D. Reese McKay
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06571, USA
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106, USA
| | - Andrew Reid
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
| | - Budhachandra Khundrakpam
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
| | - Lu Zhao
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
| | - Sherif Karama
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
- Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC H4H 1R2, Canada
| | - Pierre Rioux
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
| | - Emma Sprooten
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06571, USA
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106, USA
| | - Emma Knowles
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06571, USA
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106, USA
| | - Jack W. Kent
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - Joanne E. Curran
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - Harald H. H. Göring
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - Thomas D. Dyer
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - Rene L. Olvera
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06571, USA
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106, USA
- Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC H4H 1R2, Canada
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 2120, USA
- Research Imaging Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, TX 78229, USA
- Geriatric Institute Research Center, Université de Montréal, Montréal, QC H3W 1W5, Canada
- Department of Psychiatry, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX H3W 1W5, USA
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 2120, USA
| | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - Peter T. Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, TX 78229, USA
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX 78245, USA
| | - Pierre Bellec
- Geriatric Institute Research Center, Université de Montréal, Montréal, QC H3W 1W5, Canada
| | - Alan C. Evans
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada
| | - David C. Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06571, USA
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106, USA
| |
Collapse
|
40
|
Sprooten E, Knowles EE, McKay DR, Göring HH, Curran JE, Kent JW, Carless MA, Dyer TD, Drigalenko EI, Olvera RL, Fox PT, Almasy L, Duggirala R, Kochunov P, Blangero J, Glahn DC. Common genetic variants and gene expression associated with white matter microstructure in the human brain. Neuroimage 2014; 97:252-61. [PMID: 24736177 DOI: 10.1016/j.neuroimage.2014.04.021] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2014] [Revised: 03/29/2014] [Accepted: 04/07/2014] [Indexed: 12/29/2022] Open
Abstract
Identifying genes that contribute to white matter microstructure should provide insights into the neurobiological processes that regulate white matter development, plasticity and pathology. We detected five significant SNPs using genome-wide association analysis on a global measure of fractional anisotropy in 776 individuals from large extended pedigrees. Genetic correlations and genome-wide association results indicated that the genetic signal was largely homogeneous across white matter regions. Using RNA transcripts derived from lymphocytes in the same individuals, we identified two genes (GNA13 and CCDC91) that are likely to be cis-regulated by top SNPs, and whose expression levels were also genetically correlated with fractional anisotropy. A transcript of HTR7 was phenotypically associated with FA, and was associated with an intronic genome-wide significant SNP. These results encourage further research in the mechanisms by which GNA13, HTR7 and CCDC91 influence brain structure, and emphasize a role for g-protein signaling in the development and maintenance of white matter microstructure in health and disease.
Collapse
Affiliation(s)
- Emma Sprooten
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, CT, USA.
| | - Emma E Knowles
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, CT, USA
| | - D Reese McKay
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, CT, USA
| | - Harald H Göring
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Melanie A Carless
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Thomas D Dyer
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Eugene I Drigalenko
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Drive, San Antonio, TX, USA; South Texas Veterans Health System, 7400 Merton Minter, San Antonio, TX 78229, USA
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, USA
| | - David C Glahn
- Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, CT, USA
| |
Collapse
|
41
|
Jahanshad N, Kochunov PV, Sprooten E, Mandl RC, Nichols TE, Almasy L, Blangero J, Brouwer RM, Curran JE, de Zubicaray GI, Duggirala R, Fox PT, Hong LE, Landman BA, Martin NG, McMahon KL, Medland SE, Mitchell BD, Olvera RL, Peterson CP, Starr JM, Sussmann JE, Toga AW, Wardlaw JM, Wright MJ, Pol HEH, Bastin ME, McIntosh AM, Deary IJ, Thompson PM, Glahn DC. Corrigendum to “Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: A pilot project of the ENIGMA–DTI working group” [NeuroImage 81 (2013) 455–469]. Neuroimage 2014. [DOI: 10.1016/j.neuroimage.2013.12.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
42
|
Kochunov P, Jahanshad N, Sprooten E, Nichols TE, Mandl RC, Almasy L, Booth T, Brouwer RM, Curran JE, de Zubicaray GI, Dimitrova R, Duggirala R, Fox PT, Hong LE, Landman BA, Lemaitre H, Lopez LM, Martin NG, McMahon KL, Mitchell BD, Olvera RL, Peterson CP, Starr JM, Sussmann JE, Toga AW, Wardlaw JM, Wright MJ, Wright SN, Bastin ME, McIntosh AM, Boomsma DI, Kahn RS, den Braber A, de Geus EJC, Deary IJ, Hulshoff Pol HE, Williamson DE, Blangero J, van 't Ent D, Thompson PM, Glahn DC. Multi-site study of additive genetic effects on fractional anisotropy of cerebral white matter: Comparing meta and megaanalytical approaches for data pooling. Neuroimage 2014; 95:136-50. [PMID: 24657781 DOI: 10.1016/j.neuroimage.2014.03.033] [Citation(s) in RCA: 99] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2013] [Revised: 02/21/2014] [Accepted: 03/04/2014] [Indexed: 01/25/2023] Open
Abstract
Combining datasets across independent studies can boost statistical power by increasing the numbers of observations and can achieve more accurate estimates of effect sizes. This is especially important for genetic studies where a large number of observations are required to obtain sufficient power to detect and replicate genetic effects. There is a need to develop and evaluate methods for joint-analytical analyses of rich datasets collected in imaging genetics studies. The ENIGMA-DTI consortium is developing and evaluating approaches for obtaining pooled estimates of heritability through meta-and mega-genetic analytical approaches, to estimate the general additive genetic contributions to the intersubject variance in fractional anisotropy (FA) measured from diffusion tensor imaging (DTI). We used the ENIGMA-DTI data harmonization protocol for uniform processing of DTI data from multiple sites. We evaluated this protocol in five family-based cohorts providing data from a total of 2248 children and adults (ages: 9-85) collected with various imaging protocols. We used the imaging genetics analysis tool, SOLAR-Eclipse, to combine twin and family data from Dutch, Australian and Mexican-American cohorts into one large "mega-family". We showed that heritability estimates may vary from one cohort to another. We used two meta-analytical (the sample-size and standard-error weighted) approaches and a mega-genetic analysis to calculate heritability estimates across-population. We performed leave-one-out analysis of the joint estimates of heritability, removing a different cohort each time to understand the estimate variability. Overall, meta- and mega-genetic analyses of heritability produced robust estimates of heritability.
Collapse
Affiliation(s)
- Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
| | - Neda Jahanshad
- Imaging Genetics Center, Institute of Neuroimaging and Informatics, Department of Neurology, Keck School of Medicine of USC, Los Angeles, CA, USA
| | - Emma Sprooten
- Olin Neuropsychiatry Research Center in the Institute of Living, Yale University School of Medicine, New Haven, CT, USA
| | - Thomas E Nichols
- Department of Statistics & Warwick Manufacturing Group, The University of Warwick, Coventry, UK; Oxford Centre for Functional MRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, Oxford University, UK
| | - René C Mandl
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Tom Booth
- Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK
| | - Rachel M Brouwer
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | | | - Rali Dimitrova
- Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
| | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
| | - L Elliot Hong
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Bennett A Landman
- Department of Electrical Engineering, Vanderbilt University, Nashville, TN, USA
| | - Hervé Lemaitre
- U1000 Research Unit Neuroimaging and Psychiatry, INSERM-CEA-Faculté de Médecine Paris-Sud, Orsay, France
| | - Lorna M Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK
| | | | - Katie L McMahon
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
| | - Braxton D Mitchell
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
| | - Charles P Peterson
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - John M Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK; Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK
| | - Jessika E Sussmann
- Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
| | - Arthur W Toga
- Imaging Genetics Center, Institute of Neuroimaging and Informatics, Department of Neurology, Keck School of Medicine of USC, Los Angeles, CA, USA
| | - Joanna M Wardlaw
- Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK; Brain Research Imaging Centre, Centre for Clinical Brain Sciences, University of Edinburgh, UK
| | | | - Susan N Wright
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Mark E Bastin
- Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK; Brain Research Imaging Centre, Centre for Clinical Brain Sciences, University of Edinburgh, UK
| | - Andrew M McIntosh
- Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
| | - Dorret I Boomsma
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - René S Kahn
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Anouk den Braber
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Eco J C de Geus
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK
| | - Hilleke E Hulshoff Pol
- Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Douglas E Williamson
- Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Dennis van 't Ent
- Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Paul M Thompson
- Imaging Genetics Center, Institute of Neuroimaging and Informatics, Department of Neurology, Keck School of Medicine of USC, Los Angeles, CA, USA; Department of Neurology, Pediatrics, Engineering, Psychiatry, Radiology, & Ophthalmology, University of Southern California, Los Angeles, CA, USA
| | - David C Glahn
- Olin Neuropsychiatry Research Center in the Institute of Living, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
43
|
Curran JE, McKay DR, Winkler AM, Olvera RL, Carless MA, Dyer TD, Kent JW, Kochunov P, Sprooten E, Knowles EE, Comuzzie AG, Fox PT, Almasy L, Duggirala R, Blangero J, Glahn DC. Identification of pleiotropic genetic effects on obesity and brain anatomy. Hum Hered 2013; 75:136-43. [PMID: 24081229 DOI: 10.1159/000353953] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND/AIMS Obesity is a major contributor to the global burden of chronic disease and disability, though current knowledge of causal biologic underpinnings is lacking. Through the regulation of energy homeostasis and interactions with adiposity and gut signals, the brain is thought to play a significant role in the development of this disorder. While neuroanatomical variation has been associated with obesity, it is unclear if this relationship is influenced by common genetic mechanisms. In this study, we sought genetic components that influence both brain anatomy and body mass index (BMI) to provide further insight into the role of the brain in energy homeostasis and obesity. METHODS MRI images of brain anatomy were acquired in 839 Mexican American individuals from large extended pedigrees. Bivariate linkage and quantitative analyses were performed in SOLAR. RESULTS Genetic factors associated with an increased BMI were also associated with a reduced cortical surface area and subcortical volume. We identified two genome-wide quantitative trait loci that influenced BMI and the ventral diencephalon volume, and BMI and the supramarginal gyrus surface area, respectively. CONCLUSIONS This study represents the first genetic analysis seeking evidence of pleiotropic effects acting on both brain anatomy and BMI. Our results suggest that a region on chromosome 17 contributes to the development of obesity, potentially through leptin-induced signaling in the hypothalamus, and that a region on chromosome 3 appears to jointly influence the food-related reward circuitry and the supramarginal gyrus.
Collapse
Affiliation(s)
- Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Tex., USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Kochunov P, Charlesworth J, Winkler A, Hong LE, Nichols TE, Curran JE, Sprooten E, Jahanshad N, Thompson PM, Johnson MP, Kent JW, Landman BA, Mitchell B, Cole SA, Dyer TD, Moses EK, Goring HHH, Almasy L, Duggirala R, Olvera RL, Glahn DC, Blangero J. Transcriptomics of cortical gray matter thickness decline during normal aging. Neuroimage 2013; 82:273-83. [PMID: 23707588 DOI: 10.1016/j.neuroimage.2013.05.066] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2013] [Revised: 04/23/2013] [Accepted: 05/14/2013] [Indexed: 01/27/2023] Open
Abstract
INTRODUCTION We performed a whole-transcriptome correlation analysis, followed by the pathway enrichment and testing of innate immune response pathway analyses to evaluate the hypothesis that transcriptional activity can predict cortical gray matter thickness (GMT) variability during normal cerebral aging. METHODS Transcriptome and GMT data were available for 379 individuals (age range=28-85) community-dwelling members of large extended Mexican American families. Collection of transcriptome data preceded that of neuroimaging data by 17 years. Genome-wide gene transcriptome data consisted of 20,413 heritable lymphocytes-based transcripts. GMT measurements were performed from high-resolution (isotropic 800 μm) T1-weighted MRI. Transcriptome-wide and pathway enrichment analysis was used to classify genes correlated with GMT. Transcripts for sixty genes from seven innate immune pathways were tested as specific predictors of GMT variability. RESULTS Transcripts for eight genes (IGFBP3, LRRN3, CRIP2, SCD, IDS, TCF4, GATA3, and HN1) passed the transcriptome-wide significance threshold. Four orthogonal factors extracted from this set predicted 31.9% of the variability in the whole-brain and between 23.4 and 35% of regional GMT measurements. Pathway enrichment analysis identified six functional categories including cellular proliferation, aggregation, differentiation, viral infection, and metabolism. The integrin signaling pathway was significantly (p<10(-6)) enriched with GMT. Finally, three innate immune pathways (complement signaling, toll-receptors and scavenger and immunoglobulins) were significantly associated with GMT. CONCLUSION Expression activity for the genes that regulate cellular proliferation, adhesion, differentiation and inflammation can explain a significant proportion of individual variability in cortical GMT. Our findings suggest that normal cerebral aging is the product of a progressive decline in regenerative capacity and increased neuroinflammation.
Collapse
Affiliation(s)
- P Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Zappitelli MC, Bordin IA, Hatch JP, Caetano SC, Zunta-Soares G, Olvera RL, Soares JC. Temperament and character traits in children and adolescents with major depressive disorder: a case-control study. Compr Psychiatry 2013; 54:346-53. [PMID: 23218681 DOI: 10.1016/j.comppsych.2012.10.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 10/14/2012] [Accepted: 10/23/2012] [Indexed: 12/29/2022] Open
Abstract
OBJECTIVES To evaluate temperament and character traits using the Junior Temperament and Character Inventory (JTCI) in children and adolescents with major depressive disorder (MDD) in comparison with healthy control subjects (HC), and to verify if comorbidity with disruptive behavioral disorders and being currently depressed influence JTCI scores. METHODS A case-control study comprising 41 MDD children/adolescents matched to 40 HC by gender and age (8-17years). All participants were assessed diagnostically with the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime (K-SADS-PL). Temperament and character traits were measured with the parent and child versions of JTCI, and depression was evaluated with the Children's Depression Rating Scale (CDRS). RESULTS According to child and parent data, MDD subjects had significantly higher scores on harm avoidance and novelty seeking, and lower scores on reward dependence, persistence, self-directedness and cooperativeness compared with HC. According to parent data only, MDD subjects significantly differed from HC on self-transcendence (lower spirituality scores and higher fantasy scores). Comorbidity with disruptive behavioral disorders exerted influence on almost all dimensions, in general increasing the mean differences between MDD and HC subjects. Also, being currently depressed did not influence the results, except for reward dependence according to parent data. LIMITATIONS The cross-sectional nature of the study and its limited sample size. CONCLUSIONS MDD children/adolescents have a different temperament and character profile compared to HC subjects. This study supports previous findings of trait-like characteristics of harm avoidance and self-directedness.
Collapse
|
46
|
Jahanshad N, Kochunov PV, Sprooten E, Mandl RC, Nichols TE, Almasy L, Blangero J, Brouwer RM, Curran JE, de Zubicaray GI, Duggirala R, Fox PT, Hong LE, Landman BA, Martin NG, McMahon KL, Medland SE, Mitchell BD, Olvera RL, Peterson CP, Starr JM, Sussmann JE, Toga AW, Wardlaw JM, Wright MJ, Hulshoff Pol HE, Bastin ME, McIntosh AM, Deary IJ, Thompson PM, Glahn DC. Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage 2013; 81:455-469. [PMID: 23629049 DOI: 10.1016/j.neuroimage.2013.04.061] [Citation(s) in RCA: 283] [Impact Index Per Article: 25.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2013] [Revised: 03/28/2013] [Accepted: 04/10/2013] [Indexed: 10/26/2022] Open
Abstract
The ENIGMA (Enhancing NeuroImaging Genetics through Meta-Analysis) Consortium was set up to analyze brain measures and genotypes from multiple sites across the world to improve the power to detect genetic variants that influence the brain. Diffusion tensor imaging (DTI) yields quantitative measures sensitive to brain development and degeneration, and some common genetic variants may be associated with white matter integrity or connectivity. DTI measures, such as the fractional anisotropy (FA) of water diffusion, may be useful for identifying genetic variants that influence brain microstructure. However, genome-wide association studies (GWAS) require large populations to obtain sufficient power to detect and replicate significant effects, motivating a multi-site consortium effort. As part of an ENIGMA-DTI working group, we analyzed high-resolution FA images from multiple imaging sites across North America, Australia, and Europe, to address the challenge of harmonizing imaging data collected at multiple sites. Four hundred images of healthy adults aged 18-85 from four sites were used to create a template and corresponding skeletonized FA image as a common reference space. Using twin and pedigree samples of different ethnicities, we used our common template to evaluate the heritability of tract-derived FA measures. We show that our template is reliable for integrating multiple datasets by combining results through meta-analysis and unifying the data through exploratory mega-analyses. Our results may help prioritize regions of the FA map that are consistently influenced by additive genetic factors for future genetic discovery studies. Protocols and templates are publicly available at (http://enigma.loni.ucla.edu/ongoing/dti-working-group/).
Collapse
Affiliation(s)
- Neda Jahanshad
- Imaging Genetics Center, Laboratory of Neuro Imaging, UCLA School of Medicine, Los Angeles, CA, USA
| | - Peter V Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Emma Sprooten
- Olin Neuropsychiatry Research Center in the Institute of Living, Yale University School of Medicine, New Haven, CT, USA; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
| | - René C Mandl
- Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Thomas E Nichols
- Department of Statistics & Warwick Manufacturing Group, The University of Warwick, Coventry, UK; Oxford Centre for Functional MRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, Oxford University, UK
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Rachel M Brouwer
- Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | | | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, TX, USA; South Texas Veterans Administration Medical Center, San Antonio, TX, USA
| | - L Elliot Hong
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | | | | | - Katie L McMahon
- University of Queensland, Center for Advanced Imaging, Brisbane, Australia
| | - Sarah E Medland
- Queensland Institute of Medical Research, Brisbane, Australia
| | - Braxton D Mitchell
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Rene L Olvera
- Research Imaging Institute, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
| | - Charles P Peterson
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA
| | - John M Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
| | - Jessika E Sussmann
- Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
| | - Arthur W Toga
- Imaging Genetics Center, Laboratory of Neuro Imaging, UCLA School of Medicine, Los Angeles, CA, USA
| | - Joanna M Wardlaw
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK; Brain Research Imaging Centre, Division of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
| | | | - Hilleke E Hulshoff Pol
- Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Mark E Bastin
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK; Brain Research Imaging Centre, Division of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
| | - Andrew M McIntosh
- Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
| | - Paul M Thompson
- Imaging Genetics Center, Laboratory of Neuro Imaging, UCLA School of Medicine, Los Angeles, CA, USA.
| | - David C Glahn
- Olin Neuropsychiatry Research Center in the Institute of Living, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
47
|
Kochunov P, Glahn DC, Rowland LM, Olvera RL, Winkler A, Yang YH, Sampath H, Carpenter WT, Duggirala R, Curran J, Blangero J, Hong LE. Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression. Biol Psychiatry 2013; 73:482-91. [PMID: 23200529 PMCID: PMC3645491 DOI: 10.1016/j.biopsych.2012.10.002] [Citation(s) in RCA: 97] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2012] [Revised: 08/19/2012] [Accepted: 10/03/2012] [Indexed: 12/21/2022]
Abstract
BACKGROUND Elevated rate of aging-related biological and functional decline, termed "accelerated aging," is reported in patients with schizophrenia (SCZ) and major depressive disorder (MDD). We used diffusion tensor imaging derived fractional anisotropy (FA) as a biomarker of aging-related decline in white matter (WM) integrity to test the hypotheses of accelerated aging in SCZ and MDD. METHODS The SCZ cohort comprised 58 SCZ patients and 60 controls (aged 20-60 years). The MDD cohort comprised 136 MDD patients and 351 controls (aged 20-79 years). The main outcome measures were the diagnosis-by-age interaction on whole-brain-averaged WM FA values and FA values from 12 major WM tracts. RESULTS Diagnosis-by-age interaction for the whole-brain average FA was significant for the SCZ (p = .04) but not the MDD (p = .80) cohort. Diagnosis-by-age interaction was nominally significant (p<.05) for five WM tracts for SCZ and for none of the tracts in the MDD cohort. Tract-specific heterochronicity of the onset of age-related decline in SCZ demonstrated strong negative correlations with the age-of-peak myelination and the rates of age-related decline obtained from normative sample (r =-.61 and-.80, p<.05, respectively). No such trends existed for MDD cohort. CONCLUSIONS Cerebral WM showed accelerated aging in SCZ but not in MDD, suggesting some difference in the pathophysiology underlying their WM aging changes. Tract-specific heterochronicity of WM development modulated presentation of accelerated aging in SCZ: WM tracts that matured later in life appeared more sensitive to the pathophysiology of SCZ and demonstrated more susceptibility to disorder-related accelerated decline in FA values with age. This trend was not observed in MDD cohort.
Collapse
Affiliation(s)
- Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Kochunov P, Glahn DC, Hong LE, Lancaster J, Curran JE, Johnson MP, Winkler AM, Holcomb HH, Kent JW, Mitchell B, Kochunov V, Olvera RL, Cole SA, Dyer TD, Moses EK, Goring H, Almasy L, Duggirala R, Blangero J. P-selectin Expression Tracks Cerebral Atrophy in Mexican-Americans. Front Genet 2012; 3:65. [PMID: 22558002 PMCID: PMC3340599 DOI: 10.3389/fgene.2012.00065] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2011] [Accepted: 04/05/2012] [Indexed: 11/13/2022] Open
Abstract
Background and Purpose: We hypothesized that the P-selectin (SELP) gene, localized to a region on chromosome 1q24, pleiotropically contributes to increased blood pressure and cerebral atrophy. We tested this hypothesis by performing genetic correlation analyses for 13 mRNA gene expression measures from P-selectin and 11 other genes located in 1q24 region and three magnetic resonance imaging derived indices of cerebral integrity. Methods: The subject pool consisted of 369 (219F; aged 28–85, average = 47.1 ± 12.7 years) normally aging, community-dwelling members of large extended Mexican-American families. Genetic correlation analysis decomposed phenotypic correlation coefficients into genetic and environmental components among 13 leukocyte-based mRNA gene expressions and three whole-brain and regional measurements of cerebral integrity: cortical gray matter thickness, fractional anisotropy of cerebral white matter, and the volume of hyperintensive WM lesions. Results: From the 13 gene expressions, significant phenotypic correlations were only found for the P- and L-selectin expression levels. Increases in P-selectin expression levels tracked with decline in cerebral integrity while the opposite trend was observed for L-selectin expression. The correlations for the P-selectin expression were driven by shared genetic factors, while the correlations with L-selectin expression were due to shared environmental effects. Conclusion: This study demonstrated that P-selectin expression shared a significant variance with measurements of cerebral integrity and posits elevated P-selectin expression levels as a potential risk factor of hypertension-related cerebral atrophy.
Collapse
Affiliation(s)
- P Kochunov
- Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine Baltimore, MD, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Harzke AJ, Baillargeon J, Baillargeon G, Henry J, Olvera RL, Torrealday O, Penn JV, Parikh R. Prevalence of Psychiatric Disorders in the Texas Juvenile Correctional System. Journal of Correctional Health Care 2012; 18:143-57. [DOI: 10.1177/1078345811436000] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Amy Jo Harzke
- Division of Correctional Managed Care, University of Texas Medical Branch, Galveston, TX, USA
| | - Jacques Baillargeon
- Division of Correctional Managed Care, University of Texas Medical Branch, Galveston, TX, USA
| | - Gwen Baillargeon
- Division of Correctional Managed Care, University of Texas Medical Branch, Galveston, TX, USA
| | | | - Rene L. Olvera
- Division of Child and Adolescent Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA
| | - Ohiana Torrealday
- Division of Correctional Managed Care, University of Texas Medical Branch, Galveston, TX, USA
| | - Joseph V. Penn
- Division of Correctional Managed Care, University of Texas Medical Branch, Galveston, TX, USA
| | | |
Collapse
|
50
|
Glahn DC, Curran JE, Winkler AM, Carless MA, Kent JW, Charlesworth JC, Johnson MP, Göring HHH, Cole SA, Dyer TD, Moses EK, Olvera RL, Kochunov P, Duggirala R, Fox PT, Almasy L, Blangero J. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry 2012; 71:6-14. [PMID: 21982424 PMCID: PMC3230692 DOI: 10.1016/j.biopsych.2011.08.022] [Citation(s) in RCA: 135] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2010] [Revised: 08/24/2011] [Accepted: 08/25/2011] [Indexed: 11/26/2022]
Abstract
BACKGROUND Despite overwhelming evidence that major depression is highly heritable, recent studies have localized only a single depression-related locus reaching genome-wide significance and have yet to identify a causal gene. Focusing on family-based studies of quantitative intermediate phenotypes or endophenotypes, in tandem with studies of unrelated individuals using categorical diagnoses, should improve the likelihood of identifying major depression genes. However, there is currently no empirically derived statistically rigorous method for selecting optimal endophentypes for mental illnesses. Here, we describe the endophenotype ranking value, a new objective index of the genetic utility of endophenotypes for any heritable illness. METHODS Applying endophenotype ranking value analysis to a high-dimensional set of over 11,000 traits drawn from behavioral/neurocognitive, neuroanatomic, and transcriptomic phenotypic domains, we identified a set of objective endophenotypes for recurrent major depression in a sample of Mexican American individuals (n = 1122) from large randomly selected extended pedigrees. RESULTS Top-ranked endophenotypes included the Beck Depression Inventory, bilateral ventral diencephalon volume, and expression levels of the RNF123 transcript. To illustrate the utility of endophentypes in this context, each of these traits were utlized along with disease status in bivariate linkage analysis. A genome-wide significant quantitative trait locus was localized on chromsome 4p15 (logarithm of odds = 3.5) exhibiting pleiotropic effects on both the endophenotype (lymphocyte-derived expression levels of the RNF123 gene) and disease risk. CONCLUSIONS The wider use of quantitative endophenotypes, combined with unbiased methods for selecting among these measures, should spur new insights into the biological mechanisms that influence mental illnesses like major depression.
Collapse
Affiliation(s)
- David C Glahn
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, Hartford, CT 06106, USA.
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Anderson M Winkler
- Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, 200 Retreat Avenue, CT, 06106, USA,Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT, 06511, USA
| | - Melanie A Carless
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Jac C Charlesworth
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Matthew P Johnson
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Harald HH Göring
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Shelley A Cole
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Thomas D Dyer
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Eric K Moses
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Rene L Olvera
- Department of Psychiatry, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA
| | - Peter Kochunov
- Research Imaging Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, TX, 78229, USA
| | - Ravi Duggirala
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - Peter T Fox
- Research Imaging Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, TX, 78229, USA
| | - Laura Almasy
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, PO Box 760549, San Antonio, TX, 78245 USA
| |
Collapse
|